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I. ABSTRACT 
Acute kidney injury (AKI) is defined by the rapid loss of kidney function due to tissue 
damage. It affects 10-30 % of hospitalized patients and is independently associated with increased 
morbidity and mortality. Ischemia-reperfusion injury (IRI) is the most common pathoetiological 
mechanism of AKI, whereby tissue injury is mediated by reactive oxygen species. Ischemic AKI 
leads to the rapid upregulation of a transmembrane protein, kidney injury molecule-1 (KIM-1) on 
the apical membrane of proximal tubular epithelial cells (TECs). Previous work from our group 
and others demonstrated that the extracellular domain of KIM-1 specifically binds to 
phosphatidylserine on apoptotic cells, thereby transforming KIM-1-expressing TECs into semi-
professional phagocytes for apoptotic corpses. The pathophysiological role of KIM-1 in AKI and 
relevant signalling mechanisms have not yet been elucidated. Using an in vivo model of AKI in 
mice genetically deficient in Kim-1, we reveal that Kim-1 expression protects mice from tissue 
damage and renal dysfunction after AKI. To uncover the signalling pathways downstream of KIM-
1 in TECs, we performed protein-protein interaction studies to uncover two signalling partners, 
the alpha subunit of the heterotrimeric G12 protein (Gα12), and the dynein light chain protein 
(Tctex-1). We provide evidence that KIM-1 interacts with both Gα12 and Tctex-1, using co-
immunoprecipitation, GST-pull down and confocal microscopy co-localization studies. We show 
that KIM-1 upregulation during IRI suppresses endogenous Gα12 activation and down-stream 
effectors. Further, we reveal that KIM-1-inhibition of Gα12, and the down-stream mediator RhoA, 
are crucial for TEC-mediated clearance of apoptotic cells. Tctex-1 is bound to KIM-1 during the 
early stages of phagocytosis becoming dissociated at later stages. Here, siRNA mediated studies 
informed us that Tctex-1 expression is necessary for phagocytic uptake of apoptotic cells. Finally, 
given our data showing that TECs isolated from Kim-1-deficient mice were virtually incapable of 
phagocytosis, it can be inferred that our findings regarding Gα12 and Tctex-1 do not solely apply 
to phagocytosis by KIM-1, but to all other mechanisms of uptake of apoptotic cells by TECs. In 
summary, our results suggest an important protective role of KIM-1 in ischemic AKI that is 
mediated via non-phagocytic and phagocytic mechanisms. The work described in this thesis 
provides several novel mechanistic insights into the functional role of KIM-1 and suggest potential 
therapeutic targets for future development.  
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1.1. THE KIDNEY  
The kidney is one of the most important organs in the body, as it is responsible for filtering 
the body’s metabolic waste while retaining precious nutrients. Each kidney is made up of about 1 
million functional units, referred to as nephrons (Kurts et al., 2013). Structurally, each nephron 
consists of a glomerulus and a long tubular structure. The glomerulus is the filtration unit of the 
kidney and consists of fenestrated endothelial cells, a glomerular basement membrane, and visceral 
epithelial cells called podocytes, which collectively form the glomerular filtration barrier (Kurts 
et al., 2013). This barrier is highly selective, allowing only water and small molecules (less than 
60 kDa) to pass from the bloodstream into what is known as Bowman’s space that leads into the 
tubular lumen. The process of filtration of blood through the glomerulus is known as ultrafiltration 
or glomerular filtration, which is often quantified as the glomerular filtration rate or GFR.  A 
decrease in kidney function is defined by a reduction in the GFR. Changes in serum creatinine 
concentration, an inert metabolite that is filtered freely with no distal reabsorption and minimal 
tubular secretion, can be used to estimate the GFR (Bellomo et al., 2004).  
The tubule of the nephron consists of various differentiated segments: from proximal to 
distal these are the proximal convoluted tubule, the loop of Henle, the distal convoluted tubule, 
and the collecting duct. The collecting ducts ultimately lead to the renal pelvis where urine collects 
(Eckardt et al., 2013). The tubular lumen is surrounded by renal tubular epithelial cells (TECs). 
These TECs are responsible for reabsorbing the majority of filtered water, small proteins, amino 
acids, carbohydrates, electrolytes, and water soluble vitamins. Other organic molecules and drug 
metabolites are non-absorbed along with some water to form the urine. The secretory and 
reabsorptive function of TECs allow for tight regulation of plasma osmolality, blood pressure, 
acid-base and electrolytes balance. Distal parts of the tubule also partake in this process. In addition 
to the reuptake of filtered macromolecules, the tubular epithelium also plays a role in hormone 
homeostasis (Eckardt et al., 2013). The kidneys’ fibroblasts are also responsible for producing 
erythropoietin, a vital hormone that is induced in response to hypoxia and regulates erythropoiesis. 
Finally, the kidney produces the hormone renin, which induces angiotensin and aldosterone 
production to regulate electrolyte and acid-base balance and blood pressure. In summary, the 
kidneys play excretory, metabolic and endocrine functions that dictate homeostasis. Importantly, 
life cannot be sustained in the absence of functional kidneys and thus patients with end-stage 
kidney disease (ESRD) require some form of dialysis or kidney transplantation to sustain life.  
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The main cell type in the kidney is tubular epithelial cells (TECs), with the remainder 
consisting of endothelial cells, smooth muscle cells, podocytes, and various cells within the 
interstitium, such as resident innate immune cells and fibroblasts. Proximal TECs form a “leaky” 
epithelium due to the expression of pore-forming claudin proteins (Claudins 2 and 10) in the tight 
junctions (Muto et al., 2010). Proximal TECs also express abundant energy-dependent 
transporters, whose high energy demand is met by oxidative phosphorylation (Gstraunthaler et al., 
1985). This is a key feature that causes the proximal tubular region to be most susceptible to 
ischemic injury.  
 
1.2. ACUTE KIDNEY INJURY 
1.2.1. Definition  
Acute kidney injury (AKI), previously known as acute renal failure, is defined as the abrupt 
decrease in renal function over a period of hours to days, leading to the inability of the kidney to 
excrete waste products and maintain fluid and electrolyte homeostasis (Thadhani et al., 1996). 
However, a precise clinically diagnostic definition of AKI is still in development. Currently, most 
clinical definitions rely on serum creatinine, but newer definitions are being developed to identify 
early injury using biomarkers well before perturbations in serum creatinine are noticed (Kellum et 
al., 2002; Levey et al., 1988). To date, finding perfectly sensitive and specific markers for early 
AKI have been problematic, given the significant variation in etiology and patient populations 
affected. The first evidence-based consensus study to define AKI was done in 2004 (Bellomo et 
al., 2004; Kellum et al., 2002). It encompasses what is known as RIFLE criteria, which stands for 
three levels of increasing AKI severity (Risk, Injury, Failure), and outlines two outcome variables 
(Loss and End-stage) based on urine output and GFR level. The RIFLE criteria was later modified 
by the Acute Kidney Injury Network (AKIN) (Mehta et al., 2007) to improve sensitivity of AKI 
diagnosis (Akcan-Arikan et al., 2007; Mehta et al., 2007). In 2012, the Kidney Disease: Improving 
Global Outcomes group (KDIGO) released yet newer guidelines for diagnosing and staging AKI 
(Work et al., 2012) (Table 1.1).  
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Table 1. 1. The current staging of AKI as determined by the Kidney Disease: Improving 
Global Outcomes (KDIGO) foundation. 
Modified from source; Work, Kidney Disease: Improving Global Outcomes (KDIGO) Acute 
Kidney Injury, & Group. (2012). KDIGO Clinical Practice Guideline for Acute Kidney Injury. 
Kidney Int. Supplementary, 2(1), 138. 
 
Stage Serum Creatinine Urine Output 
1 1.5-1.9 times baseline OR,  
 ≥0.3 mg/dl (≥26.5 µmol/l) increase 
<0.5 ml/kg/h for 6-12 hours 
2 2.0-2.9 times baseline <0.5 ml/kg/h for ≥12 hours 
3 3.0 times beaseline OR, 
Increase in serum creatinine to ≥4.0 
mg/dl (≥353.6 µmol/l) OR, 
Initiation of renal replacement 
therapy OR, 
In patients <18 years, decrease in 
estimated GFR to <35 ml/min per 
1.73 m2 
<0.3 ml/kg/h for ≥24 hours OR, 
Anuria for ≥12 hours 
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1.2.2. Etiology 
Ischemia-reperfusion injury (IRI) and nephrotoxins are the most common causes of AKI 
in humans (Thadhani et al., 1996). IRI occurs with the significant reduction or cessation of blood 
flow (ischemia), resulting in immediate oxygen deprivation (hypoxia) and accumulation of toxic 
metabolic products, followed by restoration of blood flow (reperfusion) with production of reactive 
oxygen species (J. V. Bonventre et al., 2011). In patients, the reduction of blood flow is most 
commonly caused by low blood pressure (hypotension). Septic shock is the most common cause 
of AKI in hospitalized patients, accounting for >50 % of AKI cases in intensive care unit (ICU) 
patients (Hoste et al., 2007;Lopes et al., 2010; Uchino et al., 2005). Sepsis results in altered blood 
flow to vital organs including the kidneys, and is responsible for inadequate delivery of oxygen 
and metabolic substrates to cells. In this setting, ischemic AKI is exacerbated by the administration 
of vasoconstrictive drugs that are the cornerstone of treatment for septic shock (Sharfuddin et al., 
2011). Another common cause of ischemic AKI is cardiovascular surgery, where up to one fifth 
of patients will develop the condition (Pickering et al., 2015). Overall, ischemia is the major cause 
of AKI and can be caused by many specific conditions (Figure 1.1), and is influenced heavily by 
the health status of a patient or the existence of co-morbidities.  
Ischemic AKI can also occur due to secondary causes that influence systemic 
haemodynamics. Examples include cardiorenal syndrome, whereby a primary cardiac disorder 
compromises cardiac output and renal perfusion (McCullough et al., 2013; Ronco, 2010), and 
hepatorenal syndrome in which acute or chronic liver failure results in exaggerated splenic 
vasodilation and renal hypoperfusion (Garcia-Tsao et al., 2008; Gines et al., 2009).  
In addition, AKI may also be caused by extrinsic toxins (Joseph V. Bonventre et al., 2004; 
Lameire et al., 2008). Nephrotoxic agents can cause injury either by directly damaging TECs, or 
indirectly by altering renal hemodynamics (Perazella, 2012). For example, aminoglycosides are 
directly toxic to proximal tubule cells (Perazella, 2012; Schetz et al., 2005), while angiotensin 
converting enzyme inhibitors decrease GFR by causing vasoconstriction of the glomerular blood 
vessels. About ten percent of AKI is caused by post-renal etiologies that are defined by obstruction 
to urine flow beyond the kidney (Basile et al., 2012). Examples of this are benign prostatic 
hyperplasia compressing the urethra, or metastatic cancer compressing the ureters (Campbell et 
al., 2014). Other rarer causes of AKI include renal inflammation (i.e. interstitial nephritis) due to 
medication allergy, infection, or autoimmunity (Choudhury et al., 2006; Basile et al., 2012). 
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Figure 1.1. Pathophysiological conditions and medications leading to acute kidney injury  
Modified from Bonventre, J. V and Yang, L. Cellular pathophysiology of ischemic acute kidney 
injury. Review. J Clin Invest. 2011: 121 (11): 4210-21 
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1.2.3. Animal models  
The most widely used animal model of human AKI is the rodent ischemia-reperfusion 
model. It consists of transiently clamping and un-clamping the renal vascular pedicle to mimic IRI 
in humans (Heyman et al., 2009; Heyman et al., 2002). Two types of ischemia can be employed; 
i) cold ischemia to mimic what happens during organ preservation in renal transplantation, and ii) 
warm ischemia to mimic ischemic injury that occurs during shock or organ retrieval of the native 
kidney (Heyman et al., 2002; Prowle et al., 2009). In renal transplantation, cold ischemia starts 
when the organ is perfused with cold perfusion solution after procurement, and lasts until the 
temperature of the organ reaches the physiologic temperature (Jang et al., 2015). Warm ischemia 
begins when perfusion is restored after anastomosis (Alejandro et al., 1995; Halazun et al., 2007). 
An alternative model to IRI is the nephrotoxic model where animals are administered a 
nephrotoxic agent such as cisplatin, a chemotherapeutic agent, which causes nephrotoxic AKI with 
some pathophysiological similarities to the IRI model (Yap et al., 2012).  A limitation of animal 
models is that they cannot capture the impact of co-morbidities and demographics that are well 
recognized to influence the development, course, and prognosis of AKI in humans (Bihorac et al., 
2009; Zarjou et al., 2011; Grams et al., 2015; James et al., 2015). For example, one of the most 
important risk factors for the development of AKI is prior history of chronic kidney disease (Ishani 
et al., 2009; Xue et al., 2006).  
1.2.4. Epidemiology of acute kidney injury  
Despite advances in the diagnosis and management of AKI, it remains associated with high 
mortality and morbidity for patients. AKI affects between 10-20 % of all hospitalized patients 
worldwide depending on the definition used, with prevalence in the intensive care unit reaching 
over 30 % (Chertow et al., 2005; Susantitaphong et al., 2013). Almost 25 % of patients with AKI 
die, with in-hospital mortality and prolonged hospitalization being proportionally increased with 
the degree of kidney dysfunction in AKI (Hoste et al., 2007; Chertow et al., 1995). Worldwide, 
AKI affects approximately 13.3 million people each year, and is believed to contribute to 1.7 
million deaths annually (Lewington et al., 2013; Mehta et al., 2015). Population-based studies 
suggest that AKI confers a large economic burden to the health care system. Greater than one 
million hospitalizations in the United States are complicated by AKI, accounting for ten billion in 
excess costs (Wald et al., 2015).  
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In spite of advances in current therapeutic strategies to resolve AKI, the high mortality rate 
associated with AKI remains unchanged (Bihorac et al., 2009; Chertow et al., 2005; Chronopoulos 
et al., 2010). While the metabolic derangements resulting from severe AKI can be managed with 
dialysis, there is little evidence that renal replacement therapies change long-term prognosis (Lo 
et al., 2009; Metcalfe et al., 2002; Wald et al., 2009). Further, a significant proportion of surviving 
patients suffer long-term sequelae, including the development of chronic kidney disease (CKD) 
and end-stage renal disease (ESRD) (Chawla et al., 2012; Hsu, 2012; Coca et al., 2012). One recent 
study found that patients who appear to recover from their need for dialysis after an initial AKI 
episode have a 3-fold risk of eventually needing dialysis again for ESRD, compared to patients 
without AKI (Wald et al., 2009). There is now strong experimental evidence suggesting a 
pathogenic link between AKI and CKD (Coca et al., 2012; Venkatachalam et al., 2015).  
Whether the increase in mortality observed with AKI is causal or due to other factors is 
unclear, but emerging evidence suggests that AKI may lead to systemic inflammation and 
contribute to remote organ dysfunction (Awad et al., 2009; Klein et al., 2008; Vieira et al., 2007). 
Animal studies show that AKI can lead to remote organ dysfunction in the lungs (K. D. Liu, 2009; 
Rabb et al., 2003), the heart (K. J. Kelly, 2003; Kramer et al., 1999), the liver, the intestines, and 
the brain (M. Liu et al., 2008; Pratschke et al., 2001).  
1.2.5. Pathophysiology  
The pathophysiology of AKI is highly complex and varied depending on its etiology (J. 
V. Bonventre et al., 2011). As discussed above, the major pathoetiologies include ischemia, 
toxins, obstruction, and inflammation. For the purposes of this thesis, we will focus on ischemic 
AKI, the major cause of AKI in humans. The clinical course of ischemic AKI has been divided 
into several phases: initiation, extension, maintenance, and recovery. The cellular alterations 
taking place in the kidney at each phase are summarized in Table 1.2 (Molitoris et al., 2004; 
Sutton et al., 2002). 
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Table 1. 2. Summary of the different phases of acute kidney injury and the 
cellular pathophysiology occurring at the tubular and vascular endothelial cell 
levels. 
 
 
 
AKI- Acute Kidney Injury, ATP- Adenosine Triphosphate, ROS- Reactive Oxygen 
Species, KIM-1- Kidney injury molecule-1, GPNMB -Transmembrane 
glycoprotein NMB.  
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During the initiation phase, cells are exposed to the ischemic insult. This directly leads to 
pathogenic effects that occur during the extension phase, resulting in a reduced GFR and altered 
kidney function. Depending on the severity of the injury (for example, the duration of ischemia), 
cells may experience different fates ranging from sub-lethal injury to different forms of cell death. 
One of the main mechanisms of cell death during IRI is via ATP depletion and altered tubule cell 
metabolism (Devarajan, 2006; Togel et al., 2014). The proximal tubular epithelial cells of the S3 
segment of the nephron are most sensitive to ischemic injury, due to their high metabolic rate, 
dependence on oxidative phosphorylation, and the unique architecture of the blood supply in the 
kidney (Basile et al., 2012; Bastin et al., 1987; Uchida et al., 1988). When oxidative stress occurs, 
tubular cells fail to efficiently convert from oxidative to glycolytic metabolism, resulting in ATP 
depletion and cell injury through multiple mechanisms. ATP depletion leads to an increase in free 
intracellular calcium (Schrier et al., 1987), which in turn causes activation of proteases, 
phospholipases, and cytoskeletal derangements (Devarajan, 2005). Importantly, ATP depletion 
causes the production of reactive oxygen molecules (Paller et al., 1984). Reactive oxygen 
molecules activate many intermediates that cause protein oxidation (Andreoli et al., 1997), lipid 
peroxidation (Zager, 1996), and DNA damage, triggering apoptotic cell death (Safirstein, 1997; 
Ueda et al., 1992). ATP depletion also results in the loss of cell polarity, due to apical and 
basolateral mislocalization of polarized proteins (Devarajan, 2006; Molitoris, 2004). For example, 
mislocalization of the vital Na+/K+-ATPase pumps (Molitoris, 1993; Molitoris et al., 1991), causes 
bidirectional transport of sodium and water across the epithelial membrane, leading to high 
fractional excretion of sodium often seen early in ischemic AKI in patients (Sharfuddin et al., 
2011). Mislocalization of β1 integrin, a basolateral protein (Zuk et al., 1998), leads to subsequent 
detachment of viable cells from the tubular basement membrane during the extension phase. 
Experimental evidence suggests that this process of detachment contributes to cast the formation 
and obstruction within the tubular lumen, which is believed to further impair GFR (Molina et al., 
2005; Yang et al., 2015). 
In addition, ATP depletion causes alteration of the apical cytoskeleton due to dissociation 
of actin-stabilizing proteins, including tropomyosin and ezrin (Ashworth et al., 2003; Ashworth et 
al., 2004). The dissociation of these proteins allows the actin depolymerizing factor, cofilin, to 
sever apical F-actin. Sequentially, this leads to the formation of membrane-bound or free floating 
extracellular vesicles that are either internalized or released into the tubular lumen (Ashworth et 
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al., 1999). Disruption of the apical cytoskeleton also results in the loss of tight and adherence 
junctions (Devarajan, 2006; Sharfuddin et al., 2011). Specifically, the loss of interaction between 
the tight junction proteins Neph1 and zonula occludens-1 (ZO-1) results in a loss of tubular 
integrity, which is associated with proteinuria in rat model of renal ischemic injury (Wagner et al., 
2008). The loss of tight junctions is important as it leads to impaired barrier function of the tubular 
epithelium, which magnifies the pathological effects of kidney dysfunction during the extension 
phase by contributing to the back leak of glomerular filtrate (e.g. filtered creatinine or urea) (Kwon 
et al., 1998).  
The initiation phase also damages vascular endothelial cells (Basile et al., 2012), where 
disruption of actin cytoskeleton and junctional complexes occurs in a similar manner to that 
described above for TECs (Devarajan, 2006; Molitoris et al., 2004). This results in collapse of the 
perivascular matrix, increasing microvascular permeability, thus allowing fluids to be lost into the 
interstitium and impairing capillary flow during the extension phase (J. V. Bonventre et al., 2011; 
Sutton et al., 2002). Injured endothelial cells also increase production of vasoconstrictors such as 
endothelin, and decrease the production of vasodilators such as nitric oxide (Conger et al., 1991; 
Goligorsky et al., 2004). Additionally, stressed endothelial cells express a variety of adhesion 
molecules, such as intracellular adhesion molecule-1 (ICAM-1), P-selectin and E-selectin, which 
promote endothelial-leukocyte interactions to promote inflammation (Devarajan, 2006; K. J. Kelly 
et al., 1994; Linas et al., 1995). The combination of endothelial cell expression of adhesion 
molecules, production of vasoconstrictors, and increased vascular permeability significantly 
contributes to progression into the extension phase.  
It was previously thought that if the injury was sublethal, complete restitution and recovery 
could occur after the cessation of the IRI insult. However, new evidence illustrates that 
dysfunctional endothelial and tubular cells substantially contribute to the extension phase, 
propagating tissue damage (Devarajan, 2006; Molitoris et al., 2004). The extension phase is 
marked by inflammatory responses that are not only initiated by endothelial dysfunction, but 
according to recent evidence, by injured TECs (Joseph V. Bonventre et al., 2004; Friedewald et 
al.,2004; Yang et al., 2015). Together, these injured cells are responsible for the generation of 
proinflammatory cytokines (e.g. TNF-α, TGF-β, IL-6) and chemotactic cytokines (e.g. monocyte 
chemoattractant protein-1 (MCP-1), RANTES, IL-18) (Joseph V. Bonventre et al., 2004; Daha et 
al., 2000; Donnahoo et al., 2000; Ishibashi et al., 1999; Segerer et al., 2000). In humans, plasma 
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levels of the proinflammatory cytokines IL-6 and IL-8 have been shown to predict mortality in 
AKI patients (Kielar et al., 2005; Simmons et al., 2004). Injured TECs also express toll-like 
receptors 2 and 4 (TLR2 and TLR4) that enable them to recognize extracellular danger signals and 
trigger inflammatory responses from within (Leemans et al., 2005; Wu et al., 2007). The sum of 
effects mediated by the proinflammatory mediators produced by TECs and endothelial cells causes 
an escalation of inflammation via recruitment of leukocytes and inflammatory cells (Friedewald 
et al., 2004). Ultimately, the ensuing inflammatory response to the initial ischemic injury to cells 
serves to cause secondary tissue damage.  
1.2.6. Mechanisms of cell death during acute kidney injury 
During the extension phase, lethally injured TECs die either by apoptosis, regulated 
necrosis, or necrosis, depending on the level of ATP depletion and extent of cellular injury (Figure 
1.2) (Basile et al., 2012; Lieberthal et al., 1998; Schumer et al., 1992).  
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Figure 1.2. Different forms of cell death occurring in ischemic acute kidney injury and 
their contribution to inflammation. 
The different forms of cell death occurring during ischemic acute kidney injury are divided into: 
programmed cell death (apoptosis), regulated necrosis (necroptosis, ferroptosis, or pyroptosis), 
and necrosis. The immunogenicity (ability to provoke an immune response) of each of these 
forms of death is based on the ensuing morphological consequence to the dying cell. All forms of 
cell death, except apoptosis, are known to release damage associated molecular patterns 
(DAMPs), such as High mobility group box 1 (HMGB1). Additional DAMPs released are 
indicated with morphological consequences of cell death forms. This figure likely oversimplifies 
the entire spectrum of cell death that occurs during tissue injury. 
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Apoptosis or programmed cell death is an energy-dependent mechanism that results in 
nuclear shrinkage, chromatin fragmentation and cell breakdown (J. F. Kerr, 2002; Padanilam, 
2003; Wyllie et al., 1980). The apoptotic cell membrane remains intact but often several proteins 
or modified lipids that are usually localized on the inner cellular membrane are exposed on the 
plasma membrane outer leaflet. These serve as “eat me” signals to allow for their phagocytic 
clearance by professional or semi-professional phagocytes (Fadok et al., 1998; Ravichandran et 
al., 2007). For example, the membrane phospholipid, phosphatidylserine, which is displayed by 
apoptotic cells before cellular fragmentation and formation of apoptotic bodies, is the most widely 
studied “eat me” signal to date (Fadok et al., 1998; Fadok et al., 1992). Since apoptosis usually 
occurs during normal cell turnover, there is little effect of this form of cell death on the surrounding 
tissue and it is largely considered to be a non-immunogenic form of cell death (Figure 1.2). 
Interestingly, blocking apoptotic pathways in mice subjected to ischemic AKI resulted in reduced 
inflammation and tissue damage (Daemen et al., 1999).  
In contrast, necrosis is considered to be the most immunogenic form of cell death.  It begins 
with cellular and organelle swelling, followed by loss of plasma membrane integrity, with the 
consequent release of cytoplasmic and nuclear material outside the cell (Majno et al., 1960). The 
intracellular material released from necrotic cells contains highly immunogenic proteins, referred 
to as damage associated molecular patterns (DAMPs), such as ATP, IL-1α, and HMGB1, double-
stranded DNA (Kono et al., 2008; Leach et al., 1998). Extracellular DAMPs are recognized by 
specific pattern recognition receptors (PRRs), such as TLR-4 expressed by various cell types 
including tubular cells (Jang et al., 2009). Cells responding to the DAMPs via PPRs produce even 
more proinflammatory mediators further amplifying the renal inflammatory response during 
ischemic AKI (Wu et al., 2007; B. Zhang et al., 2008).  
Recently, many forms of regulated necrosis have been linked to ischemic AKI. Necroptosis 
is one type of regulated necrosis and is defined as necrotic cell death that is dependent on receptor-
interacting protein kinase 3 (RIPK3) (Linkermann et al., 2012; Tait et al., 2013). Upon the 
activation of RIPK3, it phosphorylates the Mixed Lineage Kinase domain-Like protein (MLKL) 
which leads to subsequent plasma-membrane rupture. Blocking RIPK3 signaling has been shown 
to be protective in ischemic AKI in animal models (Linkermann et al., 2012; Linkermann, et al., 
2013; Tristao et al., 2012; L. Zhang et al., 2013). Other regulated necrotic cell death pathways 
implicated in AKI include pyroptosis and ferroptosis (Linkermann, Chen, et al., 2014). Pyroptosis 
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is unique in that it results in the maturation of proinflammatory cytokines, such as IL-1β and IL-
18, via caspase-1 activation which brings about more inflammatory responses than necroptosis 
(Miao et al., 2011; Yang et al., 2014). Following 12 hours of IRI, the levels of pyroptosis-related 
proteins, such as caspase-1, were significantly elevated in renal tubular epithelial cells (Yang et 
al., 2014). Ferroptosis is an iron-dependent, oxidative, non-apoptotic form of cell death which 
involves glutathione metabolism (Dixon et al., 2012; Skouta et al., 2014). Ferroptosis was shown 
to mediate necrotic tubular cell death in renal IRI, since blocking ferroptosis via chemical inhibitor 
(ferrostatin) resulted in the protection from severe IRI as seen by lower serum creatinine and less 
histological damage (Linkermann, Skouta, et al., 2014). On the other hand, mice deficient in the 
proximal tubular cell-specific ferritin heavy chain showed greater mortality and worse renal injury 
following cisplatin-induced AKI (Zarjou et al., 2013). Due to the different forms of cell death 
involved and their respective roles in promoting tissue damage in AKI via promoting 
inflammation, the extension phase is thought to be a promising window for early diagnosis and 
active therapeutic interventions in AKI.  
1.2.7. Various inflammatory cells in acute kidney injury 
During the extension phase, various immune cells infiltrate the kidney. Based on animal 
studies, neutrophils are the earliest leukocytes to be recruited into injured endothelium (Willinger 
et al., 1992), followed by macrophages (Jang et al., 2015; Ysebaert et al., 2000). These 
macrophages are known to produce proinflammatory cytokines that stimulate the activity of other 
leukocytes and parenchymal cells (Duffield, 2010). Interestingly, depletion of kidney and spleen 
macrophages in mice prior to renal IRI was shown to prevent AKI, while adoptive transfer of 
macrophages re-established the AKI response (Day et al., 2005). Additionally, monocytes have 
been shown to migrate to inflamed kidney tissues and differentiate into M1-type macrophages or 
dendritic cells, which further participate in inflammatory responses (L. Li et al., 2008). Dendritic 
cells (DCs) are also thought to have a role in AKI; depletion of DCs leads to a lower level of TNF 
produced by kidneys (Dong et al., 2007; Tadagavadi et al., 2010). Another innate immune cell that 
has been seen to infiltrate ischemic kidney during AKI is the natural killer cell, which has been 
shown to orchestrate more neutrophil infiltration via production of interferon-gamma (IFN-γ) (L. 
Li et al., 2007).  
T cells have also been shown to be involved in AKI. Depletion of T cells was shown to 
protect mice from ischemic AKI (Yokota et al., 2002; Ysebaert et al., 2004). Interestingly, T-
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regulatory cells have been shown to traffic into the ischemic kidney (M. Liu et al., 2009), and have 
been proposed to promote repair during the maintenance phase though modulation of 
proinflammatory cytokines by other T-cells subsets (Kinsey et al., 2010; Kinsey et al., 2009). The 
inflammatory response triggered at the initiation stage involves the activation of complement 
systems, which contributes to the amplification of tissue damage from inflammation (Arumugam 
et al., 2004; Quigg, 2003). The majority of the existing research has implicated the alternative 
pathway (Thurman et al., 2003) and mannose-binding lectin pathway of complement activation in 
AKI (de Vries, Kohl, et al., 2003; De Vries, Matthijsen, et al., 2003; de Vries et al., 2004).  
1.2.8. Mechanisms of repair and regeneration after acute kidney injury 
While there are numerous injurious pathways activated in AKI, several intra-renal 
protective mechanisms are also upregulated during the extension phase that help to limit tissue 
damage and potentiate repair during the maintenance and recovery phases. Injured but surviving 
TECs upregulate many genes that promote tissue repair and curtail inflammatory responses (Wen 
et al., 2010). For example, Kidney Injury Molecule-1 (KIM-1) is specifically upregulated on TECs 
following ischemic injury (Ichimura et al., 1998). KIM-1 is a phagocytic receptor that recognizes 
phosphatidylserine on apoptotic and necrotic cells, allowing their uptake by TECs (Ichimura et al., 
2008). This uptake has been shown to clear apoptotic cells, preventing them from undergoing 
secondary necrosis, and mediating down-stream anti-inflammatory responses triggered by 
extracellular DAMPs in proximal TECs (see section 1.3.4). These included the NF-кB pathway, 
infiltration of immune cells, and production of inflammatory cytokines (Yang et al., 2015). 
Another important repair protein that is upregulated on injured TECs is the transmembrane 
glycoprotein NMB (GPNMB) (B. Li, Castano, et al., 2010; Sharfuddin et al., 2011). GPNMB is 
important in the recruitment of autophagy protein LC3 to phagosomes and the fusion of lysosomes 
with phagosomes. The latter plays an important role in uptake and degradation of apoptotic cells. 
Mice with mutated GPNMB exhibited increased inflammation, impaired repair and more apoptotic 
cell accumulation in response to renal ischemia (B. Li, Castano, et al., 2010). Other proteins 
involved in repair and regeneration during the maintenance and recovery phase expressed by TECs 
include heme oxygenase (Nath, 2006) and heat shock proteins (Z. Wang et al., 2011). 
Additionally, recruitment of regulatory T cells has been shown to promote repair through 
the modulation of proinflammatory cytokines produced by other T cells (Kinsey et al., 2010; 
Kinsey et al., 2009; Sharfuddin et al., 2011), whereby the depletion of regulatory T cells subsets 
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(Foxp3+) resulted in increased accumulation of leukocytes and inflammatory cytokines within the 
kidney (Gandolfo et al., 2009).  
During the maintenance phase, the fate of the kidney is likely determined by a balance 
between cells that survive injury or die from it, as only surviving cells can promote repair 
(Humphreys et al., 2011; Humphreys et al., 2008, Berger et al., 2014). The recovery phase aims 
to improve GFR, and regenerate the vascular and tubular epithelium (Basile et al., 2012). 
Understanding the process of regeneration and proliferation after ischemic AKI is still a work in 
progress, with much debate surrounding the source of these proliferating cells (Kramann et al., 
2015). Mesenchymal stem cells were thought to be the source of proliferative cells, since they 
could differentiate into renal epithelium and endothelium in vitro (Bussolati et al., 2005). Several 
groups have previously shown that infusing mesenchymal stem cells improved renal function 
following injury and even protected from injury if cells were infused before the ischemic insult 
(De Broe, 2005; Lange et al., 2005; Togel et al., 2005). More recently, research by Duffield et al. 
and Humphrey et al. have contradicted these findings. Their groups showed that terminally 
differentiated proximal TECs were solely responsible for the dedifferentiation, proliferation and 
redifferentiation necessary to regenerate the kidney tubular epithelium (Duffield et al., 2005; 
Duffield et al., 2011; Humphreys et al., 2011; Humphreys et al., 2008; Kramann et al., 2015). 
Whether endothelial progenitor cells originate from hematopoietic stem cells or mesenchymal 
stem cells and their role remains unclear (Reinders et al., 2006; Tongers et al., 2007). Regardless 
of the source of the endothelial progenitor cells, they are recruited to injured renal 
microvasculature to repair and improve the functional recovery of the kidney following AKI 
(Becherucci et al., 2009; B. Li, Cohen, et al., 2010).  
Emerging evidence strongly suggests that repair mechanisms following AKI are mostly 
incomplete and, when injury is severe, could lead to CKD (Basile et al., 2012; Devarajan, 2006). 
Hallmarks of incomplete recovery are persistent tubulointerstitial inflammation, fibroblast 
proliferation, excess extracellular matrix deposition, and chronic macrophage and fibrosis 
activation (Duffield, 2010; Hsu, 2012; Ko et al., 2008; Venkatachalam et al., 2010; Venkatachalam 
et al., 2015). Overall, the cellular pathophysiology of ischemic AKI is a highly complex field of 
research that is continuously developing. It is hoped that understanding the injury and repair 
pathways involved in ischemic AKI will eventually lead to the development of novel therapeutic 
strategies to ameliorate AKI and potentially prevent its systemic consequences.  
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1.2.9. Biomarkers for acute kidney injury  
A biomarker is defined as a biological “characteristic that is objectively measured and 
evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic 
responses to a therapeutic intervention” (Biomarkers Definitions Working, 2001). When patients 
develop AKI, they are asymptomatic until most of the kidney function is compromised. To date, a 
rise in serum creatinine and/or fall in urine output have been the most widely used markers of 
kidney function (Levey et al., 1988; Work et al., 2012). Unfortunately, the rise in serum creatinine 
is often delayed until much damage has occurred and is generally an unreliable indicator of kidney 
dysfunction (Coca et al., 2008). Other biomarkers traditionally used in conjunction with serum 
creatinine and urine output have been serum urea (Beier et al., 2011), and the chemical analysis of 
urine, including urine sediment (Kanbay et al., 2010), fractional excretion of sodium (Chawla et 
al., 2008) and fractional excretion of urea (Carvounis et al., 2002). None of the currently used 
diagnostic markers provide information about the severity or nature of kidney injury or whether 
the repair and recovery process has started. This information might aid clinicians to make better 
therapeutic decisions when it comes to AKI in patients.  
This knowledge gap has promoted a new area of research that aims to implement specific 
biomarkers to detect kidney injury prior at the onset of AKI, well before it is detected by increased 
serum creatinine (Bellomo et al., 2012; Devarajan et al., 2010). Several new biomarkers, such as 
cystatin C (Ahlstrom et al., 2004; Herget-Rosenthal et al., 2004; Moore et al., 2010), L-type fatty 
acid-binding protein (L-FABP) (Deitch, 1998; Nakamura et al., 2009; Zarjou et al., 2011), 
Interleukin-18 (IL-18) (Bagshaw et al., 2007; Bellomo et al., 2007; Parikh et al., 2005), Netrin-1 
(Ramesh et al., 2010; Reeves et al., 2008), neutrophil gelatinase-associated lipocalin (NGAL) 
(Haase et al., 2009; Mishra et al., 2005), and Kidney injury molecule-1 (KIM-1) (Ichimura et al., 
2004; Sabbisetti et al., 2013; Vaidya et al., 2009) have been proposed as early biomarkers for AKI 
diagnosis and prognostication (Figure 1.3). 
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Figure 1.3. Emerging and traditional biomarkers of acute kidney injury during the 
different stages of disease progression 
Kidney injury occurs before the kidney function is lost, as determined by the decreased 
glomerular filtration rate (GFR). Different markers detected in serum or urine during early 
kidney injury due to ischemic, toxic or septic insults serve as early detection markers. An 
increase in diagnostic markers might be parallel or prior to the loss of kidney function as 
determined by traditional biomarkers of decreased GFR, increased levels of serum creatinine and 
decreased urea. Following the loss of kidney injury, some traditional and new biomarkers could 
provide a prognostic assessment of outcome after AKI and possibility of kidney failure in 
patients. NGAL= neutrophil gelatinase-associated lipocalin, KIM-1= kidney injury molecule-1, 
IL-18= interleukin-18, L-FABP= liver fatty-acid-binding protein. Modified from Bellomo, R., 
Kellum, J.A, Ronco, C. Acute kidney injury. Lancet 2013:280:756-66 
 
 
 
 
 
 
 
 
20 
 
A few of these biomarkers have shown promising results in detecting AKI of various 
etiologies (Bagshaw et al., 2010; Parikh et al., 2005). Both NGAL and KIM-1 are among the 
highly upregulated genes in the early post-ischemic kidney and after nephrotoxic injury (Mishra 
et al., 2005; Mishra et al., 2003; Mishra, Mori, Ma, Kelly, Barasch, et al., 2004). NGAL is an iron-
transporting protein that is co-localizaed with endosomal markers (Bao et al., 2010). 
Adminstration of recombinant NGAL has been shown to protect from apoptosis and enhance 
tubular cell proliferation following murine IRI (Mishra, Mori, Ma, Kelly, Yang, et al., 2004; Mori 
et al., 2005). In addition, NGAL is expressed by tubular cells undergoing proliferation following 
injury, which suggests that is might play a role in the mainentance and recovery phase of AKI 
(Yang et al., 2002). These exciting functional data have led to a number of human translational 
studies to evaluate blood and urine level of NGAL as novel biomarker for AKI (Bolignano et al., 
2008; Hirsch et al., 2007). A standardized commercial bedside biomarker kit for NGAL has now 
been approved by the Food and Drug Administration for the early detection of AKI in the United 
States. 
KIM-1 is another promising candidate biomarker of AKI, as its expression is dependent on 
kidney injury (Ichimura et al., 2008; Ichimura et al., 1998). This type 1 transmembrane receptor 
undergoes spontaneous ectodomain shedding upon expression on the apical membrane of proximal 
TECs which enables its detection in the urine of patients and rodents with AKI (Han et al., 2002; 
Han et al., 2009; Ichimura et al., 2004; Sabbisetti et al., 2013). Recently, Sabbisetti, et al., showed 
that KIM-1 is also elevated in the plasma of patients who developed AKI following cardiac surgery 
(Sabbisetti et al., 2014). In addition, KIM-1 levels also predicted the progression to end-stage renal 
disease in diabetic patients with elevated serum KIM-1, presumably due to recurrent AKI in the 
setting of CKD. In conclusion, both NGAL and KIM-1 are sensitive and specific biomarkers of 
tubular injury, and are considered to be part of the potential panel of AKI biomarkers to be used 
at the bedside in the future. This thesis will focus on understanding the physiological function of 
KIM-1 and its downstream cell signalling in proximal TECs in AKI.  
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1.3. KIDNEY INJURY MOLECULE-1 
1.3.1. Classification and structure  
Kidney injury molecule-1 (referred to as KIM-1 in humans and Kim-1 in rodents) was first 
identified by Ichimura, et al. in a cDNA screen for genes upregulated in the post-ischemic rat 
kidney (Ichimura et al., 1998). KIM-1 mRNA and protein expression is undetectable in the normal 
kidney, but increases dramatically during ischemic or toxic AKI (Ichimura et al., 2004; Vaidya et 
al., 2009; Vaidya et al., 2010). It belongs to the T cell immunoglobulin mucin (TIM) gene family, 
which includes TIM-1, TIM-3 (DeKruyff et al., 2010; Nakayama et al., 2009), and TIM-4 
(Kobayashi et al., 2007; Santiago, Ballesteros, Martinez-Munoz, et al., 2007) in humans, and eight 
members (Tim 1-8) in mice (Kuchroo et al., 2003). Human TIM-1, TIM-3 and TIM-4 are 
functional orthologs of mouse Tim-1, Tim-3 and Tim-4, respectively. KIM-1 is referred to as T-
cell immunoglobulin and mucin domain-containing protein-1 (TIM-1) when expressed by immune 
cells, and KIM-1 when expressed on cells that originate from the kidney (including kidney 
cancers), but both are in fact the product of the same gene (HAVCR1) (Kuchroo et al., 2003). 
KIM-1 was first discovered as the hepatitis A virus cellular receptor 1 (HAVcr-1) in monkey cells 
(Kaplan et al., 1996). HAVcr-1 was later found to exist in humans, serving as the cellular receptor 
for Hepatotropic picornavirus, which causes acute liver disease in humans (Feigelstock et al., 
1998). In 1998, murine Kim-1 was identified on injured renal proximal TECs and exhibited some 
degree of homology to the HAVcr1 gene (Ichimura et al., 1998). In 2001, McIntire et al. performed 
positional cloning to identify a novel susceptibility gene locus for asthma and allergy (T-cell and 
airway phenotype regulator), and discovered TIM-1 within the Tapr locus as the susceptibility 
gene (McIntire et al., 2001). The genetic sequence of TIM-1 indicated that both TIM-1 and 
HAVcr-1 encoded for the same protein. In mice, the Tim gene family is located on chromosome 
11B1.1, and in humans it is located on chromosome 5q33.2 (McIntire et al., 2001). Both regions 
have been linked to asthma, allergy and autoimmunity (McIntire et al., 2004; McIntire et al., 2003; 
Umetsu et al., 2005).  
Notably, TIM-1 is an extremely polymorphic gene with over one thousand identified 
genetic variants, accounted for by single nucleotide polymorphisms, insertions or deletions 
(McIntire et al., 2003; Rodriguez-Manzanet et al., 2009). TIM-1 variants have been linked to an 
individual’s susceptibility to allergy, asthma (Gao et al., 2005; Matricardi et al., 1997; Matricardi 
et al., 2000), eczema (Graves et al., 2005), Hepatitis A infection (H. Y. Kim et al., 2011), HIV 
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progression to AIDS (Wichukchinda et al., 2010) and filovirus infection (Kuroda et al., 2014). 
Given that TIM-1 is expressed on different immune cells, it is perhaps not surprising that 
polymorphisms of TIM-1 have also been associated with susceptibility to other autoimmune 
diseases such as rheumatoid arthritis (Chae, Song, Heo, et al., 2003; Chae, Song, Lee, et al., 2003; 
Chae et al., 2004), multiple sclerosis (Grabmer et al., 2010; Khademi et al., 2004), and systemic 
lupus erythematosus leading to lupus nephritis (W. X. Li et al., 2011; Y. Wang et al., 2008).  
Structural studies reveal that all TIM proteins (including KIM-1) are similar. They are all 
type I cell surface glycoproteins made up of an N-terminal immunoglobulin variable domain (IgV) 
with six cysteines, a mucin domain with O-linked and N-linked glycosylation close to the cellular 
membrane, a single transmembrane domain, and a cytoplasmic domain with tyrosine 
phosphorylation motif(s) (Ichimura et al., 1998; Santiago, Ballesteros, Martinez-Munoz, et al., 
2007) (Figure 1.4). In addition, the mucin domain is rich in threonine, serine, and proline residues 
that play a role in O-linked glycosylation (Kuchroo et al., 2003). TIM-4 is unique in that it contains 
an Arg-Gly-Asp (RGD) motif in its IgV domain and has a shorter cytoplasmic domain that lacks 
a key cell signalling motif (Meyers, Chakravarti, et al., 2005; Santiago, Ballesteros, Martinez-
Munoz, et al., 2007; Shakhov et al., 2004). Hence, TIM-4 is believed to interact with a signalling 
intermediate or a co-receptor to transduce signals in cells (Flannagan et al., 2014; D. Park et al., 
2009). The N-terminal cysteine-rich region of the Ig domain of TIM-1, along with the mucin-
domain account for the high sequence identity of about 40 % between mouse and human TIM-1 
(Ichimura et al., 1998; Kuchroo et al.,2003; Thompson et al., 1998). The number of O-linked 
glycosylation sites varies from 37 in mouse Tim-1 to 56 in human TIM-1, which contributes to the 
size difference seen between them (Human KIM-1 ~119 kDa and mouse Kim-1 ~60 kDa) (Bailly 
et al., 2002; Freeman et al., 2010).  
The extracellular domain of KIM-1 bears similarity to the immunoglobulin superfamily, 
which is characterized by an extracellular domain containing an immunoglobulin (Ig), and a mucin 
domain (Shimizu et al., 1993; Van Klinken et al., 1995). Molecules belonging to the 
immunoglobulin superfamily usually function as membrane receptors or adhesion molecules. This 
group includes mucosal addressin cell adhesion molecule 1 (MAdCAM-1), CD34, TACTILE 
(CD96), and HAVcr-1 which is the homolog of KIM-1 (Ichimura et al., 1998; Van Klinken et al., 
1995). The MAdCAM-1 protein is most similar to KIM-1, as it contains four cysteine residues in 
the Ig domain and KIM-1 contains six cysteines (Ichimura et al., 1998). The IgV-like domain of 
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KIM-1 shares functional characteristics with sialic acid-binding immunoglobulin-type lectins 
(SIGLECs) and C-type-lectins (Wilker et al., 2007). These similarities could suggest a potential 
role for KIM-1 in cell trafficking and adhesion. Surprisingly, TIM-1/KIM-1 has been shown to 
contain a signal peptide for trafficking through clathrin-coated vesicles from the endoplasmic 
reticulum to the cell surface (Balasubramanian et al., 2012). The signal peptide-deleted TIM-1 
mutant failed to undergo glycosylation and failed to enter vesicles for proper targeting to the cell 
surface. 
The crystal structure of TIM-1 has been solved. The IgV domain contains a distinct narrow 
cleft that is formed by the four cysteines residues that bridge the CC’ loop to the GFC β sheet 
(Santiago, Ballesteros, Tami, et al., 2007). Additionally, the crystallographic analysis uncovered 
that both murine and human TIM-1 can partake in homophilic interaction (TIM-1-TIM-1 
interactions), which may be a reflection of its function as an adhesion molecule. When the crystal 
structure of phosphatidylserine (TIM-1 ligand) bound to TIM-1 was solved, the IgV domain was 
found to form a metal-ion-dependent ligand-binding site (MILIBS), where the ion is predicted to 
be calcium (Santiago, Ballesteros, Martinez-Munoz, et al., 2007). This MILIBS has asparagine 
and aspartic acid residues that engage in metal coordination, which is highly conserved in all TIM 
family members, except for mouse Tim-2 (Santiago, Ballesteros, Martinez-Munoz, et al., 2007). 
The open confirmation of the IgV domain requires that the hydrophobic aromatic phenylalanine 
and tryptophan residues remain on the tip of the CC’FG loop to allow the lipid chain of 
phosphatidylserine (PS) to penetrate the narrow cleft for binding of PS to TIM-1 (Kobayashi et 
al., 2007; Santiago, Ballesteros, Martinez-Munoz, et al., 2007; Santiago, Ballesteros, Tami, et al., 
2007). Mutations in the aromatic residues of the FG loop within the MILIBS abrogate its binding 
to PS (Kobayashi et al., 2007; Santiago, Ballesteros, Martinez-Munoz, et al., 2007). Mutations in 
MILIBS also affect TIM-1 trafficking to the cell-surface, resulting in the accumulation of mutant 
TIM-1 on the plasma membrane (Balasubramanian et al., 2012).  
KIM-1 has been shown to undergo spontaneous membrane-proximal cleavage, releasing a 
soluble 90 kDa fragment of KIM-1 into the urine or the conditioned media of the TECs expressing 
the full-length protein (Z. Zhang et al., 2007) (Figure 1.4). It is this property that has made soluble 
KIM-1 an attractive non-invasive diagnostic biomarker for tubular injury (Han et al., 2002). In 
cells expressing KIM-1, the cleavage was found to be mediated by ERK activation and that 
activation of p38 MAP kinase resulted in accelerated cleavage of KIM-1 (Bailly et al., 2002; Z. 
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Zhang et al., 2007). Recently, our lab showed that KIM-1 is cleaved by TNF-α-converting enzyme 
(TACE) or ADAM 17 (a disintegrin and metalloproteinase), which is a Zn2+-dependent cell surface 
protease (Gandhi et al., 2014). We also showed that reactive oxygen species generated during IRI, 
accelerate KIM-1 shedding. Interestingly, we found that excess apoptotic cells can accelerate 
KIM-1 cleavage, and that the shed KIM-1 binds to apoptotic cells, competitively inhibiting their 
phagocytic uptake by TECs expressing KIM-1. This may be akin to a negative feedback loop. 
When KIM-1 is shed, a 14 kDa fragment containing its transmembrane and cytosolic domains 
remains bound (retained transmembrane KIM-1) to the plasma membrane (Z. Zhang et al., 2007). 
This cytoplasmic domain of human KIM-1 contains two putative tyrosine phosphorylation sites at 
position 350 and 356. Phosphorylation at tyrosine 350 is required for TIM-1 to mediate co-
stimulatory signalling in T cells (Binne et al., 2007; de Souza et al., 2005) and likely in renal 
proximal TECs (Yang et al., 2015).  
It is important to note that human KIM-1 has two splice variants, KIM-1a and KIM1b 
(Bailly et al., 2002). The KIM-1a variant is expressed in liver and contains a short cytosolic domain 
which lacks the above tyrosine phosphorylation motif, whereas, the KIM-1b variant encodes the 
full-length protein and is expressed elsewhere including the kidney. HAVcr-1 corresponds to the 
KIM-1a splice variant, while TIM-1 on immune cells corresponds to KIM-1b (Bailly et al., 2002; 
Kaplan et al., 1996; Rees et al., 2008). In this thesis, we will be focusing on the KIM-1b variant 
and refer to it henceforth as KIM-1.  
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Figure 1.4. Human KIM-1 structural domains and the peptide sequence of its 
alternatively spliced variants. 
A: KIM-1 is type-1-transmembrane glycoprotein with an IgV like domain, mucin domain 
(glycosylation indicated by blue lines in the mucin domain), transmembrane domain and 
a cytoplasmic domain that contains tyrosine phosphorylation motifs (indicated as P). 
KIM-1 (KIM-1b) is expressed on renal proximal tubule epithelial cells after injury. It is 
cleaved by TNF-α-converting enzyme (TACE) or ADAM 17 (a 
disintegrin and metalloproteinase) into soluble shed KIM-1 (90 kDa) and a membrane-
bound cytoplasmic fragment (14 kDa). B: Peptide sequence alignment of two human 
KIM-1 variants, KIM-1a (HAVcr-1) and KIM-1b (KIM-1). KIM-1b has a tyrosine-
phosphorylation motif, QAEDNIY, highlighted in orange. This motif is missing in the 
KIM-1a variant. The human KIM-1b (KIM-1) variant size is 359 amino acids, whereas 
the human KIM-1a (HAVcr-1) protein is 334 amino acids. Modified from (Bailly et al., 
2002).  
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1.3.2. KIM-1 expression  
When KIM-1 was first identified in the kidney, it was noted to be expressed on the 
proliferating (bromodexoyurindine-positive) and dedifferentiated (vimentin-positive) epithelial 
cells in regenerating proximal tubules in post-ischemic rat kidney (Ichimura et al., 1998). KIM-1 
is expressed on the apical membrane of injured proximal tubule cells, predominantly in the S3 
segment within the corticomedullary region (van Timmeren, Vaidya, et al., 2007; van Timmeren, 
van den Heuvel, et al., 2007), where injury is most likely to occur as mentioned earlier. Since its 
identification, a large number of studies have been conducted on KIM-1 in humans with different 
etiologies of AKI. These have confirmed that KIM-1 expression on injured tubules or shedding in 
the urine serves as a sensitive and specific biomarker for AKI (Han et al., 2002; Sabbisetti et al., 
2013; Sabbisetti et al., 2014; Vaidya et al., 2010; Vaidya et al., 2006; Vaidya et al., 2008). Various 
studies in humans and mice show that KIM-1 is also highly upregulated following AKI caused by 
nephrotoxins, (Ichimura et al., 2004), such as cisplatin (Amin et al., 2004), folic acid (Waanders 
et al., 2009), cyclosproine (Perez-Rojas et al., 2007), and iodinated contrast agents (Jost et al., 
2009). This has made it an attractive biomarker to screen for nephrotoxicity of therapeutic 
compounds that are in development by the pharmaceutical industry (Han et al., 2002; Ichimura et 
al., 2004; van Timmeren, Vaidya, et al., 2007).  
Both tubular KIM-1 (~119 kDa) and urinary soluble KIM-1 (~90 kDa) have also been 
detected in patients with different proteinuric, inflammatory and fibrotic renal diseases. KIM-1 has 
been detected in CKD patient biopsies, and its expression is often associated with tubulo-
interstitial damage, inflammation, fibrosis and a dedifferentiated tubular phenotype (Rennert, 
2011; Vaidya et al., 2011; van Timmeren, van den Heuvel, et al., 2007). In the setting of CKD, 
whether KIM-1 is a marker of acute injury, inflammation, or fibrosis is not known. Recent 
evidence of KIM-1-expression on renal transplants with interstitial fibrosis and tubular atrophy 
supports the notion that it is involved in chronic kidney injury (Nogare et al., 2015; van Timmeren, 
Vaidya, et al., 2007; Yeung et al., 2011; Schroppel et al., 2010 ). In murine models, Kim-1 is 
upregulated in the kidneys of mice subjected to obstructive AKI (fibrosis model) (Humphreys et 
al., 2013) and polycystic kidney disease (Kuehn et al., 2002). Consequently, the upregulation of 
KIM-1 expression following renal injury and its persistent expression in the case of chronic injury 
has made it a useful as a non-invasive biomarker. Interestingly, KIM-1 has been shown to be highly 
expressed in human renal cell carcinoma specimen and cell lines isolated from cancer patients, 
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suggesting that it might additionally be related to cancer progression (Han et al., 2005; Shalabi et 
al., 2013).  
The wide range of stimuli that lead to KIM-1 upregulation makes it a very interesting 
protein to study from the point of view of gene regulation. Recently, some of the transcriptional 
regulators that control KIM-1 expression in the kidney were identified (Ajay et al., 2014). 
Following tubular injury in rat and human kidneys, or oxidative stress in human TECs, the 
checkpoint kinase 1 (Chk1) is phosphorylated and this allows it to interact with the signal 
transducer and activator of transcription-3 (STAT3). STAT3 is subsequently phosphorylated and 
binds to the KIM-1 promoter to upregulate its transcription.  
Interestingly, when Kim-1 expression was measured in various mouse tissues by 
quantitative RT-PCR, its RNA expression was highest in the lymph node and kidney, weakly 
expressed in the spleen, lung, and thymus, and undetectable in the heart or liver (Umetsu et al., 
2005). This suggests that Kim-1/Tim-1 expressing immune cells are enriched in lymph nodes. In 
terms of expression by immune cells, mouse Tim-1 is expressed on activated T cells, but not naïve 
CD4+ T cells (Freeman et al., 2010; McIntire et al., 2001; Umetsu et al., 2005). Following 
differentiation of T-cells into effector cells, Tim-1 is expressed by Th2, Th1 and Th17 cells 
(Angiari et al., 2014; Nakae, Iikura, et al., 2007; Nakae, Iwakura, et al., 2007; Sizing et al., 2007). 
Tim-1 is also expressed by germinal B cells and is considered a hallmark characteristic of these 
cells (S. H. Wong et al., 2010). A number of groups have recently demonstrated that Tim-1 is a 
marker of regulatory B cells that produce IL-10 (Ding et al., 2011; Xiao et al., 2015; Xiao et al., 
2012). In regards to expression by innate immune cells, Tim-1 is expressed on mast cells (Nakae, 
Iikura, et al., 2007) and invariant natural killer T cells (H. S. Kim et al., 2010; Lee et al., 2010). 
The wide expression pattern of Tim-1 might explain the different functions carried by KIM-1/TIM-
1. Whether the HAVCR1 gene is regulated differently in immune cells compared to the kidney 
remains unknown. 
1.3.3. Extrarenal KIM-1 function  
A significant body of work supporting an extra-renal function of KIM-1/TIM-1 was 
published long before its role in the kidney began to be elucidated. TIM-1 was first shown to be 
a co-stimulatory molecule for naïve CD4+ T cell activation and proliferation (de Souza et al., 
2005; Encinas et al., 2005; Umetsu et al., 2005) and an inhibitor of Th2 cell differentiation (Xiao 
et al., 2007). Most of the studies that supported TIM-1’s co-stimulatory function focussed on 
28 
 
rodent models and used indirect strategies (e.g. monoclonal antibodies to Tim-1) to determine its 
function. These studies are somewhat limited, since the amount of anti-Tim-1 antibody 
administered, the binding affinity of the antibody, and antibody binding site on Tim-1 could have 
affected the interpretation of the findings (Meyers, Sabatos, et al., 2005; Sizing et al., 2007; 
Waanders et al., 2010). For example, in the mouse model of OVA-induced lung inflammation, 
administration of monoclonal antibody against the mucin domain of Tim-1 exacerbated immune 
responses (Sizing et al., 2007). This was proposed to occur through the activation of T-cells to 
produce Th2 cytokines, which drive eosinophil and mast cell activation, and trafficking into the 
lung thereby amplifying the inflammation. On the other hand, administering Tim-1 antibodies 
against the IgV domain blocked inflammation through inhibition of T-cells activation. 
Additionally, Kim-1 was found to be expressed on natural killer T (NKT) cells, which allowed 
NKT to bind to apoptotic cells triggering their activation, proliferation, and cytokine production 
(H. S. Kim et al., 2010; Lee et al., 2010). This in turn led to exacerbated airway hyper-reactivity 
in a mouse model of asthma. Surprisingly, despite expressing Kim-1, NKT cells have not been 
reported to mediate phagocytosis of apoptotic cells. Nonetheless, these experiments did reinforce 
the role of Tim-1 in asthma and airway hypersensitivity previously proposed by genetic studies 
placing Tim-1 in the Tapr (asthma susceptibility) locus (McIntire et al., 2001).  
In 2010, the first sets of genetically modified mice with either Tim-1 deficiency or Tim-1 
transgene expression on either T or B cells were generated (S. H. Wong et al., 2010). The 
findings in this paper were surprising, because very low levels of Tim-1 were found to be 
expressed on activated T cells or Th2 cells, which was contradictory to what had been published 
previously. The expression of Tim-1 on T-cells did not stimulate Th2 differentiation and 
production of Th2 cytokines when activated. However, Tim-1 expression was seen on B-cells 
following B-cell receptor stimulation, and this was shown to be dependent on phosphoinositide-
3-kinase and the nuclear factor-кB pathway (NF-кB). Interestingly, Tim-1 was found to be 
expressed on germinal center B cells which was previously unknown at that time. These new 
findings have brought the previous findings using monoclonal antibodies to study Tim-1 function 
into question.  
The discovery of Tim-1 expression on B-cells sparked interest in its possible role in B-
cell biology. Administration of a low-affinity TIM-1-specific antibody promoted prolonged islet 
survival in an allograft transplant model (Ding et al., 2011). Tim-1 is expressed by a majority of 
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IL-10 producing regulatory B-cells. Given that: 1) Tim-1 is expressed on B regulatory cells (S. 
H. Wong et al., 2010); 2) Tim-1 is a phosphatidylserine receptor for apoptotic cells (Ichimura et 
al., 2008; Ichimura et al., 1998; Kobayashi et al., 2007); and 3) apoptotic cell-binding induces 
generation of B regulatory cells, but not phagocytosis (Gray et al., 2007; Yeung et al., 2015), the 
role of Tim-1 binding to apoptotic cells on B regulatory cells to mediate immune response has 
been studied. The generation of mice lacking the mucin domain of Tim-1 (Tim-1Δmucin) provided 
an in-depth understanding of the role of Tim-1 in immune tolerance. B regulatory cells 
expressing Tim-1Δmucin were unable to bind apoptotic cells leading to a reduction in IL-10 
production and accelerated allograft rejection (Yeung et al., 2015). In another study, these Tim-
1Δmucin mice developed autoimmune disease as characterized by the increase in T-cells, activation 
of dendritic cells, elevation of serum Ig, and generation of autoantibodies such as those to 
dsDNA (Xiao et al., 2012). These results suggest that the role of Tim-1 in mediating immune 
responses is dependent on binding apoptotic cells. Recently, it was shown that defective (Tim-
1Δmucin) or mutant Tim-1 led to more inflammatory mediators with increased proinflammatory 
cytokines, increased in Th1 and Th17 production, and reduced generation of regulatory T-cells 
(FoxP3+) (Xiao et al., 2015). This caused an enhancement of the severity of experimental 
autoimmune encephalomyelitis. Therefore, Tim-1 expression on B regulatory cells plays a 
critical role in maintaining self-tolerance and inhibiting the development of autoimmune disease 
(Nozaki et al., 2014; Sattler et al., 2014; Xiao et al., 2015; Xiao et al., 2012; Yeung et al., 2015).  
The extracellular domain of TIM-1 characterizes it as a member of the immunoglobulin 
superfamily, and was recently implicated in leukocyte adhesion and trafficking akin to SIGLECs 
and C-type lectins (Angiari et al., 2014). Tim-1 expression on Th1 and Th17 cells enables them 
to bind to endothelial P-selectin, increasing their recruitment into inflamed tissues. In addition, 
Th1 and Th17 cells from the Tim-1-mucin domain mutant (Tim-1Δmucin), as well as the Ig-like 
domain mutant of Tim-1, showed reduced ability to traffic into inflamed tissue of the skin and 
central nervous systems in models of skin hypersensitivity and experimental autoimmune 
encephalomyelitis, respectively.   
In conclusion, Tim-1 plays complex and varied roles in mammals that are largely 
dependent on which tissues it is expressed. The function of Tim-1 also depends on the 
microenvironment in which Tim-1 is expressed, and whether this microenvironment contains any 
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of its ligands, such as apoptotic cells. Moreover, Tim-1 seems to have a double-edged function in 
immune cells, where it could mediate development of inflammatory responses or tolerance. 
1.3.4. Renal function of KIM-1  
KIM-1 was first identified as a gene that is specifically upregulated following renal IRI 
(Ichimura et al., 1998). Given its expression pattern on proximal TECs, it was proposed to have a 
role in the restoration of the morphological integrity of renal tubules (Ichimura et al., 1998). 
Almost 10 years after its identification in the kidney, several groups identified KIM-1 as a receptor 
for the “eat me” signal, phosphatidylserine, which enables proximal tubular cells expressing KIM-
1 to recognize and engulf apoptotic cells (Ichimura et al., 2008; Kobayashi et al., 2007). Because 
KIM-1 also binds to a variety of other ligands, including low-density lipoprotein, 
phosphatidylethanolamine, and necrotic cell debris, KIM-1 is classified as a type B scavenger 
receptor (Ichimura et al., 2008). Based on in vitro data, it was hypothesized that KIM-1 functions 
to remove dead tubular cell debris, preventing them from obstructing the lumen and triggering 
inflammation, which would impede tissue repair (Ichimura et al., 2012; Waanders et al., 2010).  
A vastly different role for KIM-1 in promoting survival has been proposed by another 
group: KIM-1 was shown to protect against cell death using an in vitro model of ischemic injury 
via depletion of ATP and glucose (Balasubramanian et al., 2012). During ischemic stress, KIM-1 
was shown to interact with and target the pro-apoptotic orphan nuclear receptor, NUR77, for 
lysosomal degradation, thereby preventing apoptosis. Most importantly, silencing KIM-1 or 
mutating the phosphatidylserine binding pocket of KIM-1 resulted in increased NUR77 abundance 
and decreased renal cell survival following ischemic injury in vitro. While this study hinted at a 
potential effective mechanism for KIM-1 in AKI, the in vivo relevance of this finding is uncertain.  
Remarkably, transgenic overexpression of Kim-1 in kidney TECs in the absence of a 
cellular injury stimulus had been shown to cause rapid kidney failure in mice by promoting 
progressive renal fibrosis (Humphreys et al., 2013). These transgenic mice spontaneously 
developed interstitial kidney inflammation with fibrosis, marked by tubular dedifferentiation, 
microcytic tubular dilation and fibrosis. The chronic expression of Kim-1 on TECs was shown to 
spontaneously increase the level of proinflammatory cytokines such as monocytes chemotactic 
protein-1 (MCP-1), which was believed to have caused the abnormal leukocyte infiltration in the 
absence of tissue injury. The development of kidney failure in these mice was associated with the 
classic extrarenal manifestations that can be seen in patients with CKD, such as hypertension, 
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anemia, and early death.  The conflicting findings observed between the Tim-1Δmucin and the Kim-
1 transgenic overexpression mice suggest that both the level and context of renal KIM-1 expression 
profoundly influences whether it has a protective or damaging effects.  
Following renal insult and upregulation of KIM-1 (Ichimura et al., 1998), there is evidence 
of low levels of immune cell infiltration into the kidney (Nozaki et al., 2012; Nozaki et al., 2011; 
Rong et al., 2011). Most of these infiltrating immune cells are located in the outer medulla, tubular 
wall and tubular basement membrane (Yang et al., 2015). Surprisingly, it was identified that KIM-
1 is a ligand for the leukocyte mono-immunoglobulin (Ig)-like receptor 5 (LMIR5) or CD300B, 
which is expressed by myeloid cells (Yamanishi et al., 2010). LMIR5-TIM-1 interaction increased 
the accumulation of LMIR5 expressing neutrophils in the renal interstitium of mice subjected to 
renal IRI. This, in turn, led to the activation of LMIR5 expressing mast cells, which augmented 
tissue damage following IRI (Yamanishi et al., 2010). Several groups have utilized inhibitory 
monoclonal antibodies against Tim-1 to determine whether inhibiting Tim-1 would have an effect 
on kidney injury (Nozaki et al., 2014; Nozaki et al., 2012; Nozaki et al., 2011). In a mouse model 
of cisplatin-induced nephrotoxicity, inhibiting Tim-1 on T- cells resulted in less renal injury and 
histological damage, reduced leukocyte infiltration, and lower levels of proinflammatory cytokines 
(Nozaki et al., 2011). Similarly, in a model of induced crescentic glomerulonephritis or glomerular 
injury, inhibition of Tim-1 resulted in reduced injury, leukocyte accumulation, and inflammatory 
response mediated by Th1 and Th17 (Nozaki et al., 2012). These studies all suggest a role for 
KIM-1 in the recruitment of inflammatory cells and propagation of further tissue damage, either 
via Tim-1 expressed on immune or kidney epithelial cells. 
Though the above studies provided much insight into the potential roles of KIM-1 in kidney 
injury by using Tim-1Δmucin mice or antibodies blocking of KIM-1, none of them have directly 
addressed whether KIM-1 expression plays a role in ischemic AKI in vivo. Given that these studies 
have proposed opposing roles for KIM-1, it remains to be determined whether KIM-1 is protective 
or harmful in AKI. In this thesis, we aim to determine the function of KIM-1 using Kim-1-deficient 
mice (S. H. Wong et al., 2010).  
1.3.5. Renal KIM-1 signalling  
Though much research has been done to help understand the physiological role of KIM-1 
in the kidney, very little is known about its capacity to mediate intracellular signalling in TECs. 
Understanding these pathways might be key for designing novel therapeutic targets needed to 
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ameliorate acute kidney injury. As discussed above, the extracellular domains of KIM-1 have been 
shown to bind to phosphatidylserine on apoptotic and necrotic cell debris (Ichimura et al., 2008), 
nuclear receptor NUR77  (Balasubramanian et al., 2012), and leukocyte mono-immunoglobulin 
(Ig)-like receptor 5 (LMIR5)/CD300b (Yamanishi et al., 2010) in TECs. However, none of these 
studies uncovered KIM-1 intracellular signalling proteins that mediate the renal functions of KIM-
1. To uncover the signalling mechanism by which KIM-1 binds and engulfs apoptotic cells, we 
immunoprecipitated KIM-1 from human embryonic kidney-293 (HEK-293) cells expressing HA-
tagged KIM-1 after stimulation with PS containing liposomes and performed mass spectrometry 
to determine associated proteins. Using this method, we identified the alpha subunit of the 
heterotrimeric G12 protein Gα12 (M. P. Strathmann et al., 1991), a novel KIM-1 interacting 
protein. Independently, using a yeast two-hybrid system (in collaboration with Dr. Tony Zervos, 
University of Central Florida) and a HeLa cell cDNA library, we identified another novel KIM-1 
interacting protein, the dynein light chain protein Tctex-1 (Lader et al., 1989). Both of these 
proteins are interesting candidates that we will briefly cover in the rest of the introductory chapter. 
In Chapter 2 and 3, we will study the role of Gα12 in KIM-1 expressing cells in ischemic AKI and 
the phagocytic process. In Chapter 4, we will study the role of Tctex-1 in KIM-1-expressing cells.  
 
1.4. ALPHA SUBUNIT OF HETEROTRIMERIC G12 PROTEIN 
1.4.1. Classification, structure and expression  
Heterotrimeric guanine nucleotide-binding proteins (G proteins) are signal transducers that 
link extracellular stimuli to intracellular effectors that mediate cellular responses to the stimulus 
(Suzuki et al., 2009). Extracellular signals are typically received via members of the seven-
transmembrane domain receptors known as G protein-coupled receptors (GPCRs). Alternatively, 
they can be associated with other receptors or modulators to mediate non-canonical functions. As 
heterotrimers, these proteins consist of a guanine-nucleotide binding subunit Gα, and closely 
associated β and γ subunits (usually referred to as Gβγ) (Neer, 1995). In the inactive state, a single 
α subunit is bound to a GDP molecule in association with a Gβγ subunit (Figure 1.5). Upon ligand 
binding to the associated GPCR or indirect activation of the G protein by other modulators, the 
GDP molecule is exchanged for a GTP molecule on the α subunit. A family of proteins called 
GTP-exchange factors or GEFs catalyzes this process. The GDP-GTP exchange causes a 
conformation changes in the switch regions of the α subunit (Dhanasekaran et al., 1996; Fields et 
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al., 1997), allowing it to dissociate from the Gβγ subunit. Both the GTP-bound α subunit and Gβγ 
subunits are “free” to interact and activate various downstream effectors. Meanwhile, the activated 
α subunit hydrolyzes the bound GTP to GDP via its intrinsic GTPase activity, which can be 
accelerated by GTPase activating proteins (GAPs). Once Gα is in an inactive form (GDP-bound), 
it dissociates from its effectors and reassociates with Gβγ subunits to start the cycle again.  
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Figure 1.5. The G protein cycle. 
A: In the inactive state, the G-protein coupled receptor (GPCR) is not associated with 
ligand. The G protein α subunit is bound to GDP molecule and is associated with Gβγ 
subunit close to the plasma membrane. B: Upon ligand binding to GPCR, GPCR 
undergoes a conformational change that allows the exchange of GDP to GTP on the α 
subunit. This change causes dissociation of the α subunit from the Gβγ subunit. Both the 
GTP-bound α subunit and Gβγ subunit can then interact with and activate various 
downstream effectors. Activation of the Gα subunit can also occur via a guanine 
nucleotide exchange factor (GEF) mechanism, which is independent of the GPCR (non-
canonical pathway). C: Once the ligand dissociates from the GPCR, the Gα subunit 
hydrolyzes the bound GTP to GDP through its intrinsic GTPase activity, which is 
accelerated by GTPase activating proteins (GAPs). When the Gα subunit becomes 
inactive, it dissociates from its effectors and reassociates with the Gβγ subunit, ending the 
activation of downstream effectors.  
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In humans, there are at least 21 Gα subunits encoded by 16 genes, six Gβ subunits encoded 
by five genes, and 12 Gγ subunits encoded by 18 genes (Downes et al., 1999; Oldham et al., 2008). 
The heterotrimeric G proteins are divided into four subfamilies based on the amino acid sequence 
similarity of the Gα subunits: Gαs, Gαi, Gαq and Gα12 (Simon et al., 1991; M. Strathmann et al., 
1989).  The G12 class of G proteins consists of Gα12 and Gα13, which share about 67 % amino 
acid sequence identity between them and less than 45 % identity with other α subunit groups 
(Dhanasekaran et al., 1996; M. P. Strathmann et al., 1991; Vara Prasad et al., 1994). In 1991, the 
G12 class of proteins became the last and the fourth class to be identified (M. P. Strathmann et al., 
1991). They both have an approximate molecular mass of 44 kDa and are insensitive to ADP-
ribosylation by pertussis toxin. Both Gα12 and Gα13 are phosphorylated by protein kinase C, 
which serves to block any interaction with the Gβγ subunit (Kozasa et al., 1996; Offermanns et 
al., 1996; Suzuki et al., 2009). In contrast to other Gα subfamilies, both Gα12 and Gα13 are only 
post-translationally modified by palmitoylation near their N-termini (Jones et al., 1998; 
Ponimaskin et al., 2000; Veit et al., 1994). This modification is important for the association of 
Gα13 with plasma membrane (Bhattacharyya et al., 2009) and for the localization of Gα12 to lipid 
rafts (Waheed et al., 2002). The N-terminal regions of both Gα12 and Gα13 share only 16 % amino 
acid identity (Dhanasekaran et al., 1996). This sequence difference is believed to determine their 
relative subcellular localization. Gα12 is mostly localized to the plasma membrane (Waheed et al., 
2002), but contains a mitochondrial targeting sequence that allows it to be associated with 
mitochondria under certain circumstances, where it is involved in mitochondrial motility and 
membrane permeability (Andreeva et al., 2008). On the other hand, Gα13 is localized to the cytosol 
and only translocate to the plasma membranes upon activation (Yamazaki et al., 2005). In addition 
to being involved in localization, the N-terminal sequences have also been shown to determine 
their selective coupling to various receptors (Yamaguchi et al., 2003). Although Gα12 and Gα13 
interact with different effectors and receptors, they are both activated by thrombin and 
lysophosphatidic acid via the protease-activated receptor and the lysophosphatidic acid receptors 
(Aragay et al., 1995; Hains et al., 2006; Q. Wang et al., 2004). Both Gα12 and Gα13 have a 
relatively slow rate of intrinsic nucleotide exchange and GTP hydrolysis, which suggests that they 
partake in prolonged signalling (Dhanasekaran et al., 1996; Kozasa et al., 1995). Though both 
proteins can activate common downstream signalling pathways (Kurose, 2003), significant 
differences have been observed between Gα12 and Gα13 knockout mice. Transgenic mice that 
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lack Gα13 are embryonically lethal due to their defect in angiogenesis, whereas mice deficient in 
Gα12 develop normally (Gu et al., 2002; Offermanns, 2001; Offermanns et al., 1997). This 
indicates that Gα12 and Gα13 regulate distinct signalling pathways and cannot completely 
compensate for each other in a physiologically significant manner.  
Gα12 is similar in structure to all other Gα subfamilies, as it has a GTPase and a helical 
domain (Oldham et al., 2006). The GTPase domain is composed of six-stranded β-sheets 
surrounded by five α-helices. The five α-helices contain three flexible loops, named Switch I, II 
and III (Lambright et al., 1994; Lambright et al., 1996; Wall et al., 1995). These switch regions 
undergo significant structural changes when in the GDP (Lambright et al., 1994; Mixon et al., 
1995) or non-hydrolyzable GTP (GTPγS) bound forms (Coleman et al., 1994; Noel et al., 1993). 
The GTPase domain also contains sites for binding to the Gβγ dimer, GPCRs, and downstream 
effector proteins (Lambright et al., 1996; Oldham et al., 2008; Sondek et al., 1996). On the other 
hand, the helical domain, consisting of six α-helices, serves to increase the affinity of Gα for 
guanine nucleotides (Remmers et al., 1999; Warner et al., 1998) and increases the GTP hydrolysis 
activity of the protein (Markby et al., 1993). It also plays an important role in coupling specific G 
proteins to specific effectors (W. Liu et al., 1998). Based on mutagenesis studies, both the amino 
and carboxyl termini are structurally and functionally important components of the protein (Suzuki 
et al., 2009; Yamaguchi et al., 2003). 
The identification of the interaction between Ser/Thr protein phosphatase type 5 (PP5) and 
both Gα12 and Gα13 was key to the development of a tool to study the biology of G12 proteins 
(Yamaguchi et al., 2002; Yamaguchi et al., 2003). Specifically, Yamaguchi, et al. demonstrated 
that the N-terminal regulatory tetratricopeptide repeat (TPR) within PP5 binds selectively to the 
GTP-bound forms of Gα12 or Gα13. This feature of PP5 allowed the use of the TPR domain 
conjugated to GST (GST-TPR) in the form of a GST pull-down assay to detect the level of active 
Gα12 and Gα13 in vitro or ex-vivo as we have done in this thesis (Sabath et al., 2008; Yanamadala 
et al., 2007). In addition, the constitutively active Gln (Q)→Leu (L) mutant of the α subunit for 
G12 (QL Gα12), which is incapable of GTP hydrolysis, and the wild-type (WT) Gα12 have been 
routinely used to test the sufficiency of Gα12 in driving various cellular processes (Vara Prasad et 
al., 1994; K. Wong et al., 2006; Zhu et al., 2004).  
Gα12 is ubiquitously expressed in all tissues, with lower levels of expression in the 
intestine (M. P. Strathmann et al., 1991). This expression pattern is different from Gα13, as its 
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expression levels vary between different tissues. The eye, kidney, liver, lung and testis have 
exhibited a higher levels of expression of Gα13 compared to other tissues.  
1.4.2. Function   
Gα12 interacts with many down-stream effectors that have overlapping functions (P. Kelly 
et al., 2007) (summarized in Table 1.2). This allows Gα12 to be involved in a myriad of cellular 
processes, such as cell growth, cellular transformation, cell polarity, cell migration, paracellular 
permeability, apoptosis, and membrane localization of different proteins (Refer to Table 1.2 for 
more information). We will be focusing on the function of Gα12 in the kidney for the purpose of 
this thesis.  
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Table 1. 3. Various proteins demonstrated to interact with Gα12 and the functional 
outcome(s) of these interactions. 
Proteins with an asterisk (*) have been shown to interact with both Gα12 and Gα13. 
Abbreviation: PP-protein phosphatase, eNOS-endothelial nitric oxide synthase, RGS-
Regulator of G protein signalling, AKAP-A-kinase anchoring protein, ZO-Zonula 
occludens, BTK-Bruton’s tyrosine kinase, Hsp- Heat shock protein, GAP-Guanine 
activating protein, SNAP-Soluble NSF-associated protein, GEF-Guanine nucleotide 
exchange factor. 
 
Protein Function Reference  
*Rho specific GEFs 
(work as GAP for 
Gα12) 
LARG 
PDZ-
RhoGEF 
P115RhoGEF 
Stimulate RhoA activation leading to 
many down-stream protein activation 
effects, such as, phosphorylation of 
focal adhesion kinase, paxillin and 
p130 Crk-associated substrate  
(Tanabe et al., 
2004), (Fukuhara et 
al., 2000), (Kuner 
et al., 2002), 
(Iguchi et al., 
2008), (Needham 
et al., 1998) 
*Protein 
Serine/Threonine 
phosphatases 5 (PP5) 
Activates many different downstream 
mediators leading to cell growth, 
differentiation, and DNA damage  
(Yamaguchi et al., 
2002) 
Protein phosphatase 
2A (PP2A) 
Activates apoptosis  (Zhu et al., 2004) 
Zonula occludens 1 
or 2 (ZO-1 or ZO-2) 
Disrupts tight junction to increase 
paracellular permeability  
(Meyer et al., 
2003; Meyer et al., 
2002) 
*Cadherins Promotes cell migration via release of 
the transcription activator β-catenin 
(Meigs et al., 2002; 
Meigs et al., 2001) 
p120-catenin Regulates cadherin and β-catenin 
interaction   
(Noren et al., 2000) 
α-SNAP Regulates localization of cadherins (Andreeva et al., 
2005) 
Heat shock protein 
90 (Hsp90) 
Localizes Gα12 into lipid rafts  (Vaiskunaite et al., 
2001; Waheed et 
al., 2002) 
*Radixin Serves as a cross-link between plasma 
membrane proteins and the actin 
cytoskeleton  
(Gohla et al., 1999; 
Vaiskunaite et al., 
2000) 
Axin (RGS protein) Mediates WNT signalling to control 
cell growth and differentiation  
(Stemmle et al., 
2006) 
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A-kinase anchoring 
protein (AKAP) Lbc  
Translocates Gα12 into plasma 
membrane to activate RhoA 
(Diviani et al., 
2001; Niu et al., 
2001) 
Bruton’s tyrosine 
kinase BTK 
Mediates Rho activation by tyrosine 
kinase activity (BTK)   
(Jiang et al., 1998; 
Suzuki et al., 
2003)) 
Ras specific GTPase 
activating protein 
(RasGAP1) 
Downregulates Ras signalling  (Jiang et al., 1998) 
*Socius Associates with Rho-like Rand protein 
to regulate stress-fiber disassembly  
(Tateiwa et al., 
2005) 
*Endothelial nitric 
oxide synthase 
(eNOS) 
Regulates nitric oxide biosynthesis  (Andreeva et al., 
2006) 
Polycystin-1 Regulates apoptosis and cystic cell 
growth 
(Xu et al., 2015;  
Yu et al., 2010;  
Yu et al., 2011; 
Yuasa et al., 2004) 
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Madin-Darby canine kidney (MDCK) cells engineered to allow the inducible expression 
of wild type or the constitutively active Gα12 (QL Gα12) have been instrumental in helping 
investigators understand the signalling processes downstream of Gα12 in kidneys (Meyer et al., 
2002). Using these cells, Denker and colleagues identified that the tight junction scaffolding 
protein, zonula occludens 1 (ZO-1) is a downstream target of Gα12. Moreover, they demonstrated 
that constitutively active Gα12 increases paracellular permeability in cells by disrupting the 
localization of tight junction proteins (ZO-1, occluding and claudin-1) and adherens junction 
proteins (E-cadherin and β-cateinin) (Meyer et al., 2003). Consequently, this leads to significant 
reorganization of actin cytoskeletons, and loss of polarity with mislocalization of Na-K-ATPase 
molecules. These Gα12-mediated changes were later shown to occur through the Gα12-dependent 
activation of Src kinase, and subsequent Src-mediated phosphorylation of the tight junction 
proteins and their disassembly from the epithelial barrier (Meyer et al., 2003; Sabath et al., 2006; 
Sabath et al., 2008).  
The involvement of Gα12 in tight junction dynamics is very important in renal 
development and survival after injury (Denker et al., 2011). There are large differences in the 
paracellular permeability across the nephron segments due to the diversity of claudin proteins 
throughout the tubule. The proximal tubule has the lowest permeability, reflecting the importance 
of preventing the filtrate from reentering the circulation via the intercellular spaces (Denker et al., 
2011; Gonzalez-Mariscal et al., 2000; Kiuchi-Saishin et al., 2002; Muto et al., 2010). In AKI, 
ischemic and toxic insults lead to the disruption of tight junctions (Kwon et al., 1998; Meyer et 
al., 2001; Tsukamoto et al., 1999). Once dysregulated by injury, the tight junctions must 
reassemble to re-establish a functional tubule and to avert fibrosis (Denker et al., 2011; Yu et al., 
2008).  
Interestingly, Gα12 directly interacts with polycystin-1, encoded by the PKD1 gene (Yu et 
al., 2010; Yu et al., 2011; Yuasa et al., 2004), which is mutated in autosomal dominant polycystic 
kidney disease. Silencing polycystin-1 (or mutating the PKD1 gene) causes the activation of Gα12 
followed by ADAM-10 metalloproteinase maturation and activation to increase shedding of E-
cadherin (Xu et al., 2015). This eventually causes the disruption of adherens junction proteins and 
loss of polarity causing cystic growth of renal epithelial cells.  
As discussed earlier, renal IRI results in TECs undergoing detachment and apoptosis. 
Activation of Gα12 via thrombin or constitutively active Gα12 has been shown to stimulate 
41 
 
apoptosis via its interaction with and activation of protein phosphatase 2A (PP2A) (Yanamadala 
et al., 2007;Zhu et al., 2004). This leads to the activation of JNK (c-Jun N-terminal kinase), 
followed by degradation of the anti-apoptotic protein Bcl-2, and finally to upregulation of IкBα, 
which potently stimulates the apoptosis pathway. Additionally, Gα12 interaction with polycystin-
1 was found to modulate Gα12/JNK stimulated apoptosis in TECs (Yu et al., 2010; Yu et al., 2011; 
Yuasa et al., 2004). The role played by activated Gα12 in triggering apoptosis suggests that Gα12 
might be pathogenic under ischemic conditions. Indeed, the activation of Gα12 after IRI was 
recently shown to exacerbate tissue damage and renal dysfunction (Yu et al., 2012). Denker and 
colleagues elegantly showed that ROS generated during IRI is a potent activator of Gα12 and its 
downstream effector, Src kinase (Yu et al., 2012). This study demonstrated that ROS-activated 
Src subsequently phosphorylates ZO-1 and occludin, leading to disruption of tight junctions. 
Accordingly, Gα12-deficient mice were protected from renal IRI, whereas mice with TECs-
specific transgenic overexpression of constitutively active Gα12 (Gα12 QL) exhibited more severe 
tissue damage and delayed recovery after IRI (Yu et al., 2012). Collectively these findings reflect 
on the adverse effects of Gα12 activation on renal epithelial cells during ischmic AKI and naturally 
led us to an interesting avenue of research to understand whether there is a link between KIM-1 
and Gα12 signalling during AKI.  
In this thesis, we will test if KIM-1 might be protective against renal IRI by inhibiting 
Gα12 activation by ROS. We will also explore a novel role for Gα12 in the phagocytosis of 
apoptotic cells by proximal TECs via KIM-1.  
 
1.5. TCTEX-1 
1.5.1. Structure and expression  
Tctex-1, short for t complex-testis expressed-1, was identified in a cDNA screen looking 
for candidate genes in the mouse t complex whose aberrant expression may be functionally related 
to sterility and transmission ratio distortion (Lader et al., 1989). Later, it was defined as a 
component of the light chain of the cytoplasmic dynein motor complex (Hirokawa, 1998; 
Hirokawa et al., 1998; Lader et al., 1989; Vallee et al., 2004). Cytoplasmic dynein is a minus-end 
directed motor complex on microtubules (Vallee et al., 2004). It is involved in the retrograde or 
apical transport of the bound cargoes that take place during processes such as nuclear migration, 
golgi and vesicular transport, and mitotic spindle orientation (Vale, 2003). Dynein is comprised of 
42 
 
two heavy chains (~530 kDa), each with ATPase and motor activity (Mazumdar et al., 1996; 
Vallee et al., 1990), two or three intermediate chains (~74 kDa), and a group of light intermediate 
(57-61 kDa) and light chain proteins (~8-22 kDa) (S. J. King et al., 2002). Other light chain 
proteins include LC8 and LC/roadblock. Human Tctex-1 and murine Tctex-1 share about 94 % 
sequence identity (Roux et al., 1994; Watanabe et al., 1996). Typically, the cargo is carried by 
dynein on the microtubules by association with another protein, dynactin (Vaughan et al., 1995). 
Tctex-1 and LC8 are two of the three dynein light chain subunits that are tightly associated with 
dynein intermediate chains to carry out the dynein function (Makokha et al., 2002; Nyarko et al., 
2004). 
Based on the crystal structure, Tctex-1 exists in dimeric forms consisting of two α-helices 
that are flanked by four β-strands of each monomer (Williams et al., 2005). One β strand crosses 
between the monomer to form an intersubunit β sheet at the dimer interface. Tctex-1 exhibits a 
tightly controlled dissociation-coupled unfolding mechanism, which indicates the absence of 
stable monomer form of Tctex-1under normal circumstances (Talbott et al., 2006). At the dimer 
interface, a water channel exists that contains a threonine residue at position 92 (Song et al., 2007). 
The phosphorylation of Tctex-1 at Threonine-92 was shown to directly mask the binding site to 
the dynein intermediate chain, which mediates the dissociation from dynein as a phosphorylated 
dimer (Song et al., 2007). Additionally, another Tctex-1 phosphorylation site exists at Threonine-
94 (Thr-94), which can be phosphorylated by protein kinase C in vitro (Chuang et al., 2005). This 
phosphorylation site allows for the dissociation from the dynein complex to mediate dynein-
independent functions. Another important site of phosphorylation is Serine-82 of Tctex-1, and 
phosphorylation at this site has been shown to reduce its binding to dynein, but not its interaction 
with specific targets (e.g. rhodopsin) (Yeh et al., 2006). The N-terminus of Tctex-1 consists of 8-
13 amino acids and usually appears splayed away from the structure to mediate binding to 
interacting partners (Williams et al., 2005). In addition, Tctex-1 contains four tyrosine residues 
that could be post-translationally modified by phosphorylation; however, the role of 
phosphorylation at these sites is still unknown (Campbell et al., 1998; Mok et al., 2001).  
Tctex-1 has been shown to be differentially expressed in various tissues; the kidney, spleen 
and testis have higher levels of Tctex-1 than brain as determined by Western blot (S. M. King et 
al., 1996). Immunofluorescence staining of endogenous Tctex-1 suggests that it is localized to the 
Golgi apparatus and along microtubules (Tai et al., 1998). This can be disrupted if the cells are 
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treated with microtubule depolymerizating drugs (nocodazole) or a Golgi apparatus disruptor (e.g. 
Brefeldin A). 
1.5.2. Function and interacting partners 
Tctex-1 has diverse dynein-dependent and -independent functions in cells (Hirokawa, 
1998; Hirokawa et al., 1998; Lader et al., 1989) (Table 1.3). Through dynein-dependent functions, 
Tctex-1 is associated with microtubules in order to mediate a range of intracellular motility events, 
such as retrograde trafficking in neurons and receptor trafficking (Sachdev et al., 2007; Tai et al., 
1998). On the other hand, Tctex-1 also functions independently of dynein to regulate actin 
cytoskeletal dynamics (Chuang et al., 2005). These studies found that phosphorylation of Tctex-1 
at Threonine-94 or Serine-82 (Chuang et al., 2005; Machado et al., 2003; Song et al., 2007) 
promoted its dissociation from the dynein light chain allowing it to bind to other non-dynein 
proteins in order to mediate various effector functions (Chuang et al., 2005; Song et al., 2007). 
Interstingly, the role of Tctex-1 in renal TECs or in the kidney has not been elucidated. Our studies 
of the interaction of KIM-1 with Tctex-1 will be the first to implicate a role for it in the kidney.  
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Table 1. 4. Tctex-1 interacting partners and the functional outcome of their 
interactions. 
Proteins with an asterisk (*) have been shown to mediate functions independently of 
dynein. Abbreviation: Bone morphogenetic receptor type II (BMPR-II), Cluster of 
differentiation 5 (CD5), Tropomyosin receptor kinase (Trk), Voltage-dependent anion-
selective channel 1 (VDAC1), Rho-specific exchange factor (GEF-H1), Lbc's first cousin 
(Lfc) 
 
Protein  Function  Reference  
Dynein intermediate 
chain  
Mediates cargo binding and 
trafficking  
(Mok et al., 2001) 
Fyn kinase  Involves in mitosis of lymphocytes   (Campbell et al., 
1998; Kai et al., 1997) 
Doc2 Intracellular vesicle transports of 
cathepsin D 
(Nagano et al., 1998) 
Small GTPase FIP-1 Involves in adenoviruse life cycle 
and adenovirus mediated inhibition 
of tumor necrosis factor alpha-
induced apoptosis 
(Lukashok et al., 
2000) 
Rhodopsin  Transports of rhodopsin containing 
vesicles  
(Tai et al., 1999; Tai 
et al., 2001; Yeh et 
al., 2006) 
Bone morphogenetic 
receptor type II 
(BMPR-II)  
Regulates vascular remodelling in 
primary pulmonary hypertension  
(Machado et al., 2003) 
Parathyroid hormone 
receptor  
Regulates agonist induced receptor 
internalization  
(Sugai et al., 2003) 
Polio virus receptor 
(CD 155)  
Retrograde axonal transport of 
virus along neuronal cell body  
(Mueller et al., 2002; 
Ohka et al., 2004) 
Cluster of 
differentiation (CD 5 )  
Regulates vesicles transport in T 
and B cells  
(Bauch et al., 1998) 
Tropomyosin receptor 
kinase (Trk) family, 
also known as receptor 
Tyrosine Kinase  
Trk A, TrkB, TrkC 
Regulates Trafficking of vesicles 
containing nerve growth factor 
(ligand for Trk) in neuron  
(Yano et al., 2004; 
Yano et al., 2000; 
Yano et al., 2001) 
Voltage-dependent 
anion-selective channel 
1 (VDAC1) 
Involves in trafficking of the 
VDAC1 into the membrane and 
regulation of mitochondria 
permeabilization  
(Fang et al., 2011; 
Schwarzer et al., 
2002) 
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Tastin (Trophinin-
binding protein) 
Regulates spindle assembly and 
centrosome integrity during mitosis 
(Nadano et al., 2002; 
Yang et al., 2008) 
*βγ subunit of G 
protein  
Regulates neurite outgrowth  
Regulates RhoA and Rac1 
mediated actin cytoskeletal changes  
(Meiri et al., 2014; 
Sachdev et al., 2007; 
Takesono et al., 1999; 
Yeh et al., 2013) 
Rho-specific exchange 
factor (GEF-H1) 
(Human) or  
Lbc's first cousin (Lfc) 
(murine) 
 
Regulates RhoA and Rac1 activity  
Regulates actin and microtubule 
assembly  
Involves in mitotic spindle 
assembly  
(Conde et al., 2010; 
Meiri et al., 2009; 
Meiri et al., 2012) 
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Earlier studies regarding Tctex-1 revealed that its interaction with Rhodopsin, a GPCR, is 
necessary for vesicular transport of rhodopsin from the Golgi apparatus to the apical cell-surface 
(Tai et al., 1999; Tai et al., 2001). This Tctex-1-dependent transport mechanism was found to 
require the dynein intermediate chain. Phosphorylation of Tctex-1 at Serine-82 causes a reduced 
affinity for dynein, but not to rhodopsin (Yeh et al., 2006). This suggested that Tctex-1 is 
modulated by phosphorylation to control cargo release once it delivers it to the apical membrane. 
This could be the case for KIM-1, where Tctex-1 could be involved in trafficking between the 
cell surface and the lysosome or endoplasmic reticulum via clathrin-coated vesicles.  
Tctex-1 also plays an important role in actin and microtubule dynamics. This was first 
evident in embryonic hippocampal neurons development, where Tctex-1 mediated Rac1 
activation through dynein independent function (Chuang et al., 2005; Sachdev et al., 2007). 
More recently, Tctex-1 was shown to be a negative regulator of the Rho GEF; Lfc (in mice) or 
GEF-H1 (in humans) (Meiri et al., 2009). Tctex-1 interacts with Lfc and this inhibits cortical 
neurogenesis and induces disruption of proper mitotic spindle orientation (Conde et al., 2010; 
Gauthier-Fisher et al., 2009). Lfc and GEF-H1 are Rho-specific guanine nucleotide exchange 
factors (Rho GEF), which interact with microtubules, and their overexpression promotes stress 
fiber formation through RhoA activation (Birukova et al., 2006; Krendel et al., 2002; Ren et al., 
1998). Tctex-1 binding to Lfc or GEF-H1 represses their nucleotide exchange activity indirectly 
through sequestering of Lfc or GEF-H1 to microtubules (Meiri et al., 2012). In addition, the 
phosphorylation of Lfc or GEF-H1 at Serine-885 by protein kinase A is an important step 
required to create a high affinity 14-3-3 binding site that inhibits their exchange activity (Meiri et 
al., 2009). Once Lfc or GEF-H1 are activated, they are released from microtubules to activate 
and modulate actin structures. Hence, Lfc or GEF-H1 mediates cross-talk between actin and 
microtubules (Krendel et al., 2002).   
Interestingly, Tctex-1 has been identified as an activator of G protein signalling 2 
(AGS2), a G protein coupled receptor-independent activator of the heterotrimeric G proteins in 
yeast (Takesono et al., 1999). Tctex-1 activates this G protein by binding to the Gβγ subunit 
independently of dynein (Sachdev et al., 2007; Takesono et al., 1999). This binding seems to 
free the α subunit of the G protein to mediate other down-stream effects, such as neurite 
outgrowth in primary hippocampal neurons (Sachdev et al., 2007). Recently, Tctex-1 was 
specifically implicated in Gα12 signalling by the Rottapel group in Toronto (Meiri et al., 2014). 
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They elegantly showed that activation of the GPCR for Gα12 allows the interaction between 
PP2A and GEF-H1. This interaction leads to dephosphorylation of GEF-H1 on Serine-885 which 
triggers the release of GEF-H1 from the inhibitory dynein complex. Subsequently, released GEF-
H1 becomes free to bind to the Gα12, leading to the disassembly of the heterotrimeric complex. 
Meanwhile, the Gβγ subunit binds to Tctex-1, disrupting the anchoring function of Tctex-1 that 
sequesters GEF-H1 to microtubules. Ultimately, this leads to the activation of RhoA and stress 
fiber formation, which is a hallmark of Gα12 agonists and GEF-H1 activation (Figure 1.6). This 
interesting interplay between Gα12 and Tctex-1 may have implications for our work linking 
KIM-1 to both Gα12 and Tctex-1 during phagocytosis of apoptotic cells, wherein both actin and 
microtubules are suggested to be important. In professional phagocytes, both actin and 
microtubules are continuously remodelled during phagocytosis. During engulfment, localized 
actin polymerization occurs underneath the cell corpse to help in forming the phagocytic cup and 
in the extension of pseudopods, all of which require activation of Rho family of GTPases, RhoA, 
Rac and Cdc42 (Castellano et al., 2001; Hochreiter-Hufford et al., 2013). Microtubules are also 
involved in the initial process of engulfment since microtubules disruption reduces pseudopods 
dynamic (Rosania et al., 1996). Following particle uptake, disassembly of actin filament is more 
pronounced with increasing microtubule networks surrounding the engulfed particle (Castellano 
et al., 2001; Harrison et al., 2002). This allows for the maturation of the phagosome where 
microtubules function as tracks for delivery of the engulfed target to the degradation machinery. 
In KIM-1 mediated uptake of apoptotic cells, the exact dynamics of actin and microtubules is not 
known. We aim throughout this thesis to understand the link between KIM-1, its interacting 
partners and the actin/microtubules cytoskeleton.  
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Figure 1.6. Regulation of actin cytoskeleton dynamics by Gα12 or Tctex-1 via Rho 
GEF (GEF-H1). 
A: In the absence of GPCR stimulation, Tctex-1 is bound to microtubules via the dynein 
intermediate chain (DIC). Lfc or GEF-H1 is phosphorylated at Serine-885 by protein 
kinase. This creates an inhibitory site (dark blue) which allows for Lfc or GEF-H1 to be 
tethered to microtubules via Tctex-1. Under these conditions, heterotrimeric G12 protein 
is intact. As such, the α-subunit is in an inactive form (GDP-bound) and the βγ subunit is 
at the membrane. B: Upon GPCR stimulation (e.g. Thrombin), PP2A (not shown) 
interacts with Lfc or GEF-H1 and this triggers its dephosphorylation and release from the 
Tctex-1-dynein complex. LFc or GEF-H1 then binds to active Gα12, which was activated 
as a response to ligand dependent activation of the GPCR. Binding of Lfc or GEF-H1 to 
Gα12 allows the activation of the down-stream effector, RhoA. On the other hand, the 
released βγ subunit binds to Tctex-1 to stabilize it and prevent it from rebinding to Lfc or 
GEF-H1.  
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1.6. PURPOSE, HYPOTHESIS AND SPECIFIC AIMS 
Over the past few years, several research groups have independently provided evidence 
suggesting that KIM-1 is sufficient to mediate the phagocytic clearance of apoptotic cells and 
necrotic debris (Ichimura et al., 2008; Kobayashi et al., 2007). Until now, in vivo evidence for a 
functional role for KIM-1 in AKI has been lacking. Moreover, there has been limited information 
regarding whether KIM-1 mediates intracellular signalling in TECs during AKI.  
Our hypothesis is that KIM-1 upregulation on TECs protects mice from ischemic AKI and 
mediates phagocytic signalling via downstream interaction with Gα12 and Tctex-1. The purpose 
of the work described in this thesis is to understand the physiological role of KIM-1 during 
ischemic acute kidney injury and uncover the potential signalling mechanisms involved. In 
addition, we aim to understand mechanistically how KIM-1 carries out its phagocytic function. 
During this study, we have identified two novel KIM-1 interacting proteins, Gα12 and Tctex-1. 
The identification of these KIM-1 targets allowed us to focus on three main aims:  
1. Role of KIM-1 and Gα12 in renal ischemia-reperfusion injury 
2. Role of KIM-1 and Gα12 in KIM-1-mediated phagocytosis 
3. Role of KIM-1 and Tctex-1 in KIM-1-mediated phagocytosis 
The data presented in Chapters 2, 3 and 4 of this thesis will summarize our research designed to 
address these aims.    
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2.1. SUMMARY  
Ischemic acute kidney injury (AKI) is a serious untreatable condition. Activation of the G-
protein alpha-12 (Gα12) subunit by reactive oxygen species (ROS) is a major cause of tissue 
damage during renal ischemia-reperfusion injury. Kidney Injury Molecule-1 (KIM-1) is a 
transmembrane glycoprotein that is highly upregulated during AKI, but the physiologic 
significance of this is unclear. In this chapter, we show for the first time that KIM-1 inhibits Gα12 
activation, and protects mice against renal ischemia-reperfusion injury. We reveal that KIM-1 
physically interacts with and inhibits cellular Gα12 activation following inflammatory stimuli 
including ROS, by blocking GTP binding to Gα12. Compared to wild type (Kim-1+/+) mice, Kim-
1 knockout (Kim-1-/-) mice exhibited greater Gα12 and downstream Src activation, both in primary 
tubular epithelial cells after in vitro stimulation with H2O2, and in whole kidneys after unilateral 
renal artery clamping. Finally, we show that Kim-1-deficient mice had more severe kidney 
dysfunction and tissue damage after bilateral renal artery clamping, compared to wild type mice. 
Our results suggest that KIM-1 functions as part of an endogenous protective mechanism against 
renal ischemia-reperfusion injury through inhibition of Gα12.  
 
2.2. INTRODUCTION 
Acute kidney injury (AKI) is a serious medical condition that most often results from 
ischemia-reperfusion injury (IRI) and for which there is no effective treatment (Bonventre et al., 
2011; Chertow et al., 2005). Kidney injury molecule-1 (KIM-1) is a cell-surface glycoprotein 
receptor (Freeman et al., 2010) that is specifically upregulated on the apical surface of proximal 
tubular epithelial cells (TECs) following AKI (Ichimura et al., 1998). It is a highly sensitive and 
specific biomarker of tubular injury that is virtually absent in healthy kidneys (Vaidya et al., 2010). 
Both mouse and human KIM-1 [also known as T cell immunoglobulin, mucin domain-1 protein 
(TIM-1), and hepatitis A virus cellular receptor-1 (HAVCR-1)] are small type I transmembrane 
glycoproteins that belong to the TIM gene family (Freeman et al., 2010). Structurally, KIM-1 is 
made up of an IgV-like domain, a mucin domain, a transmembrane domain, and an intracellular 
domain that has been implicated in T cell signaling (de Souza et al., 2005; Z. Zhang et al., 2007). 
The pathophysiologic role of KIM-1 signaling in AKI remains unknown.  
Here we reveal a novel interaction between KIM-1 and Gα12. Gα12 is a ubiquitously 
expressed G protein belonging to the G12 family of G proteins that has pleiotropic effects on cells 
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including inducing proliferation, focal adhesion assembly, cytoskeletal reorganization, apoptosis 
and disruption of tight junctions (Dhanasekaran et al., 1996). Recently, Yu et al.,  (Yu et al., 2012) 
demonstrated that activated Gα12 is a pivotal mediator of TEC injury caused by ischemia-
reperfusion. ROS generated during ischemia-reperfusion stimulates Gα12 to activate Src-
dependent injury pathways. Specifically, Gα12-deficient mice were protected from renal IRI, 
whereas mice with TEC-specific transgenic overexpression of constitutively active Gα12 (Gα12 
QL) exhibited worse tissue damage and delayed recovery after IRI (Yu et al., 2012). Given the 
relevance of KIM-1 and Gα12 in AKI, we investigated the biological relationship between these 
proteins using in vitro and in vivo models of ischemic AKI. 
 
2.3. EXPERIMENTAL PROCEDURES  
2.3.1. Animal preparation and induction of ischemia-reperfusion injury  
 All mouse experiments were performed according to the animal experimental guidelines 
issued by the Animal Care and Use Committee at Western University (refer to the Appendix for 
approval certificate). C57BL/6 wild type (Kim-1+/+) mice were obtained from the Charles Rivers 
Laboratory. Kim-1 knock out (Kim-1-/-) mice were generously provided to us by Dr. Andrew N. 
J. McKenzie (MRC laboratory of Molecular biology, Cambridge, UK). The Kim-1-/- mice were 
backcrossed over generations to the C57BL/6 strain and homozygous knockout mice (Kim-1-/-) 
were obtained by inter-breeding the heterozygotes (Kim-1+/-). Genomic DNA was isolated from 
mice tail digests and genotypes were determined by PCR using primers ASEQ965 5’-
ATATCTCAGGAA TGGGATTG TGAC-3’ and ASEQ966 5’-CTACTGTATTT 
AACTGATTTGAAG-3’. 6-9 week-old male Kim-1+/+ or Kim-1-/- mice weighing 20-25 grams 
were subjected to unilateral or bilateral renal pedicle ligation for 25-35 minutes (as indicated) at 
32 °C, as described previously (Z. X. Zhang et al., 2010). To assess Gα12 activity in the 
ischemic and contralateral kidneys, following reperfusion, the kidneys were removed after being 
flushed with cold PBS. Sham controls were treated with the same operative procedure as in the 
injury group, but kidneys were not clamped.  
2.3.2. Renal function and histology  
Serum creatinine was detected by a Jaffe reaction method with an automated CX5 clinic 
analyzer (Beckman, Pasadena, CA). Kidney sections (5–6 microns) from animals at 24 and 48 
hours  (h) after reperfusion or sham surgery were stained with Periodic acid–Schiff (PAS) by a 
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trained pathologist-blinded to sample type (Dr. Aaron Haig) and the degree of tubular injury was 
graded by light microscopy by a single pathologist blinded to mouse strain using a 
semiquantitative score, that examined proximal tubule dilation, brush-border damage, 
proteinaceous casts, interstitial widening, and necrosis (0: none, 1: <10 %, 2: 11~25 %; 3: 26-45 
%; 4: 46-75 %; 5: >75 %) as described previously (Bakker et al., 2014). 
2.3.3. Mass spectrometry  
KIM-1 immune complexes were derived from human embryonic kidney-293 (HEK-293) 
cells stably overexpressing HA-tagged KIM-1 (Z. Zhang et al., 2007) or vector alone (Otsuka et 
al., 2005). Plasmid expressing KIM-1-HA was a kind gift from Prof. Joseph Bonventre (Brigham 
and Women's Hospital, Harvard Institutes of Medicine, Boston, MA) and it was generated in a 
similar manner as described in Zhang, et al (Z. Zhang et al., 2007). Briefly, the full-length human 
KIM-1 with an N-terminal hemagglutinin (HA) tag was generated by PCR using phKIM1.2 as 
template and then sub-cloned into the EcoRV site of eukaryotic expression vector pcDNA3 
(Invitrogen, Carlsbad, CA). Upon transfection of KIM-1-HA, protein and surface expression was 
comparable to endogenous KIM-1 expressed in human renal adenocarcinoma cells (769P) (Figure 
2.1A, B). Immunoprecipitation was done with anti-HA antibody (Santa Cruz Biotechnology, Santa 
Cruz, CA). SDS-PAGE was used to identify unique bands that co-immunoprecipitated with KIM-
1 and a target protein band of approximately 38 kDa was excised and subjected to in-gel tryptic 
digestion followed by mass spectrometry (MALDI TOF MS) and analyzed by the Taplin mass 
spectrometry facility (Harvard Medical School, Cambridge, MA).  
2.3.4. Cell lines and culture  
Human embryonic kidney-293 (HEK-293) cells stably expressing control vector or human 
KIM-1 were cultured at 37 °C in 5 % (vol/vol) CO2 and maintained in DMEM (Invitrogen, 
Carlsbad, CA) containing 5 % (vol/vol) fetal bovine serum (FBS) and 800 μg/mL Geneticin 
(G418) Sulfate (Santa Cruz Biotechnology, Santa Cruz, CA). Expression of KIM-1 was confirmed 
by Western blotting. HEK-293 cells were transfected with truncated version of KIM-1 containing 
its cytosolic domain fused to transmembrane domain using Lipofectamine 2000® (Invitrogen, 
Carlsbad, CA). Briefly, this plasmid was generated by PCR using the Not1 restriction sites of the 
human KIM-1 plasmid (Z. Zhang et al., 2007). The resulting construct containing the 
transmembrane and cytosolic domain of KIM-1 was sub-cloned into pFLAG-CMV™-3 (Sigma-
Aldrich, St. Louis, MO, USA). The expression of the construct was confirmed using Western 
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blotting (Figure 2.1C). Kidneys isolated from 3-4 week old C57BL/6 Kim-1+/+ or Kim-1-/- mice 
were cultured to select for proximal tubular epithelial cells (TECs) as described previously (Sharpe 
et al., 2012). Briefly, kidneys were homogenized and the cells isolated were cultured for the first 
6 days in serum free DMEM/F-12 mixed media (1:1) (Invitrogen, Carlsbad, CA) supplemented 
with 5 %  insulin-transferrin-selenium solution, 5 % penicillin-streptomycin solution (Invitrogen, 
Carlsbad, CA), 0.5 µg/ml of mouse epidermal growth factor (EGF) (Peprotech, Rocky Hill, NJ), 
50 ng/ml hydrocortisone (Invitrogen, Carlsbad, CA). After 6 days, cells were cultured with the 
same media mixture supplemented with 5 % FBS as described earlier.  
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Figure 2.1. Protein expression of KIM-1-HA and KIM-1 with truncated KIM-1 containing 
its transmembrane and cytosolic domains in HEK-293 cells 
A: Human embryonic kidney-293 (HEK-293) cells were transfected with either control vector 
(pcDNA3) or HA tagged KIM-1-expressing vector (KIM-1-HA). Cell lysates were compared to 
the endogenous level of KIM-1-expression in human renal adenocarcinoma cell line (769P) by 
Western blotting using antibodies against full length KIM-1 (extracellular domain), and actin. B: 
Surface staining for KIM-1 in HEK-293 cells expressing pcDNA3 or KIM-1-HA as determined 
by flow cytometry. C: HEK-293 cells were transfected with either full-length KIM-1 or truncated 
flag-tagged KIM-1 construct containing only the transmembrane (TM) and the cytosolic domain 
of KIM-1. Lysates from these cells were run on Western blot and probed for full-length KIM-1 
(antibody against extracellular domain of KIM-1), the cytosolic domain of KIM-1 (antibody 
against cytosolic domain of KIM-1), and actin. Lysate from human renal adenocarcinoma cells 
(769P) was used as a positive control. Data represent three independent experiments.  
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2.3.5. Western blot  
 Confluent monolayers of cell lines (HEK-293 or TECs) or kidney cortices were homogenized and 
lysed in ice cold lysis buffer and were centrifuged at 15,000 g for 10 minutes. The supernatant was 
collected for Western blot analysis. Protein concentrations were determined using the Pierce BCA 
Protein Assay Kit (Thermo Fisher Scientific, Rockford, IL), and 50 µg of protein was used as input 
for the experiment. 1000 µg of protein was used for immunoprecipitation or GST-TPR pull-down 
experiments. Input and immunopreciptated samples were electrophoresed on Mini-PROTEAN 
TGX gels 4-20 % (Bio-Rad Laboratories, Hercules, CA) and transferred to a polyvinylidene 
difluoride membrane (Millipore, Billerica, MA). Membranes were blocked with blocking buffer 
(Tris-buffered saline, 0.1 % Tween-20, and either 5 % nonfat dried milk (Bioshop, Burligton, ON) 
or 5 % bovine serum albumin solution (Sigma Aldrich, St. Louis, MO) for 30 minutes and were 
then incubated overnight at 4 °C with one of the following primary antibodies: cytosolic domain 
of human KIM-1 (PA 4145, Custom antibody, Thermo Fisher Scientific, Rockford, IL) (Ichimura 
et al., 1998), extracellular domain of human KIM-1 (Dr. Bonventre, Harvard medical School, 
Cambridge, MA)(Bailly et al., 2002), extracellular domain of mouse Kim-1 (AF1817, R&D 
systems, Minneapolis, MN), Gα12 (S-20)/actin (I-19)/GAPDH (V-18) or c-Src (N-16) (Santa Cruz 
Biotechnology, Santa Cruz, CA), and active Src (pY419-Src) antibody (44-660G, Invitrogen, 
Carlsbad, CA). Membranes were washed and incubated with the appropriate horseradish 
peroxidase-conjugated secondary antibody (dilution 1:30000, Jackson ImmunoResearch 
Laboratories, West Grove, PA) for 1 hour at room temperature in blocking buffer. Proteins were 
visualized using SuperSignal West Femto chemiluminescent substrate (Thermo Fisher Scientific, 
Rockford, IL). The resulting protein bands were scanned using a Brother scanner (Brother 
Electronics, Dollard-des-Ormeaux, QC) and the integrated density of each protein band was 
determined using ImageJ Software. Each densitometric graph represents at least three independent 
experimental results. To normalize for protein loading, the integrated density of each band was 
divided by the integrated density of the actin band in the same lane from the same membrane (Kerr 
et al., 1972).  
2.3.6. Immunoprecipitation and GST-Gα12 pull-down assay  
For immunopreciptation (IP), cells were lysed with ice-cold lysis buffer (25 mM Hepes 
(Sigma Aldrich, St. Louis, MO), 150 mM NaCl, 15 mM MgCl2, 1 % Triton X-100, and Mini-
protease inhibitors tablet (Roche Diagnostic, Basel, Switzerland)) (Meyer et al., 2003). Following 
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protein quantification, immunoprecipitation of 1000 µg of each lysate was done using antibodies 
against Gα12,  the cytosolic domain of KIM-1 (Z. Zhang et al., 2007), or rabbit IgG control (sc-
2027, Santa Cruz Biotechnology, Santa Cruz, CA) and protein-A/G Sepharose beads (Santa Cruz 
Biotechnology). Lysates (representing 5 % of total lysate) and immunoprecipitation samples were 
analyzed by SDS-PAGE and Western blot as described above. For GST-Gα12 pull-downs, KIM-
1-HA was in vitro translated and S35-labelled in rabbit reticulocytes lysates as described previously 
(Zhu et al., 2004). Protein lysates were incubated with 1 gram of GST-Gα12 or GST alone and 
eluted after 3 hours incubation. Samples were analyzed by SDS-PAGE and autoradiography 
(Biomax; Denville Scientific, Metuchen, NJ).  
2.3.7. Gα12 activation assay (GST-TPR pull down)  
A construct of GST-fused to the tetratricopeptide repeat (TPR) domain of Ser/Thr protein 
phosphatase type 5 (PP5) was kindly provided by Dr. N Dhanasekaran (Temple University, USA) 
(Zhu et al., 2004). GST-TPR was purified from Escherichia coli and conjugated to glutathione-
agarose beads (Thermo Fisher Scientific, Rockford, IL) as described (Yamaguchi et al., 2002). 
GST-TPR conjugated beads were freshly made for each experiment. Kidney homogenates 
following ischemia-reperfusion injury or sham surgery, as well as unstimulated cells or cells 
stimulated with 5 mM H2O2 (Bio Basic, Amherst, NY) or  2 U/ml alpha-thrombin (Enzyme 
Research Laboratories, South Bend, IN) were lysed with ice-cold lysis buffer (50 mM Hepes pH 
7.5) (Sigma Aldrich, St. Louis, MO), 1 mM EDTA, 3 mM DTT, 2 mM MgSO4, 1 % 
Polyoxyethylene (10) lauryl ether (C12E10), and mini-protease inhibitor tablet (Roche Diagnostic, 
Basel, Switzerland) (Yu et al., 2012). Supernatants containing 1 mg of the protein were incubated 
with GST-TPR coupled glutathione-agarose beads at 4 °C for 5 hours (Zhu et al., 2004). Where 
indicated, cell lysates were loaded with 1 µM non-hydrolyzable GTP analog (GTPγS) 
(Cytoskeleton, Denver, CO) following protein quantification and incubated for 15 minutes at room 
temperature prior to adding GST-TPR coupled glutathione-agarose beads. Samples were 
centrifuged at 5000g for 5 minutes and washed with 1x PBS twice before eluting the bound active 
Gα12. Both 50 µg of protein (input) and pull-down samples were analyzed by SDS-PAGE and 
Western blotting by probing for Gα12 to represent total (input) and active Gα12 (pull-down) in 
these samples.  
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2.3.8. Immunofluorescence and confocal microscopy  
HEK-293 cells were cultured at subconfluent density on poly-DL-lysine hydrobromide 
(Sigma Aldrich, St. Louis, MO) coated glass cover slips. Cells were transfected with GFP-tagged 
Gα12 construct (Andreeva et al., 2008) using Lipofectamine 2000® (Invitrogen, Carlsbad, CA). 
Cells were fixed with 4 % paraformaldehyde (Sigma Aldrich, St. Louis, MO) and stained for 
surface KIM-1 using antibody against extracellular domain of KIM-1 overnight at 4 °C. The slides 
were washed and incubated with Alexa555 conjugated secondary antibody (Molecular probes, 
Invitrogen, Carlsbad, CA). Coverslips were mounted using Shandon-Mount® (Thermo Fisher 
Scientific, Rockford, IL) permanent mounting medium. Mice kidneys following ischemia-
reperfusion injury or sham surgery were extracted and quartered. The sections were fixed in 4 % 
paraformaldehyde overnight for subsequent paraffin embedding. Kidney cortex sections (10 µm) 
were sliced at 50-μm intervals using a Leica RM2125 microtome (Leica Microsystems, Buffalo 
Grove, IL) and were mounted on glass slides. Sections were blocked with 5 % horse serum 
(Invitrogen, Carlsbad, CA) and hybridized overnight at 4 °C with antibodies specific for either the 
extracellular domain of mouse Kim-1 (SAB3500252, dilution 1:50, Sigma Aldrich, St. Louis, 
MO), or Gα12 (S-20, dilution 1:50, Santa Cruz Biotechnology, Santa Cruz, CA). Sections were 
then washed and incubated with the appropriate fluorophore-conjugated secondary antibodies 
(dilution 1:100; Invitrogen, Carlsbad, CA). Cover slips were applied to all the sections with 
Shandon-Mount® permanent mounting medium before imaging. Samples were viewed with 
FLUOVIEW X83I confocal microscopy (Olympus, Tokyo, Japan). Data were acquired and 
analyzed using FLUOVIEW FV10 ASW 4.0 viewer and ImageJ software (National Institutes of 
Health, Bethesda, MD) was used to determine Pearson’s coefficient for colocalization of KIM-1 
and Gα12. Quantification of colocalization was determined for 5 random fields per sample and 
was done in 4 independent experiments.  
2.3.9. Statistical analysis  
 Statistical analysis was done using Graph Pad Prism (Graph Pad Software Inc., La Jolla, CA). 
Mean or median differences between knockout and wild type mice were compared using unpaired 
t-tests or Mann-Whitney-U tests as appropriate; proportions were compared using Chi-squared 
tests, and 95 % confidence intervals were calculated using the method of Wilson (Wilson, 1942). 
P-values of < 0.05 were considered significant. Error bars represent the standard error of the mean 
unless otherwise indicated.  
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2.4. RESULTS 
2.4.1. KIM-1 interacts with Gα12  
To identify putative signalling proteins downstream of KIM-1, we performed mass-
spectrometric analysis on KIM-1 (anti-HA) immunoprecipitates from HEK-293 cells stably 
overexpressing KIM-1 fused to a c-terminal HA tag (Z. Zhang et al., 2007) or vector alone as 
described in the methods. Of the several target proteins identified at 40 kDa (Table 2.1), we 
focused on Gα12 because of its previously described roles in the biology of TECs and AKI (Yu et 
al., 2012; Yanamadala et al., 2007).  
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Table 2.1. Potential KIM-1 interacting proteins as determined by mass spectrometry. 
Interacting proteins Accession 
number  
 Peptide sequence identified  
Homo sapiens guanine nucleotide-binding 
protein, alpha-12 subunit (g alpha 12) 
Q03113 ILLLGAGESGK 
Homo sapiens arginase 1 (liver-type 
arginase) 
P05089 TGLLSGLDIMEVNPSLGK 
Homo sapiens set protein (phosphatase 2a 
inhibitor i2pp2a) template activating factor 
i (taf-i) 
Q01105 VEVTEFEDIK 
Homo sapiens fructose-bisphosphate 
aldolase c 
P09972 GVVPLAGTDGETTTQGLDGLSER 
Homo sapiens ig kappa chain c region P01834 TVAAPSVFIFPPSDEQLK 
Homo sapiens nucleophosmin numatrin P06748 FINYVK, GPSSVEDIK, 
VDNDENEHQLSRLR, 
MSVQPTVSLGGFEITPPVVLR 
Homo sapiens  phosphoserine 
aminotransferase 
Q9y617 FGVIFAGAQK 
Homo sapiens heterogeneous nuclear 
ribonucleoprotein a3 
P51991 SSGSPYGGGYGSGGGSGGYGSR 
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To confirm the mass-spectrometry results, we performed pull-down experiments using 
S35methionine-labelled KIM-1 from reticulocyte lysates with glutathione S-transferase (GST) 
fused to Gα12 to determine if Gα12 can interact directly with KIM-1 (Zhu et al., 2004). We found 
that KIM-1 with a c-terminal HA tag was bound to GST-Gα12, but not unconjugated GST (Figure 
2.2A). Co-immunoprecipitation of Gα12 and KIM-1 using both anti-KIM-1 and anti-Gα12, but 
not the control antibody confirmed this interaction (Figure 2.2B). The cytosolic domain of KIM-1 
was sufficient to mediate binding to Gα12, as demonstrated by co-immunoprecipitation of Gα12 
with a truncated version of KIM-1 containing its cytosolic domain fused to its transmembrane 
domain and an extracellular flag tag (Figure 2.2C) (Z. Zhang et al., 2007). To determine if 
activated Gα12 can also interact with KIM-1, we treated KIM-1 expressing HEK-293 cell lysates 
with non-hydrolyzable GTP (GTPγS) prior to performing co-immunoprecipitation (Ohga et al., 
1989); GTPγS treatment of Gα12 did not alter the interaction with KIM-1 (Figure 2.2D). To 
visualize the interaction of Gα12 with KIM-1, HEK-293 cells were co-transfected with KIM-1 and 
GFP-Gα12 and co-localization of both proteins was assessed by confocal microscopy. A 
significant proportion of KIM-1 was associated with Gα12 in cells expressing both proteins, as 
indicated by Pearson’s coefficient (0.409 ± 0.098, n=7) (Figure 2.2E). In addition, we found co-
localization of both murine Kim-1 and Gα12 in kidney tissue sections isolated from C57BL/6 wild 
type (Kim-1+/+) mice that were subjected to renal ischemia-reperfusion injury (IRI) (bilateral renal 
pedicle clamping for 30 minutes followed by 24 hours of reperfusion) in order to cause Kim-1 
upregulation (Figure 2.2F). Taken together, the above data suggest that KIM-1 interacts 
constitutively with Gα12 via its cytosolic domain, independent of Gα12 activation. 
 
 
 
 
 
 
89 
 
 
 
90 
 
Figure 2.2. KIM-1 interacts with Gα12. 
A: Autoradiogram of pull-downs with purified GST-Gα12 or GST of in vitro translated S35-
methionine-labelled HA-tagged-KIM-1. B:  Immunopreciptation (IP) of KIM-1 and Gα12 from 
lysates of HEK-293 cells stably expressing human KIM-1 using anti-Gα12, anti-KIM-1 (against 
the cytosolic domain), or rabbit IgG control antibodies. C: Lysates of HEK-293 cells expressing 
a truncated KIM-1 protein comprised of only the transmembrane and cytosolic domains were 
subjected to IP with the indicated antibodies. D: Lysates of HEK-293 cells stably expressing 
KIM-1 were pretreated with non-hydrolysable GTP (GTPγS) to activate Gα12 and then 
subjected to IP. The input lane represents 5 % of the lysate. Both lysates and IP samples were 
analyzed by SDS-PAGE and Western blotting for KIM-1 (using an antibody against the 
extracellular domain), Gα12, and actin. Results represent three independent experiments. E: Co-
localization of both KIM-1 and Gα12 proteins in HEK-293 cells co-transfected with KIM-1 and 
GFP-tagged Gα12 constructs. KIM-1 was detected using an antibody against its extracellular 
domain (600x, bar represents 20 μm). F: Kidney cortex cross-section from wild type (Kim-1+/+) 
mice that were immunofluorescently stained with anti-Kim-1 (Red) and anti-Gα12 antibody 
following renal artery clamping for 30 minutes followed by reperfusion for 24 hours (400x, Bar 
100μm). Arrows indicate areas with a high degree of co-localization between KIM-1 or Kim-1 
and Gα12.   
 
 
 
 
 
 
 
 
 
 
 
 
91 
 
2.4.2. KIM-1 inhibits Gα12 activation by blocking GTP-binding 
It has long been hypothesized that KIM-1 might play a protective role in AKI (Ichimura et 
al., 1998). Given that Gα12 activation instigates injury pathways in AKI, we hypothesized that 
KIM-1 might suppress endogenous Gα12 activation in TECs. Because Gα12 is activated by 
guanine nucleotide exchange, we studied its activation status using a GST-TPR pull-down assay  
(Yamaguchi et al., 2002). Figure 2.3A demonstrates that endogenous Gα12 activity is inhibited in 
cells expressing KIM-1, but not the control vector (pcDNA). Next, to test if KIM-1 expression 
could inhibit Gα12 activation by physiologic ligands that stimulate its cognate GPCRs, we 
measured the level of active Gα12 after stimulating HEK-293 cells transiently expressing KIM-1 
or control vector with alpha-thrombin (Figure 2.3B) (Yu et al., 2012; Yanamadala et al., 2007). 
Given that ROS stimulate Gα12 activation in IRI, we tested whether KIM-1 expression affected 
Gα12 activation by H2O2; Gα12 activation was significantly blunted in KIM-1-expressing cells 
compared to control cells upon stimulation with either alpha-thrombin or 5 mM H2O2 (Figure 
2.3B). Additionally, we didn’t observe any effect of the level of H2O2 used on cell viability (Figure 
2.3C and D).  
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Figure 2.3. KIM-1 expression inhibits cellular Gα12 activation.  
HEK-293 cells were transfected with either control vector (pcDNA) or KIM-1 plasmid in both 
panels A and B. A: Cells were left untreated. B: Cells were stimulated with either α-thrombin (2 
U/ml) or H2O2 (5 mM) for 30 minutes. Samples in A and B were subjected to the GST-TPR pull-
down assay to measure the level of Gα12 activation. Lysates (total) and pull-down (active) 
samples were analyzed by SDS-PAGE and Western blotting with antibodies against Gα12, KIM-
1 and actin as indicated. Densitometric analyses of the ratio of active to total Gα12 relative to 
control vector transfected cells are shown as a representation of three independent experiments 
(n=3, ***p<0.001). C and D: Proximal tubule epithelial cells isolated from either wild type (C) 
or Kim-1 knock out (D) mice were treated with increasing concentrations of H2O2 (mM) as 
indicated. Cell death was calculated as the percentage of propidium iodide (PI) positive cells as 
detected by flow cytometry in comparison to control treatment (water). n=3, no significant 
difference was found between the treatments. 
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Based on the above data, we suspected that KIM-1 might block nucleotide exchange on 
G12, thereby preventing its activation. To test this, we exposed lysates from HEK-293 cells 
transiently transfected with either control vector or vector encoding KIM-1 to GTPγS to 
irreversibly lock G12 in the active conformation. We observed significantly less GTP-bound 
Gα12 in KIM-1 expressing cells compared to cells not expressing KIM-1 (Figure 2.4A). Similar 
results were obtained when we used HEK-293 cells stably expressing KIM-1 or control vector. To 
extend these findings to a physiologically relevant in vitro model, we compared Gα12 activation 
in primary TECs isolated from previously generated Kim-1-/- mice (Figure 2.4B) to Kim-1+/+ mice. 
Concordant with previous reports (Wong et al., 2010), Kim-1-/- mice were phenotypically normal. 
Ex vivo culture of TECs from Kim-1+/+ mice resulted in KIM-1 upregulation as previously reported 
(Ichimura et al., 1998). As expected, this was absent in TECs isolated from Kim-1-/- mice as 
indicated by Western blot of mouse Kim-1 (Figure 2.4 C, D, E). Consistent with data in HEK-293 
cells, we observed significantly higher levels of active Gα12 in TEC-lysates from Kim-1-/- mice 
compared to TEC-lysates from Kim-1+/+ mice loaded with GTPγS (Figure 2.4C). Similarly, the 
level of Gα12 activation was significantly higher in TEC-lysates from Kim-1-/- mice compared to 
that from Kim-1+/+ mice upon stimulation with H2O2 (Figure 2.4D).  Given that Src was shown to 
mediate ROS/Gα12 mediated epithelial injury (Yu et al., 2012), we examined Src activation using 
pY419 antibodies (which recognize phosphorylated Src) in the total cell lysates from Kim-1-/- and 
Kim-1+/+ TECs after treatment with H2O2. Figure 2.4E shows significantly enhanced Src activation 
in TECs from Kim-1-/- mice compared to those from Kim-1+/+ mice after H2O2 stimulation. Taken 
together, these data suggested that KIM-1 constitutively inhibits Gα12/Src activation by blocking 
GDP-GTP exchange by Gα12. 
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Figure 2.4. KIM-1 inhibits Gα12 activation and its down-stream effector Src.  
A: HEK-293 cells were transfected with either control vector (pcDNA) or KIM-1 plasmid and 
were stimulated with the non-hydrolysable GTP analog (GTPγS) for 15 minutes. B: 
Confirmation of genotype using genomic DNA of wild type (+/+), heterozygotes (+/-) and 
homozygotes Kim-1 knock out (-/-) C57BL/6 mice by PCR. C: Tubular epithelial cells (TECs) 
isolated from wild type (Kim-1+/+) and Kim-1-deficient (Kim-1-/-) mice were stimulated with 
GTPγS for 15 minutes. D: TECs were stimulated with H2O2 (5 mM) for 30 minutes. Samples in 
A, C, and D were subjected to the GST-TPR pull-down assay to measure the level of Gα12 
activation. Lysates (total) and pull-down (active) samples were analyzed by SDS-PAGE and 
Western blotting with antibodies against Gα12, human KIM-1 (KIM-1) or mouse Kim-1 (mKim-
1) and actin where indicated. E: Activated and total Src were detected in total cell lysates from 
TECs stimulated with H2O2 by Western blotting using an anti-p-Src (Py419-Src) 
phosphospecific antibody and anti-c-Src antibody, respectively. Densitometric analysis of the 
ratio of active to total Gα12 (or pY419-Src to c-Src) relative to non-KIM-1 expressing cells or 
wild type TECs (+/+).  Figure shown is representative of three independent experiments (n=3, 
*p<0.05, **p<0.01 and ***p<0.001 compared to control vector (pcDNA), †p<0.05, ††p<0.01 
and †††p<0.001 compared to Kim-1-/-). Red arrow point to the mouse Kim-1 band.  
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2.4.3. Kim-1-deficient mice exhibit higher Gα12 and Src activation and worse tissue damage 
after ischemia-reperfusion injury  
To extend these findings to a physiologically important model, we next determined whether 
upregulation of KIM-1 by TECs during renal IRI would block Gα12 activation in the kidneys by 
ROS. To test this, we subjected Kim-1+/+ and Kim-1-/- mice to 35 minutes of unilateral renal artery 
clamping followed by 24 hours of reperfusion and measured Gα12 activation in the affected and 
contralateral kidney tissues (Yu et al., 2012). As expected, we observed both an increase in Gα12 
activation and an upregulation in Kim-1 expression (Ichimura et al., 1998; Vaidya et al., 2010) in 
the reperfused kidneys, but not the contralateral (non-ischemic) kidneys as determined by Western 
blot (Figure 2.5A). Predictably, the degree of Gα12 activation after IRI was significantly higher in 
the kidneys from Kim-1-/- mice compared to those from the Kim-1+/+ mice. Though there was a 
small difference in active Gα12 levels in the contralateral kidneys between Kim-1-/- and Kim-1+/+ 
mice, this was not significant (p>0.05).  In a parallel set of experiments, we also observed increased 
Src activation in the total cell lysates from Kim-1-/- kidneys compared to Kim-1+/+ kidneys 
subjected to ischemia-reperfusion, which is in keeping with previous work (Figure 2.5B) (Meyer 
et al., 2003; Yu et al., 2012). 
In view of the pathogenic role of activated Gα12 in IRI (Yu et al., 2012), and the above 
data demonstrating that KIM-1 inhibits Gα12 activation, we hypothesized that Kim-1-deficient 
mice would show more severe IRI compared to Kim-1+/+ mice. As shown in Figure 2.5C, after 30 
minutes of renal ischemia and 24 hours of reperfusion, renal function was significantly worse in 
Kim-1-/- compared to Kim-1+/+ mice (mean creatinine 198 vs. 87 µmol/L, respectively, p<0.01, 
n=9 per group). Kim-1-/- mice also exhibited worse histological renal damage compared to Kim-
1+/+ mice (Figure 2.5D). After 48 hours of reperfusion, 7/11 Kim-1-/- while 0/5 Kim-1+/+ mice had 
died (p<0.05) (Figure 2.5E). When we reduced ischemia time to 25 minutes, Kim-1+/+ mice 
maintained near-normal renal function (mean creatinine 17 µmol/L, n=11), while Kim-1-/- mice 
developed severe renal impairment (mean creatinine 111 µmol/L, n=12) (p<0.001) after 48 hours 
of reperfusion (Figure 2.5F). Tissue injury was also greater in Kim-1-/- than Kim-1+/+ mice (Figure 
2.5G).  After 168 hours of reperfusion, there remained a significant difference in renal function 
between Kim-1+/+ mice (mean creatinine 17 µmol/L) and Kim-1-/- mice (mean creatinine 43 
µmol/L) (p<0.01), though 4/19 Kim-1-/- while 0/14 Kim-1+/+ mice had died (p=0.067) (Figure 
2.5H).  Histology is provided in Figure 2.5I. 
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Figure 2.5. Kim-1-deficient mice exhibit increased renal Gα12 activation and tissue damage 
after IRI. 
A: Wild type (Kim-1+/+) and Kim-1-deficient (Kim-1-/-) mice underwent unilateral renal pedicle 
clamping for 35 minutes, followed by 24 hours of reperfusion. Active Gα12 was measured in 
renal cortical lysates obtained from clamped and contralateral kidneys by GST-TPR pull-down 
assay, followed by SDS-PAGE and Western blotting for active and total Gα12, mouse Kim-1 
(mKim-1) and GAPDH. B: The level of active phosphorylated Src (pY419) compared to total 
Src was measured by Western blot in renal cortical lysates from mice treated as in (A). Samples 
were analyzed by SDS-PAGE and Western blot for indicated antibodies. Densitometric analysis 
of the ratio of active Gα12 to total Gα12 (or pY419-Src to c-Src) is shown as a representation of 
three independent experiments (n=3/group, †p<0.05, ††p<0.01). C-I: Independent groups of Kim-
1+/+ and Kim-1-/- mice underwent sham surgery or bilateral renal pedicle clamping for 30 minutes 
(n=5-11/ group, C-E) or 25 minutes (n=7-12/ group, F-I), followed by 24, 48 or 168 hours (h) of 
reperfusion. C and F: Kidney function was determined by plasma creatinine levels. D and G: 
Quantification of tubular damage in whole kidneys after 48 hours of reperfusion (n=9/group). E 
and H: Percent survival after reperfusion. †p<0.05, ††p<0.01 and †††p<0.001, §p=0.078, ‡p=NS.  
I: Representative PAS stained kidney sections after 48 hours of reperfusion (Sham represents 
Kim-1-/-) (200x, Bar=0.10mm). Arrows indicate a major histological difference (tubule dilation) 
between Kim-1+/+ and Kim-1-/- following injury.   
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2.5. DISCUSSION 
AKI is a serious medical condition for which the pathogenic mechanisms are not well 
understood and for which there is no known treatment.  It has been recently discovered that Gα12 
has a crucial pathogenic role in renal IRI (Meyer et al., 2003; Yu et al., 2012).  Specifically, ROS 
stimulates Gα12 to activate tubular injury pathways, including disruption of tight junctions via Src 
activation.  To our knowledge, regulation of this pathway has never been described.  Here, we 
show that KIM-1 blocks GTP binding onto Gα12, and thus functions to reduce the level of active 
Gα12. In support of this finding, we found that Kim-1-/- mice exhibited exaggerated Gα12 and Src 
activation in vivo during renal IRI, compared to Kim-1+/+ mice. In addition, we observed worse 
renal dysfunction and histology after bilateral pedicle clamping in Kim-1-/- as compared to Kim-
1+/+ mice. Taken together, our findings suggest that KIM-1 protects against Gα12-mediated tissue 
damage during ischemic AKI.  Whether KIM-1 has additional, Gα12-independent effects on TECs 
that protect from IRI is an area of further study (Ichimura et al., 2012).  
Our results provide particular insight into the regulation of G-protein signalling. Gα12, like 
all G proteins, is a molecular switch that is activated by GTP binding (upon GDP dissociation) and 
inactivated when bound-GTP is hydrolyzed to GDP (Dhanasekaran et al., 1996).  We found that 
KIM-1 reduces binding of GTPγS to Gα12. To our knowledge, KIM-1 is the first guanine 
nucleotide dissociation inhibitor against Gα12 to be identified (Siderovski et al., 2005). 
Interestingly, the cytosolic domain of KIM-1 does not contain the 19-amino-acid sequence 
GoLoco motif that is typical of guanine nucleotide dissociation inhibitors (Kimple et al., 2002).  
The residues responsible for KIM-1 inhibition of Gα12 are unknown. It is conceivable that 
targeting Gα12 using an exogenous chemical inhibitor might ameliorate renal IRI (Yu et al., 2012).  
However, such an inhibitor does not exist and may in fact be toxic given that Gα12 is expressed 
ubiquitously and also regulates many crucial cellular functions (Dhanasekaran et al., 1996).  
Our results suggest that KIM-1 represents a natural, endogenous mechanism to protect 
against tissue damage during renal IRI. Given that KIM-1 is expressed by TECs only during the 
injury and returns to undetectable baseline levels upon renal recovery, after day seven post-IRI 
(Ko et al., 2010), Gα12 inhibition by KIM-1 is likely transient. Interestingly, the upregulation of 
KIM-1 seems to overlap with Gα12 activation by ROS during ischemia-reperfusion. The down 
regulation of KIM-1 after AKI is equally important as conditional overexpression of KIM-1 in 
TECs in the absence of an injury stimulus results in kidney fibrosis (Humphreys et al., 2013). It 
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has been proposed that antagonizing KIM-1 signalling may represent a novel therapeutic target to 
ameliorate renal fibrosis in chronic kidney disease (CKD).  However, our identification of KIM-1 
in regulating Gα12 and in protection against renal dysfunction during IRI suggest that caution is 
warranted in targeting KIM-1 in CKD, as such a therapeutic agent may exacerbate AKI episodes 
which have been linked to progression of CKD (Chawla et al., 2014).  It would also be interesting 
to know if transiently overexpressing KIM-1 during IRI would further protect against tissue 
damage. We speculate that strategies to enhance KIM-1 expression or function may be particularly 
important in patients with polymorphic variants of KIM-1 that might confer reduced ability to 
inhibit Gα12.  
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3.1. SUMMARY  
Kidney injury molecule-1 (KIM-1) is a receptor for the “eat me” signal phosphatidylserine, 
which is present on apoptotic cells. The specific upregulation of KIM-1 by injured tubular 
epithelial cells (TECs) enables them to clear apoptotic cells thereby protecting from AKI. 
Recently, we discovered that KIM-1 binds directly to the alpha subunit of heterotrimeric G12 
protein (Gα12) and inhibits its activation by reactive oxygen species during renal ischemia-
reperfusion injury (Chapter 2). Here we investigated if Gα12 has a role in KIM-1-mediated 
phagocytosis. We showed that KIM-1 remains bound to Gα12 and suppresses Gα12 activity during 
phagocytosis. When we silenced Gα12 expression by siRNA, KIM-1-mediated engulfment of 
apoptotic cells was increased significantly; in contrast overexpression of constitutively active 
Gα12 (QL Gα12) resulted in the opposite effect. Inhibition of RhoA, a key effector of Gα12, using 
a chemical inhibitor or expression of dominant-negative RhoA had the same effect as inhibition of 
Gα12 on phagocytosis. Consistent with this, silencing Gα12 suppressed active RhoA in KIM-1-
expressing cells. Finally, using primary TECs from Kim-1+/+ and Kim-1-/- mice, we confirmed that 
phagocytosis depends on KIM-1 expression, and that this process is enhanced by silencing Gα12. 
Our data reveal a previously unknown role of Gα12 in regulating phagocytosis in renal TECs. 
These results may have many implications given the known harmful role of Gα12 in acute kidney 
injury.   
 
3.2. INTRODUCTION  
The process of apoptosis or programmed cell death serves to rid the body of damaged and 
senescent cells that arise during both physiologic and pathologic conditions, such as acute tissue 
injury (Elliott et al., 2010). The final common step of apoptosis is the removal of the cell corpses 
by phagocytes without triggering inflammation (Manfredi et al., 2002). Renal proximal tubular 
epithelial cells (TECs) are particularly susceptible to apoptosis and necrosis during acute kidney 
injury (AKI) caused by ischemia and toxins (Sanz et al., 2008; Shiratsuchi et al., 1997). During 
AKI (Yang et al., 2015; Ichimura et al., 1998), proximal tubular epithelial cells (TECs) become 
transformed into semi-professional phagocytes and rapidly clear apoptotic cells through a process 
known as phagocytosis or efferocytosis (deCathelineau et al., 2003). This process is crucial to 
regulate inflammation, as uncleared apoptotic cells obstruct the tubular lumen or undergo 
secondary necrosis and trigger inflammation which can impede repair (deCathelineau et al., 2003; 
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Erwig et al., 2006; Fadok et al., 1998; Ren et al., 1998; Rosen et al., 1999; Yang et al., 2015).  
Phagocytes recognize apoptotic cells via cell-surface engulfment receptors that directly or 
indirectly bind to “eat me” signals displayed on the surface of apoptotic cells (Erwig et al., 2008; 
Lauber et al., 2004).  Ligand-binding leads to receptor activation, which then brings about a series 
of complex downstream signalling pathways that ultimately result in reorganization of the cell 
cytoskeleton enabling engulfment, internalization and degradation of the bound corpses 
(Castellano et al., 2001; Hochreiter-Hufford et al., 2013). The Rho family of small GTPases such 
as RhoA and Rac1 have been implicated in the regulation of cytoskeletal remodelling in 
professional and semi-professional phagocytes (Lauber et al., 2004; Machacek et al., 2009; 
Nakaya et al., 2006; Ren et al., 1998). Like all G proteins, RhoA and Rac1 cycle between GDP-
bound inactive, and GTP-bound active conformations regulated by GTP exchange factors (GEFs) 
or GTPase activating proteins (GAPs), respectively (Geyer et al., 1997; Ridley, 1999, 2001). 
Although both RhoA and Rac1 belong to same family, they differ in their action: Rac1 induces 
polymerization of actin leading to membrane ruffles and filopodia formation, while RhoA induces 
actin assembly into bundles and stress fibers (Hall et al., 2000). While the activation of Rac1 seems 
to be an evolutionarily conserved event in phagocytosis (including apoptotic cell engulfment) 
(Kinchen et al., 2005; Kinchen et al., 2007; Ravichandran et al., 2007), there is some controversy 
regarding the inhibitory role for RhoA in phagocytosis (Erwig et al., 2006; Olazabal et al., 2002; 
Ravichandran et al., 2007; Zhou et al., 2001).  
Several groups have previously identified kidney injury molecule-1 (KIM-1) as a 
phagocytosis receptor that is upregulated on the apical surface of proximal tubular proximal cells 
(TECs) following injury (Han et al., 2002; Ichimura et al., 1998). TIM-1 is a receptor for 
phosphatidylserine, one of the most well characterized apoptotic cell “eat-me” signals (Fadok et 
al., 1998; Ravichandran et al., 2007; Wang et al., 2003). Both mouse (termed Kim-1) and human 
KIM-1, also known as T cell, immunoglobulin and mucin domain-1 protein (TIM-1), are small 
type I transmembrane glycoproteins that belongs to the TIM gene family (Freeman et al., 2010). 
The human TIM family consists of TIM-1 (Feigelstock et al., 1998; Ichimura et al., 1998; McIntire 
et al., 2001; Santiago et al., 2007), TIM-3 (DeKruyff et al., 2010; Nakayama et al., 2009), and 
TIM-4 (Kobayashi et al., 2007; Santiago et al., 2007), which are conserved between mouse and 
man, and they all bind directly to phosphatidylserine (Freeman et al., 2010; Ichimura et al., 2008; 
Kobayashi et al., 2007; Santiago et al., 2007). KIM-1/TIM-1 is expressed on mast cells, regulatory 
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B cells, activated CD4 T cells, and TECs following AKI (Freeman et al., 2010; Han et al., 2002). 
KIM-1 contains an IgV‐like domain, a mucin‐like domain, a transmembrane region, and an 
intracellular tail that has been implicated in cell signalling in differentiated T cells (A. J. de Souza 
et al., 2005; Anjali J. de Souza et al., 2008; Ichimura et al., 1998; Santiago et al., 2007) and B 
cells (Yeung et al., 2015). The crystal structure of the IgV-like domain of KIM-1/TIM-1 has been 
solved, and reveals that it forms a conserved binding pocket termed the metal ion-dependent 
ligand-binding site (MILIBS) (Cao et al., 2007; DeKruyff et al., 2010; Santiago et al., 2007) that 
allows highly specific recognition of phosphatidylserine exposed on the surface of apoptotic cells 
(Freeman et al., 2010; Santiago et al., 2007). Cell-surface KIM-1 concentrates at the point of 
contact with an apoptotic cell and forms the phagocytic cup (Freeman et al., 2010). We previously 
showed that Kim-1-deficient mice succumb to worse tissue injury and mortality after ischemic 
AKI (Ismail et al., 2015). Moreover, TECs from mice expressing a mucin-domain deletion mutant 
of Kim-1 are unable to bind apoptotic cells, exhibit impaired phagocytic function by TECs and 
also succumb to worse AKI (Yang et al., 2015). These data underline the biological importance of 
Kim-1-mediated clearance of apoptotic cells by TECs in limiting tissue damage during AKI.  
Recently, we uncovered that KIM-1 interacts with the alpha subunit of heterotrimeric G12 
proteins (Gα12) and inhibited its activation by ROS during ischemic AKI (renal ischemia-
reperfusion injury), which is crucial to limiting downstream injury pathways triggered by Gα12 
activation in TECs (Ismail et al., 2015). Gα12 belongs to the G12 class of G proteins 
(Dhanasekaran et al., 1996; Vara Prasad et al., 1994). It is ubiquitously expressed and has 
pleiotropic effects on cells, including inducing proliferation, focal adhesion assembly/disassembly 
and cytoskeletal reorganization (Kurose, 2003; Needham et al., 1998). Gα12-driven cytoskeletal 
reorganization, including actin stress fiber formation, is mediated through activation of the RhoA 
GTPase via Rho guanine nucleotide exchange factors (GEFs) (Tanabe et al., 2004), including 
LARG (Fukuhara et al., 2000), PDZ-RhoGEF (Kuner et al., 2002), and p115 RhoGEF (Iguchi et 
al., 2008).  
Given that Gα12 activation and KIM-1 upregulation occur simultaneously during ischemic 
AKI, we investigated the role of Gα12 in KIM-1-mediated phagocytosis using cell culture models 
of TECs and primary TECs isolated from mice kidneys. We reveal that activated Gα12 inhibits 
phagocytosis and that KIM-1-suppression of Gα12 activation is crucial for TECs to mediate 
phagocytosis of apoptotic cells. In addition, we show that the inhibitory effect of Gα12 on 
107 
 
phagocytosis is mediated by its downstream effector, RhoA. Finally, our data demonstrating that 
TECs absolutely require KIM-1 expression for phagocytosis implies that altering Gα12 activity 
might be a viable therapeutic strategy to enhance clearance of apoptotic cells following AKI. 
 
3.3. EXPERIMENTAL PROCEDURES 
3.3.1. Cell culture and materials  
Human Embryonic Kidney 293 (HEK-293) cells and porcine proximal tubule epithelial 
cells (LLC-PK1) were cultured at 37 °C in 5 % (vol/vol) CO2 and maintained in DMEM 
(Invitrogen, Carlsbad, CA) containing 10 % FBS (Invitrogen, Carlsbad, CA). HEK-293 cells stably 
expressing KIM-1-GFP (herein referred to as HEK-293-KIM-1-GFP), KIM-1 (no tag) (HEK-293-
KIM-1), pcDNA-GFP (HEK-293-pcDNA), as well as, LLC-PK1 stably expressing KIM-1 (LLC-
PK1-KIM-1) and pcDNA (LLC-PK1-pcDNA) were generated by transfecting with plasmid 
constructs encoding either KIM-1 or control vector using Lipofectamine® 2000 (Life 
technologies, Thermo Fisher Scientific, Rockford, IL). Several single cell clones were selected 
using 800 µg/ml Geneticin (G418) Sulfate (Santa Cruz Biotechnology, Santa Cruz, CA). Cells 
expressing a high level of KIM-1 protein determined by Western blotting were used for further 
experiment and were maintained in DMEM containing 10 % FBS and 800 µg/ml G418. Primary 
proximal tubule epithelial cells (TECs) were isolated from 2-4 week old C57BL/6 Kim-1+/+ and 
Kim-1-/- mice and cultured for the first 6 days in serum free DMEM/F-12 mixed media (1:1) 
supplemented with 5 % insulin-transferrin-selenium solution (Invitrogen, Carlsbad, CA), 5 % 
penicillin-streptomycin solution (Invitrogen, Carlsbad, CA), 0.5 µg/ml of mouse EGF (Peprotech, 
Rocky Hill, NJ), and 50 ng/ml hydrocortisone (Thermo Fisher Scientific, Rockford, IL). After 6 
days, TECs were cultured with same media mixtures supplemented with 5 % FBS as described 
earlier (Sharpe et al., 2012). Chemicals were purchased from Sigma (Sigma Aldrich, St. Louis, 
MO) unless stated. The pH-sensitive dye pHrodo™ Red succinimidyl ester (pHrodo™ Red, SE), 
Alexa Fluor® 555 Goat Anti-Mouse antibody and DAPI were purchased from Life Technologies 
(Molecular probes, Invitrogen, Carlsbad, CA), and Rhodamine phalloidin from Cytoskeleton 
(Cytoskeleton, Denver, CO). Gα12 (S-20, 1:500 dilution) and actin (I-19, 1:1000 dilution) 
antibodies were from Santa Cruz Biotechnology (Santa Cruz Biotechnology, Santa Cruz, CA), PE-
conjugated anti-human KIM-1 (1D12, 1:100 dilution) and PE-conjugated rat IgG2b isotype control 
(RTK 4530, 1:100 dilution) were purchased from Biolegend. Allophycocyanine (APC)-conjugated 
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anti-mouse Tim-1 rat IgG2B (AF1817A, 1:100 dilution) and APC-conjugated rat IgG2B isotype 
control (1:100 dilution) were obtained from R&D system Inc. (R&D Systems Inc., Minneapolis, 
MN). RhoA specific monoclonal antibodies (ARH03, 1:500 dilution) and non-hydrolysable GTP 
analog were purchased from Cytoskeleton (Cytoskeleton, Denver, CO). A custom anti-KIM-1 (PA 
4145, cytosolic domain) antibody was generated by immunizing rabbits with a peptide 
(CKEVQAEDNIYIENSLYATD) contained within the cytosolic domain of KIM-1 and conjugated 
to KLH as previously described (Life technologies, Thermo Fisher Scientific, Rockford, IL) 
(Bailly et al., 2002; Gandhi et al., 2014). A KIM-1 antibody against the mucin domain of KIM-1 
(AKG7) was kindly provided by Dr. Bonventre (Harvard Medical School, Brigham and Women's 
Hospital, Boston, MA). Complete Mini EDTA-free protease inhibitor cocktail tablets were 
purchased from Roche (Roche Diagnostic, Basel, Switzerland). Rho inhibitor (cell permeable C3 
transferase) was purchased from Cytoskeleton, Rho kinase (ROCK) inhibitor (Y27632) and Rac1 
Inhibitor (NSC23766) were purchased from EMD Millipore (EMD Millipore, Billerica, MA). 
Plasmid constructs for Gα12, RhoA and Rac1 were kindly provided by Dr. Bradley Denker 
(Harvard Medical School, Brigham and Women's Hospital, Boston, MA), while the plasmid 
constructs for KIM-1 were provided by Dr. Bonventre (Harvard Medical School, Brigham and 
Women's Hospital, Boston, MA). Lipofectamine® 2000 (Life Technologies, Thermo Fisher 
Scientific, Rockford, IL) and Dharmafect1 (Thermo Fisher Scientific, Rockford, IL) were used for 
transfecting plasmid and siRNA, respectively.  
3.3.2. Mice 
 Wild-type C57BL/6 (Kim-1+/+) mice were obtained from the Jackson Laboratory. 
C57BL/6 Kim-1-deficient mice (Kim-1-/-) were obtained from Dr. Andrew N. J. McKenzie (MRC 
laboratory of Molecular biology, Cambridge, UK) and these were generated by targeted disruption 
of the mouse havcr1 gene in mouse embryonic stem cells as described previously (Wong et al., 
2010). All animal procedures were approved by the Western University Animal Use Subcommittee 
in accordance with the regulations of the Canadian Council on Animal Care (refer to appendix for 
certificate of approval).   
3.3.3. Phagocytosis assay and FACS analysis  
To prepare apoptotic cells for the phagocytosis assays, thymocytes were harvested from 3 
to 6 week old C57BL/6 mice, and apoptosis was induced by UV exposure for five minutes 
followed by incubation overnight at 37 °C in 5 % CO2 in DMEM media supplemented by 10 % 
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FBS and 1 % penicillin-streptomycin solution as described previously (Gandhi et al., 2014).  
Apoptosis of the thymocytes were verified by flow cytometry analysis showing positive staining 
for Annexin V and negative staining for propidium iodide. Apoptotic thymocytes were stained 
with pH-sensitive dye pHrodo™ Red succinimidyl ester (pHrodo™ Red, SE) at a final 
concentration of 150 nM for 30 minutes at room temperature. Labelled apoptotic cells were 
washed twice with 1x PBS to remove excess dye. The pHrodo dye helped in distinguishing 
between bound and internalized apoptotic cells, where apoptotic cells exhibit higher fluorescence 
upon entry into the acidic compartment of phagolysosomes (Gandhi et al., 2014; Miksa et al., 
2009; Park et al., 2009). The fluorescently-labelled apoptotic cells were counted and 3x106 were 
added to each well of 6-well plate (1.5x107 for 10 cm plates) containing phagocytes cells (HEK-
293 cells, LLC-PK cells or isolated TECs) and incubated for various time points at 37 °C in 5 % 
CO2. Cells were then placed on ice for 30 minutes to reduce non-specific binding of apoptotic 
cells. The plates were washed three times with ice-cold PBS, and cells were collected with 5 mM 
EDTA-PBS, and resuspended with FACS buffer (1x Phosphate-buffered saline (PBS), 2 % calf 
serum, and 0.1 % sodium azide) for flow analysis. For KIM-1-surface staining, the cells were 
blocked in PBS and 10 % goat serum for 15 minutes, followed by incubation for 30 minutes at 
room temperature with either PE-conjugated anti-KIM-1 (1D12, human), or APC-conjugated 
anti-Tim-1 (AF1817A, mouse) targeting extracellular domain of KIM-1 or Kim-1 and their 
respective isotype control antibodies at a ratio of 1:100. All samples were run on a BD LSR II 
flow cytometer using various filters, such as, YG 582/15 (pHrodo red, PI) and B 530/30 (GFP, 
FITC) (BD Biosciences, San Jose, CA). The percentage of phagocytosis represents the number 
of cells that have internalized the pHrodo red labelled apoptotic cell(s), as indicated by the higher 
fluorescence of pHrodo red dye (104-105 on logarithmic scale). Cells with low pHrodo red 
fluorescence (<104) were excluded from the percentage of phagocytosis calculation since they 
are not internalized.   
3.3.4. Immunoprecipitation and Western blot 
HEK-293 cells were lysed with ice-cold lysis buffer (25 mM HEPES pH 7.5, 150 mM 
NaCl, 15 mM MgCl2, 1 % Triton X-100, and Complete Mini EDTA-free protease inhibitor cocktail 
tablets (Roche Diagnostic, Basel, Switzerland). For immunoprecipitation, cell extracts containing 
1.0 –1.5 mg of the protein/mL were incubated with 10 ug of Gα12 (S-20), KIM-1 (PA4145), or 
rabbit IgG antibody (sc-2027) and 20 µl of protein-A/G Sepharose beads (Santa Cruz 
110 
 
Biotechnology, Santa Cruz, CA) at 4 °C overnight. Beads were centrifuged, washed three times, 
and suspended in 20 μL of SDS sample buffer and heated at 100 °C for five minutes. Lysates 
(representing 5 % of total lysate) and immunoprecipitation samples were separated by 
electrophoresis under reducing condition and transferred to polyvinylidene difluroide (PDVF) 
membranes (EMD Millipore, Billerica, MA). PDVF-membranes were probed with antibodies 
specific to surface KIM-1 (AKG7, 1:3 dilution), the cytosolic domain of KIM-1 (PA 4145, 1:1,500 
dilution), Gα12 (1:500 dilution), actin (1:1,000 dilution), or RhoA (1:500 dilution). The signal was 
visualized using the appropriate horseradish peroxidase-conjugated secondary antibodies and ECL 
western blot detection reagent (Luminata forte, EMD Millipore, Billerica, MA) and visualized by 
autoradiography (Biomax; Denville Scientific, South Plainfield, NJ). 
3.3.5. GST-TPR pull down  
The construct encoding the GST-fused TPR domain of PP5 was kindly provided by Dr. N 
Dhanasekaran (Temple University, PA, USA). GST-TPR protein was purified from Escherichia 
coli as described earlier (Yoshiaki Yamaguchi et al., 2002). Cells were lysed with ice-cold lysis 
buffer (20 mM HEPES pH 8.0, 2 mM MgCl2, 1 mM EDTA, 1 mM DTT, 0.5 % Triton x-100, and 
complete Mini EDTA-free protease inhibitor cocktail tablets (Roche Diagnostic, Basel, 
Switzerland). 1 mg of protein lysate and ≈1 μg of GST-TPR coupled glutathione-agarose beads 
were incubated together at 4 °C for five hours. Both lysate and pull-down samples were analyzed 
by SDS-PAGE and Western blotting to detect total and active Gα12 in these samples, respectively. 
Lysates loaded with non-hydrolyzable GTP analog (GTPγS) or GDP (Cytoskeleton, Denver, CO) 
were considered as a positive or negative controls, respectively. 
3.3.6. Immunofluorescence and confocal microscopy 
 HEK-293 cells were cultured at subconfluent density on poly-D-lysine hydrobromide 
(Sigma Aldrich, St. Louis, MO) coated glass cover slips, and were transfected with either different 
wild type or mutant versions of GFP-tagged Gα12 or siRNA against Gα12. Cells were fixed with 
4 % paraformaldehyde, followed by counterstaining of the nucleus with DAPI (0.5 µg/ml). Cell-
surface staining for KIM-1 was performed using the monoclonal antibody against the mucin 
domain of KIM-1 (AKG). For this, cells were blocked with 1 % BSA in 1x PBS for 1 hour at room 
temperature, followed by incubation with anti-KIM-1 overnight. Bound KIM-1 was labelled with 
Alexa 555 conjugated anti-mouse at concentration of 1:1000. For actin cytoskeleton staining, cells 
were permeabilized with 0.25 % Triton in 1x PBS for five minutes, and then stained with 
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rhodamine phalloidin for 0.5 hours according to the manufacturer’s instructions (Cytoskeleton, 
Denver, CO). Coverslips were mounted using Shandon-Mount® permanent mounting (Thermo 
Fisher Scientific, Rockford, IL) and viewed with a FLUOVIEW X83I confocal microscopy 
(Olympus, Tokyo, Japan). Data were acquired and analyzed using FLUOVIEW FV10 ASW 4.0 
viewer and ImageJ software (National Institutes of Health, Bethesda, MD) to determine the Van 
Steensel’s score for colocalization of KIM-1 and Gα12. Colocalization was quantified based on 
five random fields per sample and three independent experiments. Quantification of the number of 
apoptotic cells bound was assessed in eight random fields per sample and was done in four 
independent experiments. Approximately 100 to 120 cells were counted for each field as 
determined by DAPI staining of nucleus.  
3.3.7. siRNA of Gα12 in HEK-293 and proximal tubular epithelial cells  
ON Target plus® Smart pool siRNA against Gα12-specific and non-targeting pool 
(Control siRNA) were purchased from Dharmacon (Thermo Fisher Scientific, Rockford, IL). Cells 
were transfected with 50 nM of siRNA using Dharmafect1® for 24 hours before further analysis 
of knockdown.  
3.3.8. RhoA activation  
RhoA activation was determined using Rhotekin-RBD (Rho-binding domain) beads 
according to the manufacturer’s instructions (Cytoskeleton, Denver, CO) and as described before 
(Yu et al., 2012). Both lysates, and pull-down samples were analyzed by SDS-PAGE and Western 
blotting to determine the levels of total and active RhoA in these samples, respectively. Controls 
included incubating lysates with GDP (1 mM, negative control) or GTPγS (200 µM, positive 
control) for 15 minutes and then adding the beads. The ratio of active-to-total RhoA was 
determined based on densitometric analysis of Western blot images. For RhoA activation 
measurement after siRNA-mediated knockdown of Gα12, we used the G-LISA RhoA activity 
assay kit (Cytoskeleton, Denver, CO), due to its high sensitivity and the low level of the total 
protein required to perform the assay.  
3.3.9. Quantification and statistics  
Western blots were scanned and band intensity quantified using Image J software (National 
Institutes of Health, Bethesda, MD).  Background was subtracted in these analyses, normalized to 
actin and the linear range of response was determining using a standard sample that was serially 
diluted. Statistics were done in GraphPad Prism (Graph Pad Software Inc., La Jolla, CA) or IBM 
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SPSS statistic 22 (IBM, Armonk, NY). The significance for the percentage of phagocytosis or 
immunoprecipitation densitometric analysis over phagocytosis time course was determined using 
one-way ANOVA (as indicated). The significance of the results comparing active and total Gα12 
or RhoA for cells stimulated with apoptotic cells over a period of time (15, 30, 60 and 90 minutes)  
was determined using the analysis of covariance (ANCOVA). All other analyses were done using 
an unpaired t-test where indicated. P-value of <0.05 was considered significant. Error bars 
represent the standard error of the mean unless otherwise indicated. 
3.4. RESULTS  
3.4.1. KIM-1 interacts with Gα12 during phagocytosis  
KIM-1 is not expressed by healthy TECs, but is upregulated more than any other protein 
after AKI (Ajay et al., 2014;Ichimura et al., 1998; Ko et al., 2010). Because it is virtually 
impossible to perform mechanistic studies on TEC-phagocytosis in vivo, we did this in vitro using 
human embryonic kidney-293 (HEK-293) cells overexpressing KIM-1. Exogenous expression of 
KIM-1 in cultured cells is routinely used to mimic KIM-1 that is upregulated on TECs during AKI 
in vivo and HEK-293 cells are widely used to study the phagocytic signalling and phagocytic 
function of KIM-1 (Gandhi et al., 2014; Ichimura et al., 2008; kobayashi et al., 2007). In addition, 
HEK-293 cells were ideal for our studies since they express adequate level of Gα12 for detection 
by Western blotting (Figure 3.1A). We failed to detect endogenous Gα12 by Western blotting in 
cells that endogenously express KIM-1, such as the human renal adenocarcinoma cell line (769P), 
which is also routinely used to study KIM-1-mediated phagocytosis (Gandhi et al., 2014; Ichimura 
et al., 2008; Kobayashi et al., 2007). Next, we established assay conditions for our study by 
creating HEK-293 cells that stably express C-terminal GFP-tagged human KIM-1 and determining 
their efficiency and kinetics of apoptotic engulfment (Ichimura et al., 2008; Ichimura et al., 1998; 
Ismail et al., 2015). To distinguish bound from internalized apoptotic cells when using flow 
cytometry to detect phagocytosis, targets were labelled with a pH-dependent fluorescent dye 
(pHrodo) that exhibits higher fluorescence upon entry of apoptotic cells into the acidic 
compartment of phagolysosomes (Gandhi et al., 2014; Miksa et al., 2009; Park et al., 2009). Stable 
transfection with GFP-tagged human KIM-1 enabled efficient engulfment of apoptotic cells (40 % 
vs. 8 %, p<0.05) relative to cells transfected with GFP-tagged control vector (pcDNA-GFP) 
(Figure 3.1B). Phagocytosis was further confirmed using confocal microscopy, where we were 
able to visualize the formation of phagocytic cups after co-culture of HEK-293-KIM-1-GFP cells 
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with apoptotic cells over the course of phagocytosis (Figure 3.1C). Phagocytic cups were formed 
at the cell-surface within 15 minutes of the addition of apoptotic cells. Pretreatment of the 
phagocytic cells with the actin polymerization inhibitor cytochalasin D significantly reduced the 
uptake of apoptotic cells by KIM-1-expressing HEK-293 cells (Figure 3.1D).   
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Figure 3.1. KIM-1-mediates the uptake of apoptotic cells. 
A: Various cell lines were screened for KIM-1 and Gα12 expression via Western blot. These 
cells include; human embryonic kidney-293 cells (HEK-293), porcine proximal tubular epithelial 
cells (LLC-PK1), human renal adenocarcinoma cells (769P), HEK-293 cells transfected with 
human KIM-1 and Gα12 served as a positive control. Lysates were obtained, separated by SDS-
PAGE and immunoblotted (IB) for KIM-1, Gα12 and actin. B: HEK-293 cells stably expressing 
either control vector (pcDNA-GFP) or KIM-1-GFP were fed pHrodo-labelled (red) apoptotic 
cells for various time points as indicated (hours). The percentage of phagocytosis was 
determined by flow cytometry measurement of GFP and high pHrodo red double positive cells 
(n=3, *p<0.05, unpaired t-test). C: HEK-293 cells stably expressing KIM-1-GFP were fed 
pHrodo-labelled apoptotic cells (red) for various time points (minutes or min). Cells were fixed 
and stained with rhodamine-phalloidin to visualize F-actin (red) and DAPI to visualize the 
nucleus and apoptotic cells (blue) (600x, bar represents 5 µm). Apoptotic cells labelled with both 
pHrodo red and DAPI (blue) appear as purple/pink coloured cells in the merged image. Arrows 
indicate the apoptotic cell(s) in the vicinity of KIM-1 expressed on the cells. D: HEK-293 cells 
stably expressing KIM-1-GFP were treated with vehicle control (DMSO) or the actin 
polymerization inhibitor cytochalasin D (10 μM), and fed fluorescently labelled apoptotic cells 
for 90 minutes. The percentage of phagocytosis represents the percentage of KIM-1-GFP 
positive cells with high fluorescence of pHrodo red of engulfed apoptotic cells as measured by 
flow cytometry (n=3,*p<0.05, unpaired t-test). 
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Based on our previous work demonstrating that the cytosolic domain of KIM-1 interacts 
with Gα12 in TECs (Ismail et al., 2015), we sought to investigate how this was affected by 
phagocytosis. We performed co-immunoprecipitation of Gα12 with KIM-1 during the course of 
phagocytosis and found that the interaction is not dependent on apoptotic cell stimulation of HEK-
293-KIM-1-GFP cells (Figure 3.2A). Importantly, apoptotic cell-stimulation was also not required 
for the interaction of KIM-1 with GST-Gα12 in HEK-293 cells stably expressing KIM-1 (Figure 
3.2B). 
In order to visualize the interaction of Gα12 with KIM-1 in the phagocytic cells, we co-
transfected HEK-293 cells with KIM-1 and GFP-tagged Gα12 and examined the kinetics of Gα12-
KIM-1 co-localization before and after adding apoptotic cells (Figure 3.2C). In keeping with our 
previous work (Ismail et al., 2015), we observed co-localization of KIM-1 with Gα12 prior to and 
after the addition of apoptotic cells. As determined by quantification of the change in co-
localization following stimulation with apoptotic cells using the Van Steensel’s  approach (Bolte 
et al., 2006), we failed to see any significant difference between unstimulated and stimulated cells 
(Figure 3.2D). The above results suggested that KIM-1 constitutively interacts with Gα12 during 
the course of corpse engulfment.  
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Figure 3.2. KIM-1 interacts with Gα12 during phagocytosis. 
A: Human embryonic kidney-293 (HEK-293) cells stably expressing human KIM-1-GFP with 
high level of endogenous Gα12 were stimulated with apoptotic cells for indicated time and used 
for immunoprecipitation (IP) using antibody against Gα12. The ratio of bound KIM-1 to Gα12 
was determined based on densitometric values obtained by Western blotting during apoptotic cell 
stimulation (n=3, ns= not significant, one-way ANOVA).B: GST and GST-Gα12 pull-down was 
performed on extracts from HEK-293-KIM-1-GFP cells that were left unstimulated or stimulated 
with apoptotic cells for 90 minutes. All samples were analyzed by SDS-PAGE followed by 
immunoblotting (IB) with antibodies against KIM-1, Gα12 and actin. The input lane represents 5 
% of the lysate. The data represents three independent experiments. C: HEK-293 cells were 
transfected with wild type KIM-1-and GFP-tagged Gα12 construct and fed pHrodo red 
fluorescently labelled apoptotic cells (AC) (blue/red) for 30 minutes prior to fixation. Surface 
KIM-1 staining was performed using anti-KIM-1 antibody against the mucin domain (AKG) and 
Alexa555-conjugated secondary antibody (600x, bar represent 40 μm). Arrows indicate where 
phagocytic cups formed. D: Images of colocalization of both KIM-1 and Gα12 were analyzed 
using the Van Steensel’s approach, where the cross correlation function (CCFs) was calculated 
with a pixel shift of ±20. The results shown are representative of four images from three 
independent experiments (ns= not significant, one-way ANOVA).  
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3.4.2. KIM-1 down regulates Gα12 activity during KIM-1-mediated phagocytosis  
Phagocytosis involves a series of events that starts with the recognition of ligands on 
apoptotic cells by phagocytic receptors on the phagocytic cell (e.g. phosphatidylserine recognition 
by KIM-1), which then triggers phagocytic cup formation and subsequently a cascade of 
intracellular signalling events that include activation of various GTPases (Elliott et al., 2010; 
Kinchen et al., 2007; Ravichandran et al., 2007). Since Gα12 is a GTPase, which cycles between 
active (GTP-bound) and inactive (GDP-bound) status, we sought to investigate if Gα12 was 
activated during engulfment of apoptotic targets. We measured the ratio of active-to-total Gα12 in 
cell lysates using a routinely used active-Gα12 pull-down assay that utilizes the tetratricopeptide 
repeat (TPR) domain of a downstream effector of Gα12, Ser/Thr phosphatase type 5 (PP5), fused 
to GST (Y. Yamaguchi et al., 2002). Subsequently, we used Western blotting to detect both active 
and total Gα12. In KIM-1-expressing cells, we observed a steady decrease (from baseline) in the 
level of active Gα12 during phagocytosis (Figure 3.3A). The decrease in active Gα12 was more 
pronounced during later stages of phagocytosis (60-90 minutes after adding apoptotic cells). On 
the other hand, we observed no significant difference or trend in Gα12 activity in HEK-293 cells 
not expressing KIM-1 over the same period of observation (Figure 3.3B). We observed similar 
kinetics of Gα12 inactivation when porcine renal TECs (LLC-PK1) stably expressing a C-terminal 
HA-tagged KIM-1 were transfected with a Gα12 expression construct, but not in control vector 
(pcDNA) transfected cells  (Figure 3.3C and D). Together, these data suggested that Gα12 activity 
is progressively suppressed in the HEK-293 cells in a KIM-1-dependent manner during 
phagocytosis. 
 
 
 
 
 
 
120 
 
 
 
121 
 
Figure 3.3. KIM-1 down regulates Gα12 activity during KIM-1-mediated phagocytosis. 
HEK-293 cells stably expressing KIM-1-GFP (A) or pcDNA (control vector) (B) were fed 
apoptotic cells (ACs) for various time points (15, 30, 60, and 90 minutes). Similarly, porcine 
renal proximal TECs (LLC-PK1) stably expressing a C-terminal HA-tagged KIM-1 (C) or 
control vector (pcDNA) (D) were transfected with a wild-type Gα12 expression construct and 
fed apoptotic cells. Cell lysates were subjected to the GST-TPR pull-down assay to measure 
active Gα12 as described in the experimental procedure section. Samples were analyzed by SDS-
PAGE followed by immunoblotting (IB) with antibodies against Gα12 and actin. The total Gα12 
lanes represent 5 % of the lysate that used for GST-TPR pull-down. The numbers below blots 
represent the respective densitometric ratio of the active Gα12 band to total Gα12 band on the 
Western blot image normalized to the untreated sample. Graphs represent the estimated marginal 
means for active Gα12 as determined by the analysis of covariance (ANCOVA). In KIM-1-
expressing cells (A and C), a statistically steady significant decrease in the level of active Gα12 
during phagocytosis was observed (n=3, p=0.015 (A), p=0.001 (C)). Cells in B and D show no 
significant change (n=3, p=0.445 (B), p=0.278(D)). 
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3.4.3. Gα12 is a negative regulator of KIM-1-mediated phagocytosis  
Though data presented thus far demonstrate that Gα12 activity is inhibited during 
phagocytosis, they do not necessarily imply a functional role for Gα12 in KIM-1-mediated 
phagocytosis. To study this, HEK-293-KIM-1-GFP cells were transfected with a control vector, 
vector encoding wild type Gα12 (WT Gα12), or vector encoding a constitutively active (GTPase-
deficient) mutant of Gα12 (QL Gα12) (Meyer et al., 2002), and phagocytosis efficiency was 
measured using flow cytometry. Overexpression of QL Gα12 significantly inhibited engulfment 
of apoptotic cells, whereas WT Gα12 had little effect on phagocytosis of apoptotic cells (Figure 
3.4A). We obtained similar results when transfecting KIM-1-expressing LLC-PK1 cells with QL 
Gα12 (Figure 3.4B). To verify these findings, we performed confocal imaging of these cells and 
counted the number of apoptotic cells in the vicinity of the KIM-1 expressing HEK-293 cells for 
each condition. This analysis shows that there was a significant decrease in the number of apoptotic 
cells present inside cells transfected with the constitutively active mutant (Figure 3.4C).  
In order to test how suppression of Gα12 expression affected phagocytosis, we silenced 
Gα12 using siRNA in HEK-293-KIM-1-GFP cells (Figure 3.4D) and performed phagocytosis 
assays. We found a significant increase in the uptake of apoptotic cells (Figure 3.4E) in conjunction 
with effective knockdown of Gα12 in these cells. Evaluation of phagocytosis by confocal 
microscopy once again confirmed these results (Figure 3.4F). The above data suggested that active 
Gα12 has a negative effect on KIM-1-mediated engulfment of apoptotic cells. 
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Figure 3.4. Gα12 negatively regulates KIM-1-mediated phagocytosis. 
A: HEK-293 cells stably expressing wild type KIM-1 were transfected with either control vector 
encoding GFP (pcDNA-GFP), wild type GFP-tagged Gα12 (pcDNA-WT Gα12-GFP) or 
constitutively active GFP-tagged Gα12 (pcDNA-QL Gα12-GFP). B: LLC-PK1 cells stably 
expressing KIM-1 were transfected with the same constructs as in A. Cells in A and B were fed 
apoptotic cells that are fluorescently labelled with pHrodo red for 90 minutes. The percent of 
uptake of apoptotic cells was determined by flow cytometry after gating on GFP positive cells. 
The ratio of phagocytosis compared to control vector was determined (n=3, *p<0.05, 
***p<0.001, unpaired t-test). C: HEK-293 cells stably expressing wild type KIM-1 were grown 
on cover slips and transfected with either pcDNA-GFP or pcDNA-QL Gα12-GFP and fed 
fluorescently labelled (pHrodo red) apoptotic cells for 90 minutes. Confocal microscopy images 
were taken to quantify the number of apoptotic cells bound to the phagocytic cells. The results 
were plotted as a representation of eight sections from four independent experiments with 
approximately 120 cells counted for each section (n=4, *p<0.05, unpaired t-test). D: HEK-293 
cells stably expressing KIM-1 were transfected with 50 pmol of control siRNA or siRNA against 
Gα12 for 24 hours, and the levels of Gα12, KIM-1 and actin were determined by 
immunoblotting (IB) with the indicated antibodies. The graph showing the densitometric ratio of 
Gα12 in siRNA treated samples as compared to non-transfected samples represents data from 
four independent experiments (n=4, *p<0.05, ns= not significant, unpaired t-test). E: HEK-293-
KIM-1-GFP expressing cells transfected with either control or Gα12 siRNA were fed 
fluorescently labelled (pHrodo red) apoptotic cells to measure phagocytosis as in A and B (n=5, 
*p<0.05, unpaired t-test). F: cells in E were visualized with confocal microscopy to count the 
number of apoptotic cells. The number of apoptotic cells bound to the cells that were seen in 
each field was plotted based on analysis of eight representative sections from each of 4 
independent experiments with approximately 120 cells counted for each section (n=4, *p<0.05, 
unpaired t-test). 
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3.4.4. RhoA is a down-stream effector in KIM-1-mediated phagocytosis  
Gα12 has been shown to transduce signals from GPCR to activate RhoA via Rho GEFs 
(Tanabe et al., 2004). RhoA belongs to the Rho family of GTPases (Chimini et al., 2000; Hall, 
1998; Tosello-Trampont et al., 2003) that are master regulators of the actin cytoskeleton and has 
been implicated in phagocytosis (Morimoto et al., 2006; Nakaya et al., 2006; Ravichandran et al., 
2007). To determine the role of RhoA in KIM-1-dependent engulfment of apoptotic cells, we 
inhibited RhoA signalling  using a Rho inhibitor (cell-permeable C3 transferase) (Fritz et al., 1994) 
or its downstream effector Rho-associated Protein Kinase (ROCK) using Y27632 (Ishizaki et al., 
1997; Ishizaki et al., 2000). The inhibition of either RhoA or ROCK significantly increased the 
uptake of apoptotic cells when compared to control treatments respectively (Figure 3.5A). The 
comparable effects of both inhibitors on apoptotic cell-uptake suggested that ROCK might be a 
primary RhoA effector in mediating the inhibition of phagocytosis in KIM-1 expressing cells. In 
contrast, KIM-1-expressing HEK-293 cells transfected with a vector encoding either wild type 
RhoA or constitutively activated RhoA mutant (Q62L) exhibited significantly reduced phagocytic 
efficiency when compared to the cells transfected with a control vector (Figure 3.5B). However, 
when KIM-1-expressing cells were transfected with dominant negative RhoA (T19N), there was 
a significant increase in phagocytosis (Figure 3.5).  
The parallel and negative effects of both activated Gα12 and RhoA on KIM-1-mediated 
phagocytosis suggested that RhoA likely mediated the Gα12-inhibitory effect on phagocytosis. To 
formally test if endogenous RhoA activity was regulated by Gα12 in our cells, we silenced 
endogenous Gα12 expression in HEK-293-KIM-1-GFP cells and measured the RhoA activation 
using a commercially available pull-down assay that employs the binding domain of Rho effector 
protein (Rhotekin) fused to GST (Ishizaki et al., 1997). Endogenous RhoA activity was 
significantly inhibited in HEK-293-KIM-1-GFP cells treated with Gα12 siRNA, but not control 
siRNA, at baseline, at 30 minutes (early phagocytosis) and 90 minutes (late phagocytosis) after of 
exposure to apoptotic cells (Figure 3.5C). Additionally, transfection of HEK-293-KIM-1-GFP 
cells with a constitutively active mutant of Gα12 (QL Gα12) led to a significant increase in RhoA 
activity (Figure 3.5D).  
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Figure 3.5. RhoA is a down-stream effector of Gα12 in KIM-1-mediated phagocytosis. 
A: HEK-293 cells stably expressing KIM-1 were treated for 4 hours with DMSO (control), Rho 
inhibitor (cell permeable C3 transferase) (0.5 µg/ml), or Rho kinase (ROCK) inhibitor Y27632 
(10 µM). B: Cells were transfected with CFP-tagged control vector, CFP-tagged wild type 
RhoA, CFP-tagged dominant negative RhoA (T19N) or CFP-tagged constitutively active RhoA 
(Q62L). These cells (A, B) were incubated with pHrodo red-labelled apoptotic cells for 90 
minutes and the percentage of phagocytosis by CFP-positive cells was measured by flow 
cytometry (n=3, *p<0.05, **p<0.01, ***p<0.001, unpaired t-test). C: HEK-293 cells stably 
expressing KIM-1 were transfected with either control siRNA or siRNA against Gα12 for 24 
hours then stimulated with apoptotic cells (ACs) for 30 or 90 minutes. D: HEK-293-KIM-1 cells 
were transfected with either control vector or constitutively active Gα12 (QL Gα12). Levels of 
active RhoA (in C and D) were measured using the G-LISA RhoA activation assay kit 
(Cytoskeleton Inc.). Total RhoA levels in lysates were measured using RhoA ELISA kit 
(Cytoskeleton Inc.). The level of normalized active RhoA were calculated and graphed (n=3, 
*p<0.05, ***p<0.001, unpaired t-test).  
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We also examined dynamic RhoA activity during phagocytosis. Following stimulation 
with apoptotic cells, a statistically gradual significant increase in the level of active RhoA during 
KIM-1-mediated phagocytosis was observed in cells, with a peak activity occurred around 90 
minutes after the addition of apoptotic cells (Figure 3.6A). There was no discernible pattern to 
RhoA activation observed in cells not expressing KIM-1 that were also fed apoptotic cells 
(Figure 3.6B). The difference in the trend between RhoA activation and Gα12 activation during 
KIM-1-mediated phagocytosis could suggest the involvement of independent proteins affecting 
the level of active RhoA and Gα12. Taken together, the above results suggested that Gα12-RhoA 
signalling negatively regulates KIM-1-dependent phagocytosis. Our data are consistent with 
reports showing that RhoA and ROCK are negative regulators of phagocytosis mediated by other 
phagocytic receptors (Nakaya et al., 2006;Tosello-Trampont et al., 2003).  
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Figure 3.6. RhoA activity is increased during the course of KIM-1-mediated phagocytosis. 
HEK-293 cells stably expressing KIM-1-GFP (A) or pcDNA-GFP (control vector) (B) were fed 
apoptotic cells for various time points (15, 30, 60, and 90 minutes). The level of active RhoA 
was measured using active RhoA pull-down assay (Cytoskeleton Inc.). Cell lysate loaded with 
non-hydrolyzable GTP (GTPγS) or GDP were used as a positive or negative control, 
respectively. Samples were analyzed by SDS-PAGE followed by immunoblotting (IB) with 
antibodies against RhoA and actin. Densitometric analysis of the relative ratio of the active 
RhoA to their respective total fractions in comparison to the non-treated sample is shown as 
numbers below blots. Graphs represent the estimated marginal means for active RhoA as 
determined by the analysis of covariance (ANCOVA) (n=3, p=0.009 (A), p=0.965 (B)).  
 
 
 
 
130 
 
Unlike RhoA, Rac1 has been shown to have a conserved and positive role in phagocytosis 
by both professional and semi-professional phagocytes regardless of which phagocytic receptor 
was involved (Ravichandran, 2011; Ravichandran et al., 2007). Thus, we next sought to determine 
the role of Rac1 in KIM-1-mediated phagocytosis. Consistent with these reports, transfection of 
KIM-1-expressing cells with a vector encoding dominant negative Rac1 (T17N) or treatment of 
KIM-1-expressing cells with a Rac1 inhibitor significantly inhibited the phagocytic uptake of 
apoptotic cells compared to controls (Figure 3.7A and B). Hence, we reasoned that Rac1 is also 
required for KIM-1-dependent phagocytosis and has the opposite effect to RhoA on KIM-1-
dependent corpse engulfment in our cell culture models. 
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Figure 3.7. Rac1 is involved in KIM-1-mediated phagocytosis. 
A: HEK-293 cells were co-transfected with construct encoding wild type KIM-1 and either CFP-
tagged control vector (control), CFP-tagged wild type Rac1 or CFP-tagged dominant negative 
Rac1 (Rac1-T17N). B: HEK-293-KIM-1 cells were treated for 4 hours with DMSO (control) or 
Rac1 inhibitor (NSC23766) (50 µM). Cells in (A) and (B) were fed pHrodo-labelled apoptotic 
cells for 90 minutes and the percentage of uptake was measured by flow cytometry. In A, the 
percentage of pHrodo red high fluorescent cells was determined for CFP-positive cells (n=3, 
**p<0.01, ***p<0.001, unpaired t-test). 
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3.4.5. KIM-1 is the major phagocytic receptor in primary proximal tubule epithelial cells that 
control Gα12 activity  
In the context of our previous report (Ismail et al., 2015) demonstrating that KIM-1 binds 
directly to and suppresses Gα12 activation by blocking GTP-loading, our present data suggest that 
KIM-1-suppression of endogenous Gα12 activation in cells is required for efficient phagocytosis 
of apoptotic cells. To confirm the inhibitory role of Gα12 in a physiologically relevant cell type, 
we studied primary tubular epithelial cells (TECs) isolated from mice kidneys. First, we aimed to 
determine if KIM-1 is dispensable for phagocytosis in primary renal TECs or if its expression is 
absolutely required for phagocytosis. For this, we compared the phagocytic efficiency between 
primary TECs isolated from wild type (Kim-1+/+) C57BL/6 and previously generated Kim-1-
deficient mice (Kim-1-/-) (Wong et al., 2010). Ex vivo culturing of TECs from Kim-1+/+ mice 
readily resulted in spontaneous Kim-1 upregulation, as previously reported (Ajay et al., 2014; 
Humphreys et al., 2013; Ichimura et al., 2008), suggesting that cell culture condition mimics injury 
induced by IRI in AKI. As expected, compared to Kim-1+/+ TECs, there was an absence of both 
total Kim-1 protein level and Kim-1 cell-surface expression in TECs isolated from Kim-1-/- mice, 
as determined by Western blot and flow cytometry, respectively (Figure 3.8A and B). When 
apoptotic cells were fed to TECs over 24 hours to stimulate phagocytosis, we found a significant 
difference between Kim-1-/- and Kim-1+/+ TECs in phagocytosis as measured by flow cytometry 
(Figure 3.8C). Surprisingly, TECs deficient in Kim-1-expression were virtually defective in the 
uptake of apoptotic cells. To verify these findings using an alternate method, TECs were fed 
apoptotic cells for three hours and cells were stained for surface Kim-1 and imaged by confocal 
microscopy (Figure 3.8D). In contrast to Kim-1-deficient TECs and in keeping with our flow 
cytometry data, Kim-1-expressing TECs readily bound apoptotic cells and formed phagocytic cups 
around them (arrows, Figure 3.8D). Finally, to test if Gα12 negatively regulated KIM-1-dependent 
phagocytosis in primary TECs, we pretreated TECs isolated from Kim-1+/+ mice with Gα12 siRNA 
or control siRNA, and compared their relative phagocytic efficiencies (Wong et al., 2010). In 
keeping with what was observed in KIM-1-expressing HEK-293 cells, silencing Gα12 expression 
significantly increased the phagocytic capacity of TECs and its ability to mediate engulfment of 
apoptotic cells (Figure 3.8E and F).  
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Figure 3.8. KIM-1 is a major phagocytic receptor in primary proximal tubular epithelial 
cells and Gα12 is a negative regulator of phagocytosis. 
A: Proximal tubular epithelial cells (TECs) isolated from wild type (Kim-1+/+) and Kim-1 knock 
out (Kim-1-/-) mice were cultured and the expression levels of mouse Kim-1 were measured by 
Western blot. B: Surface expression of mouse Kim-1 on TECs was determined by flow 
cytometry using PE-conjugated anti-mouse Tim-1/Kim-1 antibody (R&D Systems Inc.) (n=3, 
*p<0.05, unpaired t-test). C:  TECs were fed pHrodo red-labelled apoptotic cells for various time 
points (hour(s)) and the percent phagocytosis of fluorescently labelled apoptotic cells uptake by 
TECs (as determined by high fluorescence staining (>104)) was measured by flow cytometry 
(n=3, *p<0.05, one-way ANOVA). D:  TECs were cultured on glass cover slips and fed green-
labelled apoptotic cells for 3 hours. Cells were fixed and surface stained for mouse Kim-1 using 
anti-mouse Kim-1 antibody and Cy5-conjugated secondary antibody (600x, bar 10µm). E: TECs 
isolated from wild type C57BL/6 mice were transfected with 50 pmol of control siRNA or 
siRNA against mouse Gα12 for 24 hours and the levels of Gα12, mouse Kim-1 and actin were 
determined by Western blot. F: TECs transfected with either control siRNA or Gα12 siRNA 
were subjected to the phagocytosis assay and the percentage of phagocytosis of pHrodo-labelled 
apoptotic cells was measured by flow cytometry (n=4, *p<0.5, unpaired t-test). 
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3.5. DISCUSSION 
KIM-1 is a phosphatidylserine-binding phagocytosis receptor (Freeman et al., 2010; 
Ichimura et al., 2008) that is specifically upregulated by tubular epithelial cells (TECs) during 
ischemic or toxic AKI (Ichimura et al., 2008; Ichimura et al., 1998; Ichimura et al., 2012).  
However, the relevant intracellular signalling pathway(s) that it regulates had not been appreciated 
till now. Here, we reveal for the first time that Gα12 negatively regulates KIM-1-depedent 
phagocytosis. Further, we demonstrated that Gα12 mediates this inhibition through downstream 
activation of RhoA and likely via ROCK. Given that KIM-1-mediated phagocytosis prevents AKI 
(Yang et al., 2015), our data demonstrating that KIM-1 is indispensable for phagocytosis by renal 
TECs implies that the Gα12-RhoA signalling axis plays an important role in regulating 
phagocytosis by TECs in vivo during AKI. 
While we did not specifically address how Gα12 is activated in TECs during phagocytosis 
or the molecular mechanisms of Gα12 inhibition by KIM-1, our findings are supported by our 
previous work which suggested that KIM-1, when upregulated following ischemia-reperfusion 
injury (IRI), binds directly to Gα12 and inhibits its activation by ROS (Ismail et al., 2015). This 
inhibition is mediated by the ability of KIM-1 to block GDP-GTP exchange onto Gα12. As a result, 
we showed that Kim-1-deficient mice exhibited a higher level of active Gα12 and worse kidney 
function following renal ischemic injury when subjected to renal IRI. This demonstrates that KIM-
1 expression protected mice from tissue damage caused by ROS-mediated activation of injury 
pathways downstream of Gα12 (Yu et al., 2012). These downstream injury pathways include 
activation of Src kinase and inhibition of tight junctions assembly and reassembly that are required 
for tubular repair (Meyer et al., 2002; Sabath et al., 2008). Our current findings here suggest that 
ability of KIM-1 to suppress Gα12 activation is also crucial for TECs to carry out phagocytosis 
during AKI. This finding is particularly relevant because it was later shown that KIM-1-mediated 
phagocytosis contributes to protection from AKI by curtailing immune responses (Yang et al., 
2015). Thus, aberrant Gα12 activation by ROS during AKI not only destabilizes tight junctions 
(via Src kinase) (Meyer et al., 2003; Yu et al., 2012),  but also impedes phagocytic clearance of 
dying cells. Thus, we propose that upregulation of KIM-1 on TECs during AKI and subsequent 
inhibition of Gα12 protects from renal damage during renal IRI via at least two potential 
mechanisms. The first one is by blocking ROS-mediated activation of injury pathways via 
activated Gα12 that leads to worse tissue damage and impaired repair (Yanamadala et al., 2007; 
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Yu et al., 2012). The second mechanism is by enhancing phagocytic clearance of apoptotic and 
necrotic cells by surviving TECs (Gandhi et al., 2014; Ichimura et al., 2008) via suppression of 
Gα12. This inhibitory mechanism of KIM-1 on Gα12 would help regulate inflammation caused by 
spillage of the intracellular contents of necrotic and secondary necrotic cells into the extracellular 
milieu within the kidney (Elliott et al., 2010; Ren et al., 1998; Silva, 2010).   
Actin cytoskeletal rearrangement is crucial for the engulfment of apoptotic cells 
(Castellano et al., 2001; Chimini et al., 2000). Rac1 and RhoA belong to the Rho family of 
GTPases that regulate actin cytoskeletal reorganization (Ridley, 2001) and have long been 
implicated in phagocytosis (Ravichandran et al., 2007). The reciprocal role for Rac1 and RhoA in 
KIM-1-dependent phagocytosis in TECs proposed by our work is novel for KIM-1-mediated 
uptake of apoptotic cells and is consistent with what has been reported by other groups studying 
additional phosphatidylserine receptors (Erwig et al., 2008; Nakaya et al., 2006; Tosello-Trampont 
et al., 2003). In those studies, the inhibitory effect of RhoA on apoptotic cell-clearance was 
mediated by ROCK, as was also the case in our experiments (Tosello-Trampont et al., 2003). 
Activated RhoA increases the kinase activity of ROCK, which in turn phosphorylates myosin light 
chain (MLC) and promotes contractility via actin stress fiber formation (Riento et al., 2003). The 
latent activation of RhoA in our cells might lead to an increase in contractility, causing stress fiber 
formation, which has been postulated to inhibit phagocytosis (Deery et al., 1993; Ravichandran et 
al., 2007). The later has not been tested in this paper and requires future experimental work. In 
contrast to RhoA, activated Rac1 has an evolutionarily conserved positive role in promoting 
phagocytosis (Henson, 2005; Kinchen et al., 2005; Nakaya et al., 2008). It is generally accepted 
that Rac1 is recruited to help form phagocytic cups and generate membrane ruffles that are 
necessary to facilitate corpse engulfment (Kraynov et al., 2000; Nakaya et al., 2008). Rac1 is then 
down regulated when the phagocytic cup closes in conjunction with abrupt disruption of the 
associated actin patches. Our data are consistent with a requirement for Rac1 in phagocytosis. 
Whether one or more of the conserved phagocytic signalling pathways regulates Rac1 activation 
downstream of KIM-1 in TECs remains to be tested (Kinchen et al., 2005; Tosello-Trampont et 
al., 2007). Moreover, the opposing roles of RhoA and Rac1 in KIM-1-mediated phagocytosis 
might suggest a spatiotemporal pattern of activation. This may be better visualized in future studies 
through the use of biosensors with fluorescence resonance energy transfer (FRET) that respond to 
RhoA and Rac1 activation (Nakaya et al., 2008; Wong et al., 2006) 
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To our knowledge, this is the first report describing any aspect of phagocytic signalling  by 
KIM-1, despite the fact that other members of the TIM family of phosphatidylserine receptors, 
such as TIM-3 and TIM-4, have been the subjects of much research (Balasubramanian et al., 2012; 
Binne et al., 2007; Curtiss et al., 2011; Freeman et al., 2010; Mariat et al., 2009; Yeung et al., 
2015). Studies on TIM-1 signalling thus far have focused primarily on the non-phagocytic 
functions of KIM-1 (that is TIM-1), for instance in its role in co-stimulation of T cell responses 
(Balasubramanian et al., 2012; Bonventre et al., 2011; Anjali J. de Souza et al., 2008; Lee et al., 
2010; Mariat et al., 2009). Balasubramanian et al. recently reported that TIM-1 mediates the 
degradation of NUR77, a nuclear receptor implicated in apoptosis and cell survival, but did not 
investigate phagocytic signalling (Balasubramanian et al., 2012). Additionally, Yang et al. 
demonstrated that KIM-1 interacts with p85 in TECs and down-modulates NF-кB signalling (Yang 
et al., 2015). On the other hand, TIM-3 is expressed by dendritic cells, where it mediates 
phagocytosis of apoptotic cells, but very little is known regarding how it mediates phagocytic 
signalling (Miyanishi et al., 2007; Nakayama et al., 2009; Sanchez-Fueyo et al., 2003). Tim-4 
does not mediate phagocytic signalling directly, but has been postulated to signal via a yet 
unidentified co-receptor (Park et al., 2009).  
Although various GTPases make up fundamental components of the phagocytic signalling 
machinery (Hochreiter-Hufford et al., 2013; Ravichandran et al., 2007), to our knowledge, our 
study is the first one to implicate Gα12 in phagocytosis. Given the various fundamental processes 
that Gα12 regulates, such as motility (Kelly et al., 2006), modulation of cell-cell junctions (Meyer 
et al., 2003), cellular transformation (Dermott et al., 1999) and contractility (Buhl et al., 1995; 
Gavard et al., 2008), our study suggests a relationship between these processes and phagocytosis 
in TECs. For example, pathological activation of Gα12 during ischemic-reperfusion injury results 
in activation of injury pathways via destabilization of tight junctions (Samarin et al., 2009) through 
its interaction with zonula occludens-1 (ZO-1) and Src kinase (Meyer et al., 2003; Meyer et al., 
2002; Sabath et al., 2008). This disruption of the tight junction has been shown to be a hallmark 
of epithelial cell damage and is believed to be a contributor to kidney dysfunction (Denker et al., 
1998; Meyer et al., 2001). The relationship between tight junction assembly and disassembly 
during phagocytosis has not yet been studied and will be of major interest to our research. 
Deciphering KIM-1 signalling pathway(s) may have future clinical implications in AKI. 
Our work presented here and previously (Ismail et al., 2015) suggests that targeting Gα12 might 
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be a potential strategy to treat AKI by enhancing clearance of apoptotic cells and simultaneously 
inhibiting downstream injury pathways. Unfortunately, there is no specific Gα12 inhibitor 
available to currently test this in vivo. Nonetheless, our detailed work uncovering the importance 
of KIM-1 in TEC-phagocytosis and how it is regulated offers important insights into TEC biology 
that might be relevant to AKI.  
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4.1. SUMMARY   
In this chapter, we identify and study another novel KIM-1-interacting protein. Using a 
yeast two-hybrid system, we describe the identification of the 14-kDa light chain of cytoplasmic 
dynein motor protein, Tctex-1, as a potential KIM-1 interacting protein. Given that Tctex-1 is 
involved in microtubule and actin cytoskeletal dynamics, we hypothesized that Tctex-1 functions 
to enhance KIM-1-mediated engulfment of apoptotic cells. First, we established that Tctex-1 
interacts with KIM-1 via co-immunoprecipitation. When we stimulated KIM-1-expressing cells 
with apoptotic cells, we observed that this interaction is significantly reduced upon longer 
incubation with apoptotic cells (90 minutes). The time dependent reduction in the interaction 
between Tctex-1 and KIM-1 was further confirmed by GST-Tctex-1 pull-down assay and 
immunofluorescence staining. When we inhibited KIM-1-mediated phagocytosis through 
inhibition of actin cytoskeleton changes by treatment with cytochalasin D or nocodazole, we 
restored the interaction between KIM-1 and Tctex-1 during the later stages of phagocytosis. In 
addition, we tested whether phosphorylation at Threonine-94 of Tctex-1 influenced the interaction 
with or phagocytic efficiency of KIM-1. Surprisingly, a phosphomimetic mutant of Tctex-1 at 
Threonine-94 (T94E) displayed a decreased ability to interact with KIM-1 without influencing 
KIM-1-mediated uptake of apoptotic cells. To determine the role of Tctex-1 during KIM-1-
mediated phagocytosis, we silenced Tctex-1 expression via siRNA and found a significant 
reduction in uptake of apoptotic cells that was accompanied by highly disorganized actin 
structures. Furthermore, in a search for down-stream mediators of Tctex-1 signalling in KIM-1-
expressing cells, we failed to find a link between Tctex-1 and RhoGTPase. This suggest that Tctex-
1 might exhibit its function through different RhoGTPases that are novel to KIM-1.  
 
4.2. INTRODUCTION 
The process of programmed cell death, or apoptosis, is characterized by distinct 
morphological characteristics that serve as a mechanism for removing damaged or unwanted cells 
from the tissues of an organism (Kerr, 2002; Kerr et al., 1972; Wyllie et al., 1980). Phagocytosis 
of apoptotic cells, termed phagocytosis (Vandivier et al., 2006), prevents the release of noxious 
and immunogenic materials from dying cells, which reduces tissue damage associated with 
inflammation or inappropriate autoimmune response (Ren et al., 1998). Phagocytosis is 
increasingly being recognized to be important in tissue repair after acute organ injury (Juncadella 
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et al., 2013; Yeung et al., 2015). The process of phagocytosis is usually carried out by professional 
phagocytes (Albert et al., 1998; Duvall et al., 1985). However, emerging data suggests that 
amateur phagocytes, such as fibroblasts, retinal pigment epithelial cells, sertoli cells, and more 
recently renal proximal tubular epithelial cells, also play roles in this process (Finnemann et al., 
1997; Ichimura et al., 2008; Monks et al., 2002; Patel et al., 2010; Shiratsuchi et al., 1997). The 
direct or indirect recognition of apoptotic cells by phagocytes involves the recognition of “eat-me” 
signals that are newly (e.g. exposed or modified lipids or proteins) exposed on the surface of 
apoptotic cells. One of the most well characterized “eat me” signals is phosphatidylserine (PS) 
(Ravichandran et al., 2007).  
Kidney injury molecule-1 (KIM-1) is a well characterized phagocytic receptor that is 
expressed on renal proximal tubular epithelial cells (TECs). It recognizes phosphatidylserine on 
apoptotic cells (Ichimura et al., 2008). KIM-1 was first identified in a cDNA screen looking for 
genes that are upregulated in the post-ischemic rat kidney (Ichimura et al., 1998). KIM-1 is mostly 
localized to the apical membrane of TECs following injury to kidney commonly caused by 
ischemia or toxic insult (Ichimura et al., 2004). Structurally, KIM-1 is a type I transmembrane 
glycoprotein consisting of an N-terminal immunoglobulin V (IgV) domain, a mucin domain, a 
transmembrane domain and a cytoplasmic tail (Ichimura et al., 1998; Santiago et al., 2007). The 
signalling mechanisms underlying KIM-1-mediated uptake of apoptotic cells are still not well 
understood. Recently, KIM-1 was shown to interact with p85 following apoptotic cell binding 
(Yang et al., 2015). This was shown to lead to down-regulation of the NF-кB pathway and 
subsequent inhibition of inflammatory signalling during AKI. In addition, we have uncovered 
another protein that KIM-1 interacts with to carry its phagocytic function, known as the α subunit 
of heterotrimeric G12 protein (Gα12). Despite the fact that several proteins have been identified 
to interact with KIM-1, the overall signalling mechanisms by which KIM-1 regulates the uptake 
of apoptotic cells has not yet been fully elucidated.  
Here we uncovered another a novel KIM-1 interacting protein, Tctex-1 (t-Complex testis-
expressed-1), using a yeast two hybrid screen that exploited the cytoplasmic tail of KIM-1 as bait 
and a HeLa cell cDNA library (done by Dr. Zervos, University of Central Florida, Orlando, 
Florida). Tctex-1 was initially identified in a cDNA screen looking for candidate genes in the 
mouse t complex whose aberrant expression maybe functionally related to sterility and 
transmission ratio distortion (Lader et al., 1989). Tctex-1 is a key component of the cytoplasmic 
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light chain of the dynein motor complex (King et al., 1996). Cytoplasmic dynein is a 
multicomponent, microtubule-based, ATP-dependent motor unit that has several roles in 
intracellular retrograde transport, mitotic spindle localization and centrosome separation (Barton 
et al., 1996; Schroer, 1994; Steuer et al., 1990). Tctex-1 has diverse dynein-dependent and -
independent functions (Hirokawa, 1998; Hirokawa et al., 1998; Lader et al., 1989). Through 
dynein-dependent functions, Tctex-1 is associated with microtubules in order to mediate a range 
of intracellular motile events that are important in the intracellular targeting or sorting of proteins 
(Mueller et al., 2002; Sachdev et al., 2007; Tai et al., 1999).  For example, Tctex-1 interaction 
with rhodopsin, a GPCR, and transports vesicles containing rhodopsin from the Golgi apparatus 
to the apical cell surface via tethering of Tctex-1 to the dynein complex on microtubules (Tai et 
al., 1999; Tai et al., 2001). On the other hand, Tctex-1 has been shown to function independently 
of dynein, to regulate actin cytoskeletal dynamics (Chuang et al., 2005). Phosphorylation of Tctex-
1 at Threonine-94 (Thr-94) has been shown to promote its dissociation from the dynein light chain 
and may allow it to bind to other non-dynein proteins to mediate dynein-independent functions 
(Chuang et al., 2005; Song et al., 2007). In addition, Tctex-1 expression is restricted to certain 
tissues, where immunoprecipitation of kidney, spleen and testis tissues lysate showed higher levels 
of Tctex-1 than brain tissue lysate (King et al., 1996). Despite advances in the research regarding 
Tctex-1, most of the research on this protein has focused on the role of Tctex-1 in neurogenesis, 
with little information about its role in the kidney.  
In this report, we uncovered a novel interaction between Tctex-1 and KIM-1 and we 
investigated the role of Tctex-1 in the phagocytic uptake of apoptotic cells. Our data show that 
when KIM-1 is upregulated, it interacts with Tctex-1 to enable phagocytosis. Altering actin or 
microtubules polymerization leads to a restoration of interaction that is lost during later stages of 
phagocytosis. When Tctex-1 is phosphorylated at Threonine-94, its interaction with KIM-1 is 
severely decreased. Furthermore, Tctex-1 appears to be important in KIM-1-mediated 
phagocytosis, since silencing Tctex-1 decreases the uptake of apoptotic cells. Altogether, our 
findings support the idea that Tctex-1 is important in KIM-1-mediated phagocytosis and that its 
interaction with KIM-1 is a very dynamic process. The mechanisms by which Tctex-1 affects 
phagocytosis remains to be studied.  
 
150 
 
4.3. EXPERIMENTAL PROCEDURES 
4.3.1. Cell culture and materials 
Human Embryonic Kidney 293 (HEK-293) cells and human renal adenocarcinoma cells 
(769-P) were cultured at 37 °C in 5 % (vol/vol) CO2 and maintained in DMEM or RPMI media 
(Invitrogen, Carlsbad, CA) containing 10 % FBS (Invitrogen). Chemicals were purchased from 
Sigma (Sigma Aldrich, St. Louis, MO) unless stated. The pH-sensitive dye pHrodo™ Red 
succinimidyl ester (pHrodo™ Red, SE), Alexa Fluor® 555 goat anti-mouse, Alexa Fluor® 488 
goat anti-rabbit and DAPI (4',6-diamidino-2-phenylindole) were purchased from Life 
Technologies (Molecular probes, Invitrogen, Carlsbad, CA). Rhodamine phalloidin stain was 
purchased from Cytoskeleton Inc. (Cytoskeleton, Denver, CO). The Tctex-1/DYNLT-1 antibody 
used for confocal microscopy was purchased from Proteintech Group (11954-1-AP, Proteintech 
Group Inc., Chicago, IL) and was used at a dilution of 1:50. Antibodies for Western blot against 
Tctex-1 (D9944, 1:800 working dilution), actin (SAB4301137, 1:1000 working dilution) were all 
purchased from Sigma (Sigma Aldrich, St. Louis, MO). PE-conjugated anti-human KIM-1 (1D12, 
1:100 working dilution) and PE-conjugated rat IgG2b isotype control (RTK4530, 1:100 working 
dilution) were purchased from Biolegend (Biolegend, San Diego, CA). Anti-KIM-1 (cytosolic 
domain) antibody was custom generated by immunizing rabbits against the cytosolic domain of 
KIM-1 (PA 4145, Life technologies, Thermo Fisher Scientific, Rockford, IL) as previously 
described (Bailly et al., 2002; Gandhi, et al, 2014). A monoclonal KIM-1 antibody binding against 
to the mucin domain of KIM-1 (AKG7) was kindly provided by Dr. Bonventre (Harvard Medical 
School, Brigham and Women's Hospital, Boston, MA). Complete Mini EDTA-free protease 
inhibitor cocktail tablets were purchased from Roche (Roche Diagnostic, Basel, Switzerland). 
Cytochalasin D and Nocodazole were purchased from EMD Millipore (EMD Millipore, Billerica, 
MA). The plasmid constructs encoding Tctex-1 were kindly provided by Dr. Robert Rottapel 
(University of Toronto, Toronto, ON) and the plasmid constructs for KIM-1 were from Dr. 
Bonventre (Harvard Medical School, Brigham and Women's Hospital, Boston, MA). 
Lipofectamine® 2000 (Life Technologies, Thermo Fisher Scientific, Rockford, IL) and 
INTERFERin® (Polyplus-transfection Inc., New York, NY) were used for transfecting plasmid 
DNA and siRNA, respectively.  
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4.3.2. Immunoprecipitation and Western blot  
Cells were lysed with ice-cold lysis buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 2 mM EDTA, 1 mM NaVO4, 1 mM NaF,  1 % Triton X-100, and complete mini EDTA-
free protease inhibitor cocktail tablets (Roche Diagnostic, Basel, Switzerland). For 
immunoprecipitation, cell extracts containing 1.0–1.5 mg of protein/mL were incubated with 10 
µg of anti-KIM-1 antibody (PA 4145, cytosolic domain), or rabbit IgG antibody (sc-2027, control) 
and 20 µl of protein-A/G Sepharose beads (Santa Cruz Biotechnology, Santa Cruz, CA) at 4 °C 
overnight. Beads were centrifuged, washed three times, suspended in 20 μL of SDS sample buffer 
and heated at 100 °C for five minutes. Lysates (representing 5 % of total lysate) and 
immunoprecipitated samples were separated under reducing condition and transferred to 
polyvinylidene difluroide (PVDF) membranes (EMD Millipore, Billerica, MA). PDVF-
membranes were probed with antibodies specific to mucin domain of KIM-1 (AKG7, 1:1 working 
dilution), cytosolic domain of KIM-1 (PA 4145, 1:1,500 working dilution), Tctex-1 (D9944, 1:800 
working dilution) or actin (SAB4301137, 1:2,000 working dilution). The primary antibody was 
visualized using the appropriate horseradish peroxidase-conjugated secondary antibodies and ECL 
Western blot detection reagent (Luminata forte, EMD Millipore, Billerica, MA) by 
autoradiography (Biomax; Denville Scientific, South Plainfield, NJ).  
4.3.3. GST-Tctex-1 pull down  
The GST-Tctex-1 construct (provided by Dr. King, (King, et al., 1996)) was transformed 
into E.coli strain BL21 and expression of the fusion protein was induced by the addition of 0.3 
mM isopropyl-β-D-thiogalactopyranoside (IPTG) for three hours at 37 °C. After lysing the 
bacterial cells by sonication, GST-fusion proteins were purified by incubation with 1 ml of 
glutathione-Sepharose beads (Thermo Fisher Scientific, Rockford, IL) overnight at 4 °C. This was 
followed by three washes with 1x PBS and aliqouts of GST-Tctex-1 conjugated to glutathione-
Sepharose beads were kept at -80 °C for future use. Cells were lysed with ice-cold lysis buffer (50 
mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1 mM NaVO4, 1 mM NaF,  1 % Triton X-
100) supplemented with complete mini EDTA-free protease inhibitor cocktail tablets (Roche 
Diagnostic, Basel, Switzerland). One milligram of protein lysate and 30 µl of GST-Tctex-1 
coupled glutathione-sepharose beads were incubated together at 4 °C for overnight. Beads were 
washed to reduce non-specific binding and eluted using 20 μL of SDS sample buffer and heated 
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at 100 °C for five minutes. For each condition, both lysate and pull-down samples were analyzed 
by SDS-PAGE and Western blotting to detect total and pull-down KIM-1, respectively.  
4.3.4. Immunofluorescence and confocal microscopy  
HEK-293 cells were cultured at subconfluent density on poly-D-lysine hydrobromide 
(Sigma Aldrich, St. Louis, MO) coated glass cover slips, and were transfected with constructs 
encoding KIM-1 and flag-tagged Tctex-1. 769-P cells were grown on glass cover slips (without 
coating) and fed apoptotic cells for the indicated time points (15-90 minutes). Cells were washed 
three times with 1x PBS and fixed with 4 % paraformaldehyde, followed by counterstaining of the 
nucleus with DAPI (0.5 µg/ml), which stained both apoptotic cells and HEK-293 or 769-P. Cells 
were then permeabilized with 0.25 % Triton X-100 in 1x PBS for five minutes, and then blocked 
for 1 hour at room temperature with 1 % bovine serum albumin (BSA) and 0.05 % Triton X-100 
in 1x PBS. Cells were then incubated with anti-Tctex-1 antibody (11954-1-AP, 1:50 working 
dilution) (Proteintech Group Inc., Chicago, IL) in 0.5 % BSA/PBS at 4 °C overnight. Coverslips 
were washed three times with 1x PBS and incubated with Alexa Fluor® 488 goat anti-rabbit (1:500 
working dilution) at 37 °C for 1 hour. Coverslips were washed three times with PBS and surface 
staining of KIM-1 was done using an antibody against the mucin domain of KIM-1 (AKG7, 1:1 
working dilution) at 4 °C overnight. Bound KIM-1 was labelled with Alexa 555 conjugated anti-
mouse (1:1000 working dilution) at room temperature for 1 hour. The specificity of 
immunostaining was demonstrated by the absence of signal in samples processed using non-
specific rabbit or mouse IgG followed by staining with the corresponding secondary antibody. For 
actin cytoskeleton staining, cells were permeabilized with 0.25 % Triton in 1x PBS for five 
minutes, and then stained with rhodamine phalloidin for 30 minutes according to the manufactures 
instructions (Cytoskeleton, Denver, CO). Coverslips were mounted using Shandon-Mount® 
permanent mounting (Thermo Fisher Scientific, Rockford, IL) and viewed with a FLUOVIEW 
X83I confocal microscopy (Olympus, Tokyo, Japan). Data were acquired and analyzed using the 
FLUOVIEW FV10 ASW 4.0 viewer and ImageJ software (National Institutes of Health, Bethesda, 
MD) to determine the Pearson’s coefficient and Van Steensel’s score for colocalization of KIM-1 
and Tctex-1. Quantification of the colocalization score was assessed in three random fields per 
sample and was done in three independent experiments.  
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4.3.5. Phagocytosis assay and FACS analysis  
To prepare apoptotic cells for the phagocytosis assay, thymocytes were harvested from 3-
6 week old C57BL/6 mice, and apoptosis was induced by UV exposure for five minutes followed 
by incubation overnight at 37 °C in 5 % CO2 in DMEM media supplemented by 10 % FBS and 1 
% penicillin-streptomycin solution (Ichimura et al., 2008). Apoptotic thymocytes were stained 
with pH-sensitive dye pHrodo™ Red succinimidyl ester (pHrodo™ Red, SE) at a final 
concentration of 150 nM for 30 minutes at room temperature. Labelled apoptotic cells were washed 
twice with 1x PBS to remove excess dye. The cells were counted and 3x106 were added to each 
well of 6-well plate (15x106 for 10 cm plates) and incubated for various time points at 37 °C in 5 
% CO2 incubator. Cells were then placed on ice for 30 minutes to reduce non-specific binding of 
apoptotic cells. The plates were then washed three times with ice-cold 1x PBS, and cells were 
collected with 5 mM EDTA-PBS, and resuspended with FACS buffer (1xPhosphate-buffered 
saline (PBS), 2 % calf serum, and 0.1 % sodium azide) for flow analysis. For KIM-1-surface 
staining (or TIM-1), the cells were blocked in PBS and 10 % goat serum for 15 minutes, followed 
by incubation for 30 minutes at room temperature with PE-conjugated anti-TIM-1 (1D12, human) 
and respective isotype control antibody  (RTK4530) at concentration of 1:100. All samples were 
run on BD LSR II flow cytometer (BD Biosciences, San Jose, CA). Percentage of phagocytosis 
represents the number of cells that have internalized the apoptotic cell(s) as indicated by higher 
pHrodo red fluorescence (104-105 on logarithmic scale). Engulfed cells with low fluorescence were 
excluded from analysis (Gandhi et al., 2014). 
4.3.6. siRNA targeting of Tctex-1 
  ON Target plus® Smart pool siRNA against Tctex-1 and a non-targeting pool (Control 
siRNA) were purchased from Dharmacon (Thermo Fisher Scientific, Rockford, IL). Cells were 
transfected with 100 nM of siRNA using INTERFERin® for 24 hours before further analysis of 
knockdown using Western blotting and flow cytometry.  
4.3.7. Rac1 and RhoA activation  
Rac1 or RhoA activation was determined using the G-LISA Rac1 or RhoA activity assay 
according to the manufacturer’s instructions (Cytoskeleton, Denver, CO). Total RhoA was 
determined using Total RhoA ELISA kit (Cytoskeleton, Denver, CO). About 40 µg of protein was 
used for the activation assay and 20 µg of protein was used for the total assay. Treatment with 5 
% serum after serum starvation overnight served as positive control for Rac1 activation (Curtiss et 
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al., 2011). Treatment of cells with 10 µM Nocodazole for 15 minutes served as positive control 
for RhoA activation as indicated previously (Martin et al., 2001). 
4.3.8. Quantification and statistics  
Western blots were scanned and band intensity quantified using Image J software (National 
Institutes of Health, Bethesda, MD). Background was subtracted in these analyses and the linear 
range of response was determining using a standard sample that was serially diluted. The level of 
interaction between two proteins was determined by diving the intensity value (obtained from 
Western blotting) of protein being co-immunoprecipitated (Tctex-1) by the intensity value of 
protein being immunoprecipitated (KIM-1). Graphs obtained were generated by using GraphPad 
Prism software (Graph Pad Software Inc., La Jolla, CA).  Statistics were done in GraphPad Prism 
(Graph Pad Software Inc., La Jolla, CA) or IBM SPSS statistic 22 (IBM, Armonk, NY). The 
significance for the percentage of phagocytosis or immunoprecipitation densitometric analysis 
over phagocytosis time course was determined using one-way ANOVA (as indicated). All other 
analyses were done using an unpaired t-test where indicated. P-value of <0.05 was considered 
significant. Error bars represent the standard error of the mean. 
 
4.4. RESULTS  
4.4.1. KIM-1 interacts with Tctex-1 during the early phase of phagocytosis 
Previously, we had identified the alpha subunit of the heterotrimeric G12 protein as a novel 
KIM-1 interacting protein (Ismail et al., 2015). As an alternative strategy to identify other potential 
KIM-1-interacting proteins, we performed a yeast two-hybrid screening using the cytoplasmic tail 
of KIM-1 as a bait plasmid and a HeLa cell cDNA library as a “fish/prey” plasmid (in collaboration 
with Dr. Zervos, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, 
Florida). This identified two cDNA clones, one of which encoded for the dynein light chain 
protein, Tctex-1 (Lader et al., 1989). Because of the important role that Tctex-1 plays in the 
modulation of actin cytoskeletal dynamics (Chuang et al., 2005;Meiri et al., 2012), and the 
requirement of the cytoskeleton for the formation of phagocytic arms in phagocytosis (Chimini et 
al., 2000), we selected this candidate protein for further studies. To validate the results from the 
yeast two-hybrid screen, we performed co-immunoprecipitation (co-IP) experiments where HEK-
293 cells were transfected with both human GFP-tagged KIM-1 and human flag-tagged Tctex-1 
(Figure 4.1A). We further confirmed this interaction by detecting the co-localization of both 
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proteins when overexpressed by HEK-293 cells via immunofluorescent labelling and confocal 
microscopy imaging (Figure 4.1B). 
Given the role of KIM-1 in the uptake of apoptotic cells (Ichimura et al., 2008), we sought 
to determine whether the interaction between KIM-1 and Tctex-1 remains intact during the course 
of phagocytosis. Using co-IP experiments, we found a significant decrease in the interaction 
between KIM-1 and with Tctex-1 between 60 and 90 minutes after stimulation with apoptotic cells 
(later stages of phagocytosis) (Figure 4.1C). This exogenous overexpression of both proteins in 
HEK-293 cells provided evidence of the interaction, but did not necessarily reflect physiologic 
relevance. To address this, we utilized human renal adenocarcinoma cells (769-P) which 
endogenously and constitutively express both human KIM-1 (Bailly et al., 2002) and Tctex-1. This 
confirmed the co-IP results obtained above, including the observed diminishment in interaction 
between KIM-1 and Tctex-1 during the later stages of phagocytosis (Figure 4.1D, E). To 
substantiate the interaction between KIM-1 and Tctex-1 in vitro, GST pull-down assays were 
performed.  A fusion protein consisting of GST fused to full-length Tctex-1 (GST-Tctex-1) was 
used to test GST-Tctex-1 interaction with KIM-1 during the course of phagocytosis (Gauthier-
Fisher et al., 2009). As observed before, a significant reduction in the interaction between KIM-1 
and GST-Tctex-1 was observed during the later stages of uptake of apoptotic cells (90 minutes) 
(Figure 4.1F, G). These data confirm that the interaction between KIM-1 and Tctex-1 is dynamic 
and appears to decline during the course of KIM-1-dependent phagocytosis.  
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Figure 4.1. KIM-1 interacts with Tctex-1 during the early stages of phagocytosis. 
A: Human embryonic kidney-293 (HEK-293) cells transfected with human KIM-1-GFP and 
flag-tagged Tctex-1 were lysed for immunoprecipitation (IP) using antibody against the cytosolic 
domain of KIM-1 or control non-specific mouse immunoglobulin antibody (IgG). B: Cells in A 
were visualized for interaction using immunostaining for KIM-1 (red) and Tctex-1 (green) as 
indicated in the experimental procedures section. Nuclei was stained with DAPI (blue) (600x, 
bar represents 40 μm). C: Cells in A were stimulated with apoptotic cells for various time points 
(minutes) and IP was performed using KIM-1 antibody or control mouse IgG. D: 769-P cells 
were stimulated with apoptotic cells and IP was performed similarly to C. E: The level of bound 
Tctex-1 to KIM-1 was determined based on densitometric values obtained by Western blotting 
(n=3, **p<0.01, ***p<0.001, one-way ANOVA). F: GST and GST-Tctex-1 pull-down was 
performed on 769-P cells that were left unstimulated or stimulated with apoptotic cells for 
indicated time (in minutes). G: The level of KIM-1 bound to GST-Tctex-1 was determined based 
on densitometric values obtained from Western blotting (n=3, **p<0.01, one-way ANOVA). All 
samples in A, C, D and F were analyzed by SDS-PAGE followed by immunoblotting with 
antibodies against KIM-1, Tctex-1 and actin. The input lane represents 5 % of the lysate. The 
data represents three independent experiments. 
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4.4.2. Intracellular colocalization of Tctex-1 and KIM-1 occurs during the early stages of 
phagocytosis  
Confocal immunofluorescence analysis was performed to determine the degree of 
localization of both KIM-1 and Tctex-1 during the course of phagocytosis triggered by apoptotic 
cells. Using an antibody directed against the extracellular domain of KIM-1 to stain for 
endogenous KIM-1 expression in 769-P cells, we found KIM-1 to be distributed on the cell-surface 
and within the intracellular compartments reminiscent of the golgi apparatus as previously reported  
(Machacek et al., 2009). On the other hand, immunostaining for endogenous Tctex-1 revealed 
diffuse cytoplasmic staining with some staining concentrated in the perinuclear region as 
previously shown (Campbell et al., 1998). Double staining showed that both Tctex-1 and KIM-1 
colocalized in the cytoplasmic compartment of the cells prior to adding apoptotic cells (Figure 
4.2A, none). During the course of the uptake of the apoptotic cells (15-90 minutes after addition 
of apoptotic cells), the colocalization between KIM-1 and Tctex-1 appears to decrease during later 
stages (Figure 4.2A). In order to quantify the colocalization images of KIM-1 and Tctex-1, we 
analyzed the results using JACoP software (as indicated in the experimental procedures section) 
to determine the Pearson’s coefficient. We concluded that the level of colocalization decreased 
significantly during the later stages of phagocytosis (Figure 4.2B). Given the fact that some 
consider evaluating colocalization using Pearson’s coefficient to be ambiguous since it 
incorporates noise and fluorescence intensity variation in analysis (Li et al., 2011), we also 
analyzed the data according to Van Steensel’s approach (Wong et al., 2006). Similar to Pearson’s 
coefficient, we found that the colocalization decreased significantly during later stages of apoptotic 
cells uptake (Figure 4.2C). These results suggest that during the process of KIM-1-mediated 
phagocytosis, there is a temporal decrease in the colocalization between KIM-1 and Tctex-1 in 
later stages.  
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Figure 4.2. KIM-1 co-localizes with Tctex-1 during the early stages of phagocytosis. 
A: 769-P cells were stimulated with apoptotic cells (blue) for various time points. Both KIM-1 
and Tctex-1 were visualized using immunostaining for Tctex-1 (green) and KIM-1 (red) using 
Alexa-488 and Alex-555 labelled secondary antibodies as indicated in the experimental 
procedures section. Nuclei was counter-stained with DAPI (blue) (600x, bar represents 40μm). 
Further magnification is shown for the phagocytic cup formed by KIM-1 and apoptotic cells (bar 
represents 10 μm). Vertical lines appearing at 90 minutes of apoptotic cells-stimulation are 
suggestive of Tctex-1 trafficking along microtubules as indicated previously (Campbell et al., 
1998). B: Images of colocalization of both KIM-1 and Tctex-1 over the time course of 
phagocytosis were analyzed using Pearson’s coefficient (n=3, **p<0.01, ***p<0.001, one-way 
ANOVA). C: Colocalization of both KIM-1 and Tctex-1 during the course of uptake of apoptotic 
cells was analyzed using the Van Steensel’s  approach, where the cross correlation function 
(CCF) was calculated with a pixel shift of ±20 (n=3, **p<0.01, ***p<0.001 compared to none 
stimulated cells, one-way ANOVA). Quantification of colocalization score was assessed based 
on three random fields per sample and was done in three independent experiments.  
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4.4.3. Inhibition of KIM-1-mediated phagocytosis restores the KIM-1 and Tctex-1 interaction 
during the later stages of phagocytosis  
Previous results showed that the interaction between KIM-1 and Tctex-1 was influenced 
by events occurring at later stages of phagocytosis. Generally, during later stages of the uptake of 
apoptotic cells, local remodeling of the underlying actin cytoskeleton and microtubule network 
was shown to be crucial for corpse uptake (Freeman et al., 2014; Harrison et al., 2002; Toda et al., 
2012). To determine the importance of actin and microtubule stability during KIM-1-mediated 
phagocytosis, we pretreated 769-P cells with cytochalasin D and nocodazole, inhibitors of actin 
filament polymerization and microtubule formation, respectively. These 769-P cells were 
subsequently fed fluorescently-labelled apoptotic cells and the level of uptake was determined by 
flow cytometry. As expected, there was a significant reduction in the level of the uptake of 
apoptotic cells compared to the no treatment control cells (Figure 4.3A). In order to determine 
whether actin and microtubule changes during phagocytosis contributed to the loss of KIM-1 and 
Tctex-1 interaction at later stages of phagocytosis, we performed co-IP following pretreatment 
with either vehicle, nocodazole or cytochalasin D and stimulated with apoptotic cells for 90 
minutes. We observed a restoration of the interaction between KIM-1 and Tctex-1 following 
cytochalasin D and nocodazole treatment, which occurred at a similar level to non-stimulated cells 
(Figure 4.3B, C). Altogether, these results suggest that the inhibition of phagocytosis by disrupting 
the actin network or microtubule cytoskeleton would strengthen the interaction between KIM-1 
and Tctex-1.  Thus, this disruption of the KIM-1 and Tctex-1 interaction requires phagocytosis to 
proceed. 
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Figure 4.3. Inhibition of actin and microtubule dynamics restores the interaction between 
Tctex-1 and KIM-1 following apoptotic cell uptake. 
A: 769-P cells were treated with vehicle (DMSO), nocodazole (10 µM) or cytochalasin D (1 µM) 
prior to adding fluorescently labelled apoptotic cells (pHrodo red) for 90 minutes (ACs 90). The 
percentage of uptake of the apoptotic cells as indicated by high pHrodo red fluorescence was 
measured by flow cytometry (n=3, ***p<0.001, unpaired t-test). B: Cells in A were either 
unstimulated or stimulated with apoptotic cells for 90 minutes and used for immunoprecipitation 
(IP) using KIM-1 antibody as described in the experimental procedures section. All samples 
were analyzed by SDS-PAGE followed by immunoblotting with antibodies against KIM-1, 
Tctex-1 and actin. The input lane represents 5 % of the lysate. C: Level of Tctex-1 bound to 
KIM-1 following different treatments was determined based on densitometric values obtained 
from three independent Western blotting experiments (n=3, *p<0.05, unpaired t-test).  
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4.4.4. Phosphomimetic mutant of Tctex-1 fails to interact with KIM-1, but does not affect 
KIM-1-mediated phagocytosis  
Tctex-1 partakes in dynein dependent and independent functions, where the 
phosphorylation of Tctex-1 at Threonine-94 (Thr-94) has been shown to be a crucial step in the 
dissociation of Tctex-1 from the dynein light chain and consequently the microtubules (Chuang et 
al., 2005; Song et al., 2007). We sought to determine whether the phosphorylation status of Tctex-
1 and its ability to bind dynein would influence its interaction with KIM-1. HEK-293 cells were 
transfected with KIM-1 and various Tctex-1 constructs. One of these plasmids is the 
phosphomimetic mutant of Tctex-1 (T94E), which fails to be incorporated into the dynein 
complex, resulting in a dynein-free form of Tctex-1 (Chuang et al., 2005). As a control, a construct 
encoding an unphosphorylated mimic of Tctex-1 mutant (T94A) was used, since it has been shown 
to have a similar action to wild type Tctex-1 in its ability to bind to dynein complex, which is the 
opposite effect of T94E. We also compared the effects of these mutants to wild type Tctex-1. We 
then performed co-IP experiments to detect the binding of KIM-1 to the different forms of Tctex-
1 either before or after stimulation with apoptotic cells for 90 minutes. The phosphomimetic 
mutant of Tctex-1 (T94E) showed a significant decrease in the interaction with KIM-1 regardless 
of whether the cells were stimulated with apoptotic cells or not (Figure 4.4A and B). On the other 
hand, both wild type and unphosphorylated mimic mutant (T94A) forms of Tctex-1 bound KIM-
1 and showed no significant difference in their ability to interact with KIM-1. Next, we tested 
whether the phosphorylation status of Tctex-1 would have an effect on KIM-1-mediated 
phagocytosis. Following transfection of HEK-293 cells with KIM-1 and each individual Tctex-1 
construct, cells were fed fluorescently-labelled apoptotic cells for 90 minutes and phagocytic 
ability was measured by flow cytometry (Figure 4.4C). Remarkably, no significant differences in 
phagocytic ability were seen between KIM-1-expressing HEK-293 cells that were transfected with 
either wild type, unphosphorylated mimic of Tctex-1 mutant (T94A) or the phosphomimetic 
mutant of Tctex-1 (T94E) (Figure 4.4D). Altogether, these results argued that the phosphorylation 
of Tctex-1 at Threonine-94 had an effect on the interaction between KIM-1 and Tctex-1, but do 
not impact KIM-1-mediated phagocytosis.  
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Figure 4.4. Phosphomimetic mutant of Tctex-1 exhibits a reduced binding to KIM-1, but 
does not influence KIM-1-mediated phagocytosis.  
A: HEK-293 cells were co-transfected with GFP-labelled KIM-1 and either control vector 
encoding flag-tag, wild type flag-tagged Tctex-1 (Tctex-1-WT), unphosphorylataed mimic of 
flag-tagged Tctex-1 (Tctex-1-T94A) or phosphomimetic mutant of flag-tagged Tctex-1 (Tctex-1-
T94E). Cells were either unstimulated or stimulated with apoptotic cells for 90 minutes (ACs 90) 
and extracts were used for co-immunoprecipitation using KIM-1 antibody as described in the 
experimental procedures section. All samples were analyzed by immunoblotting with antibodies 
against KIM-1, Tctex-1 and actin. The input lane represents 5 % of the lysate. B: The level of 
Tctex-1 bound to KIM-1 was determined based on densitometric values acquired from Western 
blotting (n=3, *p<0.05, **p<0.01, unpaired t-test). C: Cells in A were fed apoptotic cells that 
were fluorescently labelled with pHrodo red for 90 minutes and the percent of uptake of 
apoptotic cells was determined by flow cytometry as shown in pHrodo red Vs. side scatter (SSC) 
plot. D: The percentage of phagocytosis was determined based on high pHrodo red fluorescence 
as measured by flow cytometry (n=4, not significant data, unpaired t-test).  
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4.4.5. Tctex-1 mediates phagocytosis by KIM-1  
The above data characterized the interaction between KIM-1 and Tctex-1 during 
phagocytosis, but did not identify whether Tctex-1 was required for phagocytosis of apoptotic 
cells. To test this, we silenced Tctex-1 using siRNA in 769-P cells (Figure 4.5A) and carried out 
phagocytosis assays. When we compared the phagocytic capacity between cells left untransfected 
or transfected with control siRNA to the Tctex-1 siRNA treated cells, Tctex-1-silenced cells 
exhibited a significant decrease in the level of uptake of apoptotic cells following 90 minutes of 
incubation with apoptotic cells (Figure 4.5B and C). Since Tctex-1 had been shown to play a role 
in cellular cargo trafficking through its dynein-dependent function (Mueller et al., 2002; Palmer 
et al., 2011; Tai et al., 1999), we wondered whether silencing Tctex-1 inhibited phagocytosis as a 
result of decreased trafficking of KIM-1 to the cell-surface. To this end, we measured KIM-1 
surface expression in 769-P cells transfected with Tctex-1 siRNA and compared it to cells 
transfected with control siRNA (Figure 4.5D). Importantly, we did not observe any significant 
difference in KIM-1 surface expression between 769-P cells treated with Tctex-1 siRNA or control 
siRNA (Figure 4.5E). The above data suggested that Tctex-1 plays an important positive role in 
KIM-1-mediated phagocytosis independent of affecting surface expression of KIM-1.  
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Figure 4.5. Tctex-1 expression in required for phagocytosis by KIM-1, but does not affect 
its surface expression. 
A: 769-P cells were left untransfected or transfected with either control siRNA or Tctex-1 siRNA 
for 24 hours. Cells were lysed and protein levels of Tctex-1, KIM-1, and actin were determined 
by immunoblotting. B: Cells in A and cells treated with transfection reagent only were fed 
fluorescently labelled apoptotic cells (pHrodo red) for 90 minutes. The percent of uptake of 
apoptotic cells was determined by flow cytometry as shown in the plots of side-scatter (SSC) vs. 
pHrodo red (apoptotic cells). C: The percentage of phagocytosis by cells in B was measured by 
flow cytometry and shown as representation of five independent experiments (n=5, *p<0.05, 
**p<0.01, unpaired t-test). D: Cells in A were stained for surface KIM-1 using PE-conjugated 
anti-KIM-1 antibody and its isotype control, without permeabilization, and the level of KIM-1-
surface expression was determined by flow cytometry. E: Representative graph of the mean 
fluorescence intensity (MFI) of the flow cytometry data from D was shown as representative of 
four independent experiments (n=4, ns= not significant, unpaired t-test).   
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Since Tctex-1 had been previously shown to play a pivotal role in regulating the actin 
cytoskeleton in neuronal cells, we assessed whether silencing Tctex-1 would have any effect on 
actin cytoskeleton remodeling that happens during KIM-1-mediated phagocytosis. To this end, we 
silenced Tctex-1 expression with siRNA, stained the cells with rhodamine phalloidin to detect F-
actin and took confocal microscopy images to look for cytoskeletal changes. The majority of cells 
transfected with Tctex-1 siRNA exhibited highly disorganized actin fibers with poorly bundled 
filaments in the center of the cells as compared to untreated cells or cells transfected with control 
siRNA (Figure 4.6A). The phenotype of Tctex-1-silenced cells did not change following apoptotic 
cell uptake (Figure 4.6B). To test the responsiveness of these cells to actin reorganization stimulus, 
we treated 769-P with 10 nM thrombin and found a striking reorganization of F-actin and an 
increase in fluorescence intensity, as previously shown (Tai et al., 1999) (Figure 4.6C). All in all, 
this suggest that Tctex-1 might play an important role in KIM-1-mediated phagocytosis potentially 
though its ability to modulate actin cytoskeleton.  
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Figure 4.6. Silencing Tctex-1 induces changes in the actin cytoskeleton that persist after 
stimulation with apoptotic cells 
A: 769-P cells were transfected with either transfection reagent alone, control siRNA or Tctex-1 
siRNA for 24 hours. Cells were fixed and stained for F-actin using rhodamine phalloidin (red) 
and immunostained for intracellular Tctex-1 using Tctex-1 antibody and secondary Alexa-488 
antibody (green), as described in the experimental procedures section. Nuclei was counter-
stained with DAPI (blue) (600x, bar represents 40 μm). B: Cells in A were fed apoptotic cells 
(blue) for 90 minutes and actin and Tctex-1 staining was performed to detect any F-actin changes 
following addition of apoptotic cells. C: As a control, 769-P cells were stimulated with thrombin 
(10 nM) and actin staining was done to confirm the cells’ responsiveness to an unrelated 
stimulus (thrombin).  
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4.4.6. Tctex-1 modulates the actin cytoskeleton through a RhoGTPase-independent pathway 
during KIM-1-mediated uptake of apoptotic cells  
Based on the above experiments, it became obvious that cells transfected with siRNA 
targeting Tctex-1 showed a decrease in apoptotic cell uptake and had consistently less actin 
structures, similar to what was previously reported (Meiri et al., 2012). Tctex-1 has been shown 
previously to modulate the actin cytoskeleton through activation of Rac1 (Albert et al., 2000; 
Campbell et al., 1998; Chuang et al., 2005) and RhoA (Conde et al., 2010; McIntire et al., 2001; 
Meiri et al., 2009). In term of phagocytosis, it is well established that these Rho GTPases play 
important roles in actin cytoskeleton organization (Ridley, 2001; Ridley et al., 1992). RhoA and 
Rac1 have been proposed to have opposing effects on the actin cytoskeleton (Hall et al., 2000; 
Meyer et al., 2003; Mueller et al., 2002; Nakaya et al., 2006). In Chapter 3, we showed that 
inhibition of RhoA significantly increased KIM-1-dependent uptake of apoptotic cells (Figure 
3.5A and B). On the other hand, Rac1 was found to have a positive role in KIM-1-mediated 
phagocytosis (Figure 3.7A and B). With this in mind, the level of Rac1 activity was measured 
following 769-P cell incubation with apoptotic cells over the course of phagocytosis (0-90 
minutes). Surprisingly, Rac1 activity seemed to increase minimally during uptake of apoptotic 
cells (Figure 4.7A). To test whether Tctex-1 silencing modified the actin cytoskeleton via Rac1, 
we measured Rac1 activation of 769-P cells with Tctex-1 siRNA or control siRNA following 
stimulation with apoptotic cells. The level of Rac1 activation was not significantly altered 
following silencing of Tctex-1 during the course of apoptotic cell engulfment (Figure 4.7B). To 
test the role of RhoA, we first measured the level of active RhoA during KIM-1-mediated 
phagocytosis. We found a steady increase in the level of active RhoA during the uptake process of 
apoptotic cells by 769-P cells (Figure 4.7C). This result was consistent with our previous data 
measuring the level of active RhoA during uptake of apoptotic cells in HEK-293 cells expressing 
human KIM-1 (Figure 3.6 A). Moreover, upon silencing of Tctex-1 in 769-P cells, we did not 
observe any change in level of active RhoA when compared to control siRNA-transfected cells 
(Figure 4.7D).  
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Figure 4.7. Tctex-1 regulates the actin cytoskeleton independent of Rho GTPases in KIM-1-
mediated phagocytosis. 
A: 769-P cells were fed apoptotic cells for various time periods (15-90 minutes) and the level of 
Rac1 activation was measured by G-LISA Rac1 activation kit (Cytoskeleton, Denver, CO).  
(n=4, all not significant, one-way ANOVA). B: 769-P cells were transfected with either control 
siRNA or Tctex-1 siRNA for 24 hours. These cells were fed apoptotic cells for various time 
periods and the level of Rac1 activation was graphed (n=5, all not significant, unpaired t-test). 
Treatment of 769-P cells transfected with control siRNA with 5 % serum after serum starvation 
overnight served as a positive control for Rac1 activation (Curtiss et al., 2011). C: 769-P cells 
fed apoptotic cells (15-90 minutes) were subjected to active RhoA and total RhoA assay 
measurements as determined by the active G-LISA RhoA activation assay and the total RhoA 
ELISA kit (Cytoskeleton, Denver, CO), respectively. Normalization of active RhoA was done 
according to manufacturer’s recommendation and was graphed to represent data (n=3, all not 
significant, one-way ANOVA). D: 769-P cells were transfected with either control siRNA or 
Tctex-1 siRNA for 24 hours. These cells were fed apoptotic cells for various time periods 
(minutes) and the level of normalized active RhoA was determined as in C. Cells treated with 10 
µM Nocodazole for 15 minutes served as a positive control for RhoA activation (Martin et al., 
2001) (n=3, all not significant, unpaired t-test).  
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4.5. DISCUSSION 
KIM-1 is a phosphatidylserine receptor that is specifically upregulated by tubular epithelial 
cells (TECs) during ischemic or toxic AKI and enables TECs to clear apoptotic and necrotic cell 
debris (Ichimura et al., 2008; Ichimura et al., 2004). In the previous chapter, we showed that TECs 
require KIM-1 expression to mediate the clearance of apoptotic cells. This necessitated an 
understanding of the intracellular signalling pathway(s) downstream of KIM-1. Here we identify 
a novel functional interaction between the actin cytoskeleton regulatory protein Tctex-1 (Chuang 
et al., 2005; Meiri et al., 2012) and KIM-1. We have shown that the interaction between KIM-1 
and Tctex-1 is a dynamic process that appears to dissipate during the later stages of apoptotic cell 
engulfment. Inhibition of phagocytosis by inhibiting actin and microtubule polymerization also 
restored KIM-1 binding to Tctex-1 during the later stages of phagocytosis. Furthermore, we have 
shown that phosphorylation of Tctex-1 at Threonine-94 diminishes interaction between KIM-1 
and Tctex-1 regardless of whether apoptotic cells were added or not. Using siRNA against Tctex-
1, we uncovered a novel positive role of Tctex-1 in KIM-1-mediated phagocytosis. Finally, we 
found that Tctex-1 probably mediates KIM-1 function through a non-canonical pathway that is 
independent of Rho GTPases.  
The loss of interaction between KIM-1 and Tctex-1 during the later stages of phagocytosis 
is still a puzzling observation, which may suggest a role for Tctex-1 in corpse engulfment. 
Recently, it was reported that TIM-1 (or KIM-1) undergoes dynamic cycling through clathrin-
dependent vesicles to mediate the lysosomal degradation of NUR77 (Balasubramanian, et al., 
2012), a nuclear receptor implicated in apoptosis and cell survival (Machacek et al., 2009). 
Throughout our experiments, we did not find any evidence of Tctex-1 degradation during the entire 
period of phagocytosis (90 minutes) as determined by Western blot. Given what is known about 
Tctex-1 in the trafficking of various cell-surface receptors (Machado et al., 2003; Mueller et al., 
2002; Tai et al., 1998), it was surprising that Tctex-1 did not regulate KIM-1 trafficking to the 
cell-surface.  
The phosphorylation of Tctex-1 at Threonine-94 has been shown to promote Tctex-1 
dissociation from the dynein light chain complex which is required to promote dynein-independent 
functions (Chuang et al., 2005; Li et al., 2011). For example, phosphorylation of Tctex-1 has been 
linked to enhanced neurite outgrowth activity (Chuang et al., 2005), such as cilliary disassembly, 
leading to cell cycle progression and S-phase entry for neural progenitor cells (Li et al., 2011). The 
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perplexing data with regards to the lack of an effect of phosphomimetic mutant of Tctex-1 (T94E) 
on phagocytosis is likely reflective of the persistent expression of a low level wild type endogenous 
Tctex-1, which confounded the data. This can be tested by simultaneously silencing endogenous 
Tctex-1 with siRNA and then transfecting the mutant form Tctex-1 as described by others (Meiri 
et al., 2012).  
Cytoplasmic Tctex-1 has been shown to regulate microtubules and the actin cytoskeleton 
through activation of Rac1 and RhoA, respectively (Chuang et al., 2005; Meiri et al., 2012). 
Recently, it was shown that Tctex-1 sequesters a key Rho guanine exchange factor, GEF-H1 and 
tethers it to microtubules allowing Rac1 to execute its function unopposed by RhoA (McIntire et 
al., 2001; Meiri et al., 2012). Upon activation, Tctex-1 was shown to release GEF-H1 tethered to 
microtubules, allowing it to then activate RhoA by promoting GDP exchange for GTP. Because 
we previously demonstrated that Rac1 is required for KIM-1-dependent phagocytosis, we tested 
whether Tctex-1 relay its signalling through Rac1 in KIM-1-expressing cells. We failed to see any 
difference in the level of Rac1 activation upon stimulation with apoptotic cells or when Tctex-1 
expression was silenced. Thus, we propose that Rac1 is involved in phagocytosis independently 
of Tctex-1. Furthermore, our preliminary data failing to show RhoA activation downstream of 
Tctex-1 suggests that RhoA is not involved in mediating Tctex-1 signalling during KIM-1-
mediated phagocytosis. Moreover, we propose that other GTPases (e.g. cdc42) or non-GTPase 
pathways might be involved in KIM-1-mediated phagocytosis downstream of Tctex-1 (Conde et 
al., 2010). Taking this into consideration, we could envision that dynein-independent Tctex-1 (or 
phosphorylated Tctex-1) might have a role in these KIM-1-expressing cells.  
To our knowledge, this is the first study that has explored a physiological function for 
Tctex-1 in kidney cells, and moreover in phagocytosis. The logical next step would be to determine 
if Tctex-1 has any role in AKI or repair. Given that Tctex-1 has been shown to be involved in 
regulating cilium resorption during neurogenesis (Li et al., 2011), a potential mechanism for 
involvement in AKI might be through regulation of the cilium of renal TECs, which act as flow 
sensors (Kotsis et al., 2007). In fact, a number of human renal syndromes, including polycystic 
kidney disease, Bardet-Biedl syndrome and nephronophthisis (Balasubramanian et al., 2012), have 
been shown to involve dysfunctional cilia, a microtubule-based organelle. Interestingly, KIM-1 is 
expressed on TECs during cyst development in a mouse model for autosomal dominant polycystic 
kidney disease (Kuehn et al., 2002), and was later implicated in cilliary calcium signalling via its 
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interaction with the cilliary protein, polycystin 2 (TRPP2) (Kotsis et al., 2007; Kuehn et al., 2007). 
Our present work linking Tctex-1 to KIM-1-mediated phagocytosis by TECs for the first time is 
likely to lead to new avenues of research into the role of Tctex-1 in AKI and other chronic kidney 
diseases.  
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5.1. SUMMARY AND GENERAL DISCUSSION  
AKI is a clinically important disorder that is most commonly caused by an ischemic or 
toxic insult to the kidney (Bellomo et al., 2004; Bonventre et al., 2011; Lattanzio et al., 2009; 
Mehta et al., 2007). The pathophysiology of ischemic AKI is highly complicated, involving 
multiple processes including inflammation, tubular injury and vascular damage (Bonventre et al., 
2011; Togel et al., 2014). Renal ischemia reperfusion injury results from the transient cessation of 
blood flow to an organ with immediate oxygen deprivation, followed by restoration of blood flow 
(reperfusion) (Bonventre et al., 2011; Le Dorze et al., 2009). This process leads to generation of 
reactive oxygen species (ROS). ROS are a major contributor to cellular injury (Oliver et al., 1990), 
where they exhibit their pathogenic effects by causing protein oxidation, lipid peroxidation, and 
DNA damage (Bonventre et al., 2011; Devarajan, 2005, 2006; Kaushal et al., 2004). Depending 
on the severity of cellular injury and the resiliency of affected cells, TECs can recover from sub-
lethal injury or undergo apoptosis, necrosis or necroptosis (Linkermann et al., 2013; Vanden 
Berghe et al., 2014). The failure to clear apoptotic cells can result in secondary necrosis, triggering 
further inflammation and secondary tissue damage (Balasubramanian et al., 2012; Bonventre et 
al., 2011; Devarajan, 2006; Yang et al., 2015). KIM-1 was identified as a non-myeloid 
phosphatidylserine receptor that is expressed on injured renal proximal TECs that enables them to 
clear apoptotic and necrotic cells (Ichimura et al., 2008). The aim of this thesis was to better 
understand the physiological function of KIM-1 in AKI in vivo and to uncover how KIM-1 
mediates direct signalling to enable phagocytosis by TECs. To this end, we identified two novel 
KIM-1 interacting proteins, the alpha subunit of the heterotrimeric G12 protein (Gα12), and the 
dynein light chain protein Tctex-1, and characterized their respective roles in phagocytosis by 
TECs. 
In Chapter 2, we discovered that the cytosolic domain of KIM-1 interacts with Gα12 to 
block its activation by blocking exchange of GDP for GTP. Previously, Yu et al., demonstrated 
that Gα12 is activated by ROS during IRI and that this promoted the disruption of junctional 
complexes via Src activation, thereby intensifying renal tissue damage (Yu et al., 2012). This led 
us to uncover that TECs and kidneys from Kim-1-deficient mice exhibit exaggerated renal Gα12 
and Src activation following exposure to hydrogen peroxide, a situation that mimics renal IRI in 
vitro. This resulted in worse renal dysfunction and kidney damage in Kim-1-deficient mice 
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subjected to renal insult compared to wild type mice. Taken together, our findings in Chapter 2 
suggest that KIM-1 protects against Gα12-mediated tissue damage during ischemic AKI.  
Shortly after our findings were published, Yang et al., (2015) published that transgenic 
mice expressing a mucin-domain mutant KIM-1 (Kim-1Δmucin), which is unable to recognize 
apoptotic cells, are unable to down regulate innate immune responses and failed to protect mice 
from ischemic or toxin (cisplatin) induced AKI (Yang et al., 2015). This group proposed two 
mechanisms to explain how KIM-1 was protective in AKI: (1) via phagocytic clearance of 
apoptotic debris by KIM-1-expressing tubular cells and prevention of tubular obstruction; (2) via 
down-regulation of proinflammatory NF-кB signalling in tubular cells by phosphorylated KIM-1 
upon recognition of apoptotic bodies. An important distinction between our Kim-1 knockout and 
the Kim-1Δmucin mice is that Kim-1Δmucin mice still express a full-length Kim-1 including its 
cytosolic domain (albeit lacking a portion of the mucin domain) at levels of expression comparable 
to wild type Kim-1 in the injured kidney (Yang et al., 2015), whereas our mice completely lack 
the expression of Kim-1 (Wang et al., 2010; Ismail et al., 2015). Also, while Yang et al., (2015) 
found that tubular epithelial cells isolated from the Kim-1Δmucin mutant mice had decreased ability 
to clear apoptotic cells (Yang et al., 2015), tubular cells from our Kim-1-deficient mice exhibited 
a near complete defect in the clearance of apoptotic cells (Ismail et al., 2015), likely reflecting a 
complete absence of the protein. As the interaction of Gα12 with Kim-1 occurs independent of 
apoptotic cell recognition and via the cytosolic domain, it is more than likely that the TECs from 
the Kim-1Δmucin mutant mice have intact Gα12-inhibitor capacity during renal IRI. However, this 
needs to be confirmed. We propose that the more severe phenotype of the Kim-1 deficient mice 
during IRI is explained by deficiencies in phagocytosis, and aberrant NF-кB and Gα12 signalling. 
All in all, our findings support the growing notion that KIM-1 is protective during ischemic AKI.  
 In Chapter 3, we investigated the role of Gα12 in KIM-1-mediated phagocytic signalling. 
We found that KIM-1 interacts with Gα12 and suppresses its activation to permit phagocytosis. 
Gα12 inhibition is required for efficient phagocytosis because it negatively regulates the 
phagocytic process via its known downstream mediator, RhoA. We also discovered opposing roles 
of RhoA and Rac1 during KIM-1-dependent uptake of apoptotic cells. Whereas RhoA seems to 
have an inhibitory role, Rac1 seems to have a stimulatory role on phagocytosis. This has also been 
shown to be the case in various professional phagocytes (Caron et al., 1998; Chimini et al., 2000). 
Our work is the first to demonstrate a role of Gα12 in phagocytosis and in KIM-1 signaling during 
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acute injury. Since KIM-1 expression is absolutely required for uptake of apoptotic cells by 
primary TECs, our findings have broad implications for understanding tubular cell behaviour after 
AKI.  
Taken together, our findings in both Chapter 2 and 3 suggest that KIM-1 upregulation on 
TECs protects the kidney from ischemic AKI by at least two distinct mechanisms that involve 
inhibition of Gα12. First, KIM-1 blocks ROS-mediated activation of damaging Gα12 signalling 
via Src kinase, which may also enhance renal recovery after tissue damage as seen in Gα12 mice 
(Yu et al., 2012). Second, KIM-1-suppression of Gα12 is required for efficient phagocytosis by 
tubular cells to clear cellular debris and mitigate inflammation (Yang et al., 2015). These findings 
are consistent with the previously proposed role for KIM-1 as a regulator of immune function 
(Freeman et al., 2010) that is upregulated during ischemic or toxin induced AKI (Ichimura et al., 
2008; Ichimura et al., 2012). Our findings offer new insights into the down-stream signalling that 
takes place in tubular cells during ischemia-reperfusion injury.  
Gα12 has been shown to a play a direct role in tight junction complex disassembly and 
thereby contributes to paracellular permeability of polarized epithelial cells (Meyer et al., 2003; 
Meyer et al., 2002; Sabath et al., 2008). Once activated, Gα12 interacts with the heat shock protein 
(HSP) 90 chaperone to bring about phosphorylation and activation of Src kinase (Sabath et al., 
2008). Phosphorylation of scaffolding proteins, such as zona occludens-1(ZO-1), by activated Src 
is ultimately what leads to destabilization of tight junction complexes (Meyer et al., 2003; Meyer 
et al., 2002). Aberrant epithelial tight junction function occurs in several kidney diseases 
(Balasubramanian et al., 2012), including ischemia-reperfusion injury (Balasubramanian et al., 
2012; Yu et al., 2012). During AKI, a leaky epithelium permits the backleak of filtered or secreted 
electrolytes and waste products back into the circulation. 
The importance of phagocytic clearance of apoptotic cells by TECs during AKI is now 
becoming more clear (Ismail et al., 2015; Yang et al. 2015) and we are beginning to realize the 
full impact of aberrant Gα12 signalling during ischemic AKI, and the importance of KIM-1 in 
limiting this process (Ismail et al., 2015). While Denker and colleagues have suggested that the 
harmful effect of ROS generated during renal IRI is at least in part mediated by activated Gα12 
(Yu et al., 2012), the mechanism of tissue damage caused by exaggerated Gα12 signalling is less 
clear. Yu et al. have suggested that aberrant Gα12 activation leads to impaired renal function and 
tissue damage during IRI as a result of Gα12 downstream effects on the disassembly and improper 
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reassembly of tight junction complexes (Figure 5.1A and B), the latter of which can impair renal 
recovery (Yu et al., 2012). Whether these tight junction abnormalities affect phagocytic clearance 
of apoptotic cells by TECs is not known, but recent findings by Fornetti et al. suggest that this 
might be the case (Fornetti et al., 2015). Whether KIM-1 protects from tissue damage by indirectly 
blocking the disruption of tight junctions by activated Gα12 remains to be tested.   
In addition to its role in deregulating tight junction proteins, activated Gα12 is also a potent 
activator of RhoA signalling (Figure 5.1B) (Buhl et al., 1995). Aberrant Rho signalling has been 
shown to be detrimental in AKI, and treatment with Rho kinase inhibitors can attenuate renal 
ischemia-reperfusion injury (Prakash et al., 2008). The detrimental effects of activated Gα12 
during AKI may be in part be caused by its effects on the actin cytoskeletal reorganization 
(Molitoris, 2004). Indeed, cytoskeletal dysregulation is a hallmark of AKI (J. V. Bonventre et al., 
2011). Our work shows that following IRI, KIM-1 upregulation on TECs allows for the 
suppression of Gα12 activation which inhibits Src and RhoA activation (Figure 5.1C). While 
Denker and colleagues showed that the Gα12 effects on tight junction disassembly was not 
mediated by RhoA (Yu et al., 2012), our work highlights the importance of inhibiting RhoA in 
phagocytosis (Figure 5.1D). Given that phagocytic clearance of apoptotic cells plays a crucial 
protective role in renal injury and repair during AKI (Ichimura et al., 2008; Yang et al., 2015, 
Ismail et al., 2015) and that activated Gα12 inhibits this process, uncovering the detailed 
mechanism of Gα12-inhibition of phagocytosis (i.e. via tight junctions) may help identify novel 
therapeutic strategies for AKI. 
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Figure 5.1. Working model for the KIM-1 and Gα12 signalling pathway in tubular 
epithelial cells during ischemia-reperfusion injury and phagocytosis. 
A: In healthy tubular epithelial cells (TECs), Gα12 is inactive and tethered to the cell inner 
membrane surface through its association with the Gβγ subunit of the heterotrimeric G protein 
family. This prevents any activation of down-stream signal mediators, such as RhoA and Src. B: 
Reactive oxygen species (ROS) are rapidly generated during ischemia-reperfusion injury and 
lead to activation of Gα12 signalling. Activated Gα12 can trigger Src activation via Src 
phosphorylation, which then subsequently leads to disassembly of tight junction complexes. 
Active Gα12 could also activate RhoA (Prakash et al., 2008), which play a negative role in the 
uptake of apoptotic cells by TECs. C: With prolonged ischemia-reperfusion injury, KIM-1 is 
gradually upregulated on TECs and this lead to suppression of Gα12 activity. Suppression of 
Gα12 activity results in decreased Src activation and stops the disruption of tight junction 
complexes. KIM-1-mediated suppression of Gα12 also influences RhoA activation. D: Cells that 
succumb to the injury undergo apoptosis and expose phosphatidylserine (PS) on their cell-
surface. PS on apoptotic cells is recognized by KIM-1 on TECs, which then rapidly engulf the 
apoptotic cells to prevent secondary necrosis. The persistent suppression of Gα12 activation in 
TECs and subsequent inhibition of RhoA stimulation is required to promote the efficient 
clearance of apoptotic cells. Solid lines are based on evidence presented throughout this thesis. 
Dotted lines represent hypothetical or predicted events based on our data and published results 
from other studies not related to KIM-1.  
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In Chapter 4, we explored the role of Tctex-1, yet another novel KIM-1-interacting protein, 
which was identified in a yeast-two hybrid screen. We showed that KIM-1 interacts with Tctex-1 
under normal baseline conditions in TECs, but that interaction decreases during the uptake of 
apoptotic cells, especially at the later stages of phagocytosis (Figure 4.1 and 4.2). Silencing Tctex-
1 expression impaired the uptake of apoptotic cells by TECs (Figure 4.5). In addition, we showed 
that phosphorylation of Tctex-1 at Threonine-94, which prevents Tctex-1 from binding to 
microtubules via dynein, reduced its interaction with KIM-1 (Figure 4.4). The exact mechanisms 
of how Tctex-1 regulates KIM-1-dependent phagocytosis is currently under investigation. 
Our identification of Gα12 and Tctex-1 as KIM-1-binding proteins involved in 
phagocytosis using entirely different approaches (mass spectrometry and yeast two-hybrid), could 
suggest a possible cooperation between these proteins in mediating changes in cell behaviour 
required for phagocytosis (e.g. cytoskeletal reorganization). Interestingly, a link between Gα12 
and Tctex-1 has been proposed by Takesono et al., (1999), who were the first to show that Tctex-
1 works as an activator of G-protein signalling (AGS), independent of G-protein coupled receptors 
(Takesono et al., 1999). Tctex-1 was shown to carry out this function by binding to the Gβγ subunit 
of heterotrimeric G protein in order to free the alpha subunit. This leads to Gα activation and 
neurite outgrowth in neurons (Sachdev et al., 2007).  
Recent work by the Rottapel group in Toronto has eluded to a possible mechanism for this 
interaction by showing that Tctex-1 interacts with a microtubule-associated guanine nucleotide 
exchange factor, GEF-H1 (or Lfc in mice), along with dynein intermediate chain (DIC) (Conde et 
al., 2010; Meiri et al., 2009; Meiri et al., 2012; Ren et al., 1999). Given that GEF-H1 is an 
important protein that couples microtubules and actin together, Tctex-1 was shown to tether GEF-
H1 to microtubules, inhibiting its action on actin filament organization via RhoA (Meiri et al., 
2012). Even more recently, the Rottapel group demonstrated that both the Gβγ and Gα subunits of 
the heterotrimeric G12 protein work together to activate or suppress GEF-H1 activity (Meiri et al., 
2014). This happens through the interaction of the Gβγ subunit with Tctex-1, which releases GEF-
H1 from the microtubule complex with dynein. This release allows GEF-H1 to interact with Gα12 
to mediate actin cytoskeletal changes, such as stress fiber formation and focal adhesion assembly 
via RhoA (Meiri et al., 2014).  
Based on the above information, we hypothesize that the interaction of both Gα12 and 
Tctex-1 with KIM-1 might serve to simultaneously modulate changes in actin and microtubule 
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structures during phagocytosis. We speculate that the interaction of KIM-1 with Tctex-1 tethers it 
via the dynein complex (along with GEF-H1) to the microtubule cytoskeleton, which has been 
shown to be important for phagocytosis (Blocker et al., 1997; Blocker et al., 1996; Harrison et al., 
2002; Newman et al., 1991) (Figure 5.2A). Following from this, upon KIM-1 binding to apoptotic 
cells, KIM-1 maintains its interaction with Tctex-1, which in turn is still tethered to microtubules 
along with GEF-H1 and dynein intermediate chain proteins, to help bring the apoptotic cell cargo 
to the phagosome (Figure 5.2B). The continued interaction with Tctex-1 and GEF-H1 would 
inhibit the activation of RhoA, which we found impedes corpse uptake. Simultaneously, KIM-1 
would continue to interact with and suppresses Gα12 to mediate the uptake of apoptotic cells. 
During later stages of phagocytosis, the loss of interaction between Kim-1 and Tctex-1 (potentially 
via Tctex-1 phosphorylation at Threonine-94) would then allow GEF-H1 to be released and to 
interact with Gα12 (Figure 5.2C). This would cause RhoA activation, which has been shown to 
enable phagosome formation around apoptotic targets (Ravichandran et al., 2007). This 
hypothetical pathway could explain the consistent increase in RhoA activity we observed in our 
studies during the later stages of phagocytosis (Figure 3.6A and Figure 4.7C). Much exciting work 
lies ahead as we pursue testing this model and further study the signalling mechanisms that are 
triggered in TECs by IRI and that regulate phagocytosis.  
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Figure 5.2. Proposed signalling pathways of KIM-1-mediated phagocytosis. 
A: Following injury to tubular epithelial cells (TECs), KIM-1 is expressed on the apical surface 
of TECs. Expression of KIM-1 suppresses Gα12 activation, which leads to the inhibition of 
RhoA activity. Tctex-1 is tethered to microtubules along with GEF-H1 and dynein intermediate 
chain (DIC) and dynein heavy chain (DHC) component of the dynein motor protein. GEF-H1 is 
inactive since it is bound to the Tctex-1-Dynein-Microtubule complex and hence, it further 
inhibits RhoA activity. B: Upon apoptotic cell-binding to KIM-1, KIM-1 still interacts with 
Gα12 and suppresses Gα12 activity. KIM-1 also interacts with Tctex-1 in a manner similar to 
conditions without binding to apoptotic cells. This situation is predicted to last for the first 60 
minutes. C: During the last stages of phagocytosis, when the phagosome is formed, KIM-1 loses 
its interaction with Tctex-1 due to potential phosphorylation of Tctex-1 at Threonine-94. This 
loss of interaction with KIM-1 will potentially cause the disassembly of the Tctex-1-Dynein-
GEF-H1 complex. This will allow GEF-H1 to be released, allowing it to interact with Gα12 and 
mediate the RhoA activation that plays a role in actin cytoskeletal reorganization (Meiri et al., 
2014).  
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5.2. LIMITATIONS  
An important limitation that hindered our Gα12 and KIM-1 studies was the lack of cell 
lines that expressed high levels of endogenous Gα12 and KIM-1. Throughout our experiments in 
Chapters 2 and 3, we used human embryonic kidney 293 (HEK-293) cells that we found to express 
a high level of endogenous Gα12 and which were subsequently made to stably express KIM-1. We 
have confirmed that these cells engulf apoptotic cells in a manner similar to cells expressing 
endogenous KIM-1. In addition, we have confirmed our findings in primary TECs isolated from 
wild type and Kim-1-deficient mice. In Chapter 4, we failed to see differences in the phagocytosis 
in HEK-293 cells transfected with KIM-1 and either one of the different Tctex-1 constructs (wild 
type Tctex-1, phosphomimetic mutant of Tctex-1 (T94E) or unphosphorylated mimic of Tctex-1 
mutant (T94A)) (Figure 4.4.C and D), yet we found a reduced interaction between KIM-1 and the 
phosphomimetic mutant of Tctex-1 (T94E) (Figure 4.4A and B). Since the effects of 
phosphomimetic mutant of Tctex-1 on its interaction with KIM-1 and phagocytosis were 
inconsistent, this challenged our initial hypothesis which suggested that KIM-1-binding to Tctex-
1 served to tether the apoptotic cargo to microtubules via dynein to allow for engulfment. This 
issue raises many questions that need to be addressed in future studies. For example, “What is the 
regulatory mechanism between KIM-1, Tctex-1, dynein and hence microtubules?”, “Does Tctex-
1 modulate KIM-1-mediated phagocytosis through its interaction with dynein/microtubules?”, 
“Does the phosphorylation of Tctex-1 affects its ability to interact with KIM-1 by impairing its 
interaction with dynein?”  
Another limitation we have struggled with is the 60 % homology between the N-terminal 
cysteine-rich region of human KIM-1 and murine Kim-1 (Kuchroo et al., 2003; Santiago et al., 
2007). Even though both human and murine KIM-1 are upregulated after ischemia-reperfusion 
injury (Ichimura et al., 2008; Ichimura et al., 2004), and carry out the same function of uptake of 
dead cells (Ichimura et al., 2008; Kobayashi et al., 2007), there is a marked difference in the length 
of the mucin domain and the number of O-linked glycosylation sites between them (Kuchroo et 
al., 2003). This might explain our inability to perform co-immunoprecipitation of KIM-1 and Gα12 
or Tctex-1 in primary cells using the existing antibodies against mouse Kim-1 which recognize the 
mucin-domain of Kim-1. This limitation might suggest a role for the mucin domain of KIM-1 in 
carrying out its signalling function. 
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5.3. FUTURE RESEARCH  
To date, research in AKI has primarily focused on the mechanism of apoptosis and necrosis 
of TECs caused by the injury (Burns et al., 1998; Daemen et al., 1999; Kelly et al., 2001; Kelly et 
al., 2003; Schumer et al., 1992). The novel findings presented in this thesis highlight a new area 
of research involving the signalling mediators that are involved in phagocytic clearance of 
apoptotic cells during AKI. Recently, a new pathway of regulated necrosis, known as necroptosis, 
has emerged. Necroptosis is a receptor-interacting protein kinase-based necrotic cell death process 
(Linkermann et al., 2012; Tait et al., 2013). Blocking the pathway leading to necroptosis via 
chemical inhibition or knocking out RIPK3 has been shown to have a protective effect in ischemic 
and cisplatin-induced AKI (Linkermann et al., 2013; Tristao et al., 2012; L. Zhang et al., 2013). 
It would be interesting to investigate whether KIM-1 clears necroptotic cells in a similar manner 
to that of apoptotic cells. In addition, newly discovered death pathways, such as mitochondrial 
permeability transition-mediated regulated necrosis (Vanden Berghe et al., 2014) and ferroptosis 
(Dixon et al., 2012; Linkermann et al., 2014), could also play an important role in AKI and thereby 
engage KIM-1 signalling. Furthermore, it would be interesting to determine if the various types of 
dead cells display phosphatidylserine or yet undiscovered “eat me” ligands for KIM-1 that mediate 
clearance of these cells.  
Another aspect of KIM-1 that we did not explore in this thesis work is the fact that upon 
upregulation on TECs, KIM-1 undergoes spontaneous membrane-proximal cleavage leading to the 
release of its soluble extracellular domain (90 kDa) and retention of a membrane-bound fragment 
(14 kDa) on cells (Bailly et al., 2002). The soluble fragment is recognized as a sensitive and 
specific urinary biomarker for AKI (Han et al., 2002; Vaidya et al., 2009; Vaidya et al., 2010). 
KIM-1 membrane-proximal cleavage was shown to be accelerated by pervanadate via activating 
ERK and p38 MAP Kinase (Bailly et al., 2002; Z. Zhang et al., 2007). Recently, our lab showed 
that KIM-1-cleavage is mediated by TNF-α-converting enzyme (TACE or ADAM17) and that this 
cleavage is accelerated by reactive oxygen species generated during injury to renal tubular 
epithelial cells, or by the addition of apoptotic cells (Gandhi et al., 2014). Furthermore, excess 
KIM-1 shedding was shown to bind to apoptotic cells, thus competitively inhibiting phagocytosis 
by KIM-1-expressing TECs. It would be exciting, for example, to engineer a transgenic mouse 
expressing a cleavage-defective KIM-1 mutant to determine whether these mice exhibit different 
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outcomes following ischemic AKI. An equally important question is whether KIM-1 phagocytic 
signalling (i.e. Gα12 and Tctex-1) would be altered by KIM-1 shedding.   
Another area of interest is the multiple serine and tyrosine phosphorylation sites that have 
been described within the intracellular region of KIM-1 (Meyers et al., 2005; Santiago et al., 2007). 
The cytoplasmic tail of human KIM-1 is relatively short and contains two putative tyrosine 
phosphorylation sites, at positions 350 and 356, which play a role in signalling (Binne et al., 2007). 
For example, phosphorylation at Tyrosine-350 was shown to be required for TIM-1 (KIM-1 
expressed on T cells) to mediate co-stimulatory signalling in T cells (de Souza et al., 2005). This 
raises several important questions that need to be answered. For example, “What is the role of 
KIM-1 phosphorylation in ischemia-reperfusion injury or the uptake of apoptotic cells?” “Does 
phosphorylation of KIM-1 influence its interaction with Gα12 or Tctex-1?” “Does the 
phosphorylation allow KIM-1 to suppress pathogenic Gα12 activity?” Using site-directed 
mutagenesis of KIM-1, we could generate KIM-1 mutants where tyrosine residues are substituted 
with phenylalanine, which mimics unphosphorylated tyrosine, or glutamic acid, which some 
consider to mimic phosphorylated tyrosine. Transfecting these mutants into TECs would enable 
us to test KIM-1’s ability to interact with Gα12 or Tctex-1 following additions of pervanadate, a 
protein tyrosine phosphatase inhibitor, which is known to induce KIM-1-phosphorylation (Z. 
Zhang et al., 2007). The studies proposed above will allow us to better understand KIM-1 
signalling in TECs.  
In Chapter 4, we explored another KIM-1-interacting protein, Tctex-1, and its role in 
phagocytosis. Since Tctex-1 is part of the dynein motor protein which is involved in the trafficking 
of proteins via microtubules (King et al., 1996), several questions remained unanswered. For 
example, “What is the regulatory mechanism between KIM-1, Tctex-1, dynein and, hence, 
microtubules?” “Does Tctex-1 modulate KIM-1-mediated phagocytosis through its interaction 
with dynein?” “Does the phosphorylation of Tctex-1 affect its ability to interact with KIM-1 by 
impairing its interaction with dynein?” These questions represent the next steps of this project. 
Given that Tctex-1 has been shown to be involved in regulating the cell cycle in ciliated cells 
(Chuang et al., 2005; Conde et al., 2010; Li et al., 2011), it is exciting to speculate that Tctex-1 is 
involved in the cell cycle progression of KIM-1-expressing cells during renal regeneration after 
AKI. Interestingly, Tctex-1 has shown to play a protective role in hypoxia through its interaction 
with microtubules and voltage-dependent anion-selective channels (VDAC) on mitochondria 
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(Fang et al., 2011; Schwarzer et al., 2002). In this context, silencing Tctex-1 or phosphorylation 
at serine-82 has been shown to exacerbate hypoxia induced mitochondrial damage and the 
disruption of microtubules (Fang et al., 2011; Xu et al., 2013). Due to time constraints, we did not 
explore the role of Tctex-1 in IRI and whether IRI leads to any changes in Tctex-1 expression or 
modification, such as phosphorylation, that might influence its interaction with KIM-1.  
 
5.4. SIGNIFICANCE OF FINDINGS  
This thesis presented several novel signalling pathways through which KIM-1 carries out 
its protective effect during ischemia-reperfusion injury and in the clearance of apoptotic cells. 
Understanding how KIM-1 functions at a mechanistic level to clear dead cells and prevent further 
inflammation may allow us to identify novel therapeutic strategies to enhance its protective effects 
in AKI. AKI remains a serious and common medical complication in hospitalized patients for 
which there are no effective therapies (Bock, 1997; Lopes et al., 2010; Togel et al., 2014). 
Incomplete recovery from AKI has been shown to lead to chronic kidney disease (CKD) or fibrosis 
(Hsu, 2012; Wald et al., 2009). Both AKI and CKD have been associated with an increased risk 
of death and may result in complications, such as cardiovascular disease, diminished quality of 
life, and the development of end-stage renal disease (Chawla et al., 2014; Venkatachalam et al., 
2015). Understanding the signalling mechanisms of protection from AKI by KIM-1 might help 
elucidate important steps leading to enhanced recovery from AKI, as well as preventing 
subsequent progression to CKD or fibrosis. Moreover, given the scarcity of mechanistic data 
regarding phagocytic mechanisms in non-professional phagocytes, our work contributes 
significantly to advance knowledge in this growing field. 
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